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Checklists and Illustrative Financial Statements for Life and Health Insurance Entities

1

FSP Section 20,000
Checklists and Illustrative Financial
Statements for Life and Health
Insurance Entities
.01 The checklists and illustrative financial statements in this section have been developed by the AICPA
Accounting and Auditing Publications Team to serve as nonauthoritative practice aids for use by preparers
and auditors of financial statements. They have not been reviewed, approved, disapproved, or otherwise
acted on by any senior technical committee of the AICPA and do not represent official positions or
pronouncements of the AICPA. Readers should be aware of the following:

• The checklists and illustrative financial statements do not include all disclosures and presentation
items promulgated; as a result, pronouncements deemed unlikely to be encountered in financial
statements of life insurance companies are not included.

• The checklists and illustrative financial statements are “tools” and in no way represent official
positions or pronouncements of the AICPA.
The checklists have been updated to include relevant reporting and disclosure guidance issued
through the following pronouncements:

• Financial Accounting Standards Board (FASB) Statement of Financial Accounting

Standards (SFAS) No. 159, The Fair Value Option for Financial Assets and Financial
Liabilities—Including an amendment of FASB Statement No. 115

• FASB Interpretation No. (FIN) 48, Accounting for Uncertainty in Income Taxes—an
interpretation of FASB Statement No. 109

• FASB Technical Bulletin (TB) No. 01-1, Effective Date for Certain Financial Institutions of
Certain Provisions of Statement 140 Related to the Isolation of Transferred Financial Assets

• FASB Emerging Issues Task Force (EITF) consensuses adopted through December 2007
meeting

• FASB Staff Positions (FSP) issued through December 31, 2007
• AICPA Statement on Auditing Standards (SAS) No. 114, The Auditor’s Communication
With Those Charged With Governance (AICPA, Professional Standards, vol. 1, AU sec. 380)

• AICPA Statement of Position (SOP) 07-1, Clarification of the Scope of the Audit and

Accounting Guide Investment Companies and Accounting by Parent Companies and Equity
Method Investors for Investments in Investment Companies (AICPA, Technical Practice Aids,
ACC sec. 10,930)

• AICPA SOP 07-2, Attestation Engagements That Address Specified Compliance Control
Objectives and Related Controls at Entities That Provide Services to Investment Companies,
Investment Advisers, or Other Service Providers (AICPA, Technical Practice Aids, AUD sec.
14,430)

• AICPA Practice Bulletin (PB) No. 15, Accounting by the Issuer of Surplus Notes (AICPA,
Technical Practice Aids, PB sec. 12,150)

(continued)
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• AICPA Statement on Standards for Accounting and Review Services (SSARS) No. 15,

Elimination of Certain References to Statements on Auditing Standards and Incorporation of
Appropriate Guidance Into Statements on Standards for Accounting and Review Services
(AICPA, Professional Standards, vol. 2)

• AICPA Statement on Standards for Attestation Engagements (SSAE) No. 14, SSAE
Hierarchy (AICPA, Professional Standards, vol. 1, AT sec. 50)

• Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 5, An

Audit of Internal Control Over Financial Reporting That Is Integrated with An Audit of Financial
Statements (AICPA, PCAOB Standards and Related Rules, Rules of the Board, “Standards”)

• AICPA Audit and Accounting Guide Life and Health Insurance Entities (with conforming
changes through May 1, 2006)

The checklists and illustrative financial statements should be modified, as appropriate, for
subsequent pronouncements. In determining the applicability of a pronouncement, its
effective date should also be considered.
.02 A description of the insurance industry and a description of common accounting and reporting
features of stock life insurance companies are presented in the AICPA Audit and Accounting Guide Life and
Health Insurance Entities (2006) (product no. 012636kk).
.03 The checklists and illustrative financial statements should be used by, or under the supervision of,
persons having adequate technical training and proficiency in the application of generally accepted accounting principles, generally accepted auditing standards, PCAOB Auditing Standards, and Statements on
Standards for Accounting and Review Services.
.04 Users of the checklists and illustrative financial statements are urged to refer directly to applicable
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical
Hotline at 1-877-242-7212.

Note: This publication was extracted from sections 20,000 through 20,600 of the AICPA Financial Statement
Preparation Manual (FSP).
[The next page is 20,101.]
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FSP Section 20,100
Introduction
.01 The function of insurance is to pool the risks of many persons who are exposed to similar risks. For
a payment known as a premium, insurance companies undertake to relieve the policyholder of all or part of
a risk and to spread the total cost of similar risks among large groups of policyholders. One of the primary
purposes of life insurance is to provide financial assistance to named beneficiaries at the time of the death of
the insured. The long-term nature of the coverage involving the risk of death—a risk that increases with
age—is the distinguishing characteristic that sets life insurance apart from other forms of insurance.
Traditionally, life insurance entities provided life and health products to protect against the loss of financial
stability resulting from premature death or illness, and provided annuity products to protect against the risk
of outliving one’s financial resources. The primary emphasis was on meeting the customer’s insurance needs.
The provisions of the AICPA Audit and Accounting Guide Life and Health Insurance Entities (2006) (product
no. 012636kk) apply to all life and health insurance entities including stock, mutual, fraternal, and assessment
entities.
.02 The National Association of Insurance Commissioners (NAIC) codified statutory accounting practices for certain insurance enterprises, resulting in a revised Accounting Practices and Procedures Manual (the
revised manual). The insurance laws and regulations of the states require insurance companies domiciled in
the states to comply with the guidance provided in the NAIC Accounting Practices and Procedures Manual
except as prescribed or permitted by state law.
.03 In December 2001, the AICPA issued Statement of Position (SOP) 01-5, Amendments to Specific AICPA
Pronouncements for Changes Related to the NAIC Codification (AICPA, Technical Practice Aids, ACC sec. 10,840),
which amends SOP 94-5, Disclosures of Certain Matters in the Financial Statements of Insurance Enterprises
(AICPA, Technical Practice Aids, ACC sec. 10,630), as a result of the completion of the NAIC codification of
statutory accounting practices for certain insurance enterprises.
.04 The amendments to SOP 94-5 included in SOP 01-5 require insurance enterprises to disclose, at the
date each balance sheet is presented, a description of the prescribed or permitted statutory accounting
practice and the related monetary effect on statutory surplus of using an accounting practice that differs from
either state prescribed statutory accounting practices or NAIC statutory accounting practices.
.05 Those disclosures should be made if (a) state prescribed statutory accounting practices differ from
NAIC statutory accounting practices or (b) permitted state statutory accounting practices differ from
either state prescribed statutory accounting practices or NAIC statutory accounting practices, and the
use of prescribed or permitted statutory accounting practices (individually or in the aggregate) results
in reported statutory surplus or risk-based capital that is significantly different from the statutory
surplus or risk-based capital that would have been reported had NAIC statutory accounting practices
been followed.
.06 Those disclosures should be applied by a U.S. insurance enterprise, a U.S. enterprise with a U.S.
insurance subsidiary, or a foreign enterprise with a U.S. insurance subsidiary if the enterprise prepares
U.S. generally accepted accounting principles (GAAP) financial statements. If a foreign insurance
enterprise that does not have a U.S. insurance subsidiary prepares U.S. GAAP financial statements or is
included in its parent’s consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose permitted regulatory accounting practices that significantly differ from the
prescribed regulatory accounting practices of its respective regulatory authority and their monetary
effects.
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.07 SOP 01-5 also includes the following auditing guidance that has been updated as a result of the
completion of the NAIC codification: SOP 95-5, Auditor’s Reporting on Statutory Financial Statements of
Insurance Enterprises (AICPA, Technical Practice Aids, AUD sec. 14,310); SOP 94-1, Inquiries of State Insurance
Regulators (AICPA, Technical Practice Aids, AUD sec. 14,290); and AICPA Auditing Interpretation No. 12,
“Evaluation of the Appropriateness of Informative Disclosures in Insurance Enterprises’ Financial Statements Prepared on a Statutory Basis,” of AU section 623, Special Reports, as amended (AICPA, Professional
Standards, vol. 1, AU sec. 9623, paragraphs .60–.81). The included auditing guidance has been approved by
the Auditing Standards Board.

[The next page is 20,201.]
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FSP Section 20,200
Checklists—General
.01 AICPA disclosure checklists have been designed as practice aids to assist accountants in the preparation of financial statements and to assist auditors in their evaluation of the adequacy of disclosures in the
financial statements they audit. Authoritative literature does not require the use of checklists, nor does it
prescribe their format or content.
.02 Within these checklists are a number of questions or statements that are accompanied by references
to the established sources of generally accepted accounting principles (GAAP) in which the disclosure
requirements are found. These sources include Financial Accounting Standards Board (FASB) Statements of
Financial Accounting Standards (SFAS), FASB Interpretations (FIN), FASB Staff Positions (FSP), Accounting
Principles Board Opinions (APB), Accounting Research Bulletins (ARB), AICPA Audit and Accounting
Guides, AICPA Statements of Position (SOP), and FASB Emerging Issues Task Force Consensuses (EITF).
Checklists are designed to serve as convenient memory aids but should not be used as a substitute for direct
reference to authoritative literature.
.03 The checklists provide spaces for checking off or initialing each question or point to indicate that it
has been considered. Carefully review the topics listed and consider whether they represent potential
disclosure items for the reporting entity for which you are preparing or auditing financial statements. Users
should check or initial

• Yes—If the disclosure is required and has been made appropriately.
• No—If the disclosure is required but has not been made.
• N/A (Not applicable)—If the disclosure is not required to be made.
.04 It is important that the effect of any “No” response be considered on the auditor’s report. A “No”
response that is material to the financial statements may warrant a departure from an unqualified opinion
as discussed in paragraphs .20–.64 of AU section 508, Reports on Audited Financial Statements (AICPA,
Professional Standards, vol. 1). If a “No” response is indicated, the authors recommend that a notation be made
in the margin to explain why the disclosure was not made (for example, because the item was not considered
to be material to the financial statements) or to indicate the effect that the response will have on the auditor’s
report.
.05 At the beginning of certain sections, a appears in the “N/A” column. If the entire section is
deemed to be nonapplicable, place a check mark in the and proceed to the next section.
.06 Users may find it helpful to use the right margin for certain other remarks and comments as
appropriate, including
a. For each disclosure for which a “Yes” is indicated, a notation as to where the disclosure is located in
the financial statements and a cross-reference to the applicable workpapers where the support to a
disclosure may be found.
b. For items marked as “N/A,” the reasons for which they do not apply in the circumstances of the
particular report.
.07 The use of these or any other checklists requires the exercise of individual professional judgment.
These checklists are not substitutes for original authoritative pronouncements. Users of these checklists and
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illustrative materials are urged to refer directly to applicable authoritative pronouncements when appropriate. The checklists and illustrative materials may not include all disclosures and presentation items promulgated, nor do they represent minimum standards or requirements. Users of the checklists and illustrative
materials are encouraged to tailor them as required to meet specific circumstances of each particular
engagement.

[The next page is 20,301.]
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FSP Section 20,300
Financial Statements and Notes Checklist
.01 This checklist has been developed by the Accounting and Auditing Publications Team of the AICPA
as a nonauthoritative practice aid for use by preparers and auditors of financial statements.
This checklist includes disclosures commonly encountered in the financial statements of stock life insurance
companies and reporting issues likely to be encountered by accountants who audit, compile, and review
those types of financial statements. They do not include all disclosures required by generally accepted
accounting principles (GAAP) or address all reporting situations that may arise in performing engagements
in accordance with generally accepted auditing standards (GAAS), Public Company Accounting Oversight
Board (PCAOB) standards, and Statements on Standards for Accounting and Review Services (SSARS).
.02 Explanation of References:
AAG =

AICPA Audit and Accounting Guide Life and Health Insurance Entities (with
conforming changes as of May 1, 2006)

ACC =

Reference to a section number in AICPA Technical Practice Aids, Statement of
Position—Accounting

APB =

Accounting Principles Board Opinion

ARB =

Accounting Research Bulletin

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

EITF =

Emerging Issues Task Force Consensus

FASCON =

FASB Concept Statement

FIN =

FASB Interpretation

FSP =

FASB Staff Position

FTB =

Technical Bulletin issued by the staff of the FASB

PB =

AICPA Practice Bulletin

SFAS =

FASB Statement of Financial Accounting Standards

SOP =

AICPA Statement of Position

.03 Checklist Questionnaire:
This checklist is organized into the sections listed below. Carefully review the topics listed and consider
whether they represent potential disclosure items for the life insurance company.
Place ✓ by
Applicable Sections

• Balance Sheet
A.
B.
C.
D.
E.
F.

General
Cash
Investment Securities
Investments Accounted for by the Equity Method
Impairment of a Loan
Accounts and Notes Receivable and Agents’ Balances
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Place ✓ by
Applicable Sections

G.
H.
I.
J.
K.
L.
M.
N.
O.
P.
Q.
R.
S.
T.

Reinsurance Receivables
Lease Finance Receivables
Deferred Acquisition Costs
Property and Equipment
Lessee Leases
Other Assets
Intangible Assets and Goodwill
Separate Account Assets
Deposit Accounting
Policy Liabilities
Income Taxes
Current Liabilities, Notes Payable, and Long-Term Debt
Other Liabilities
Shareholders’ Equity

_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________

• Income Statement
A.
B.
C.
D.
E.
F.
G.
H.
I.

Premium Revenue
Investment Income
Other Income
Benefits and Expenses
Income Taxes
Extraordinary Items, Unusual Items, Infrequent Items
Earnings Per Share
Comprehensive Income
Other

_________
_________
_________
_________
_________
_________
_________
_________
_________

• Statement of Changes in Shareholders’ Equity

_________

• Statement of Cash Flows

_________

• General
A.
B.
C.
D.
E.
F.
G.
H.
I.
J.
J1.
K.
L.
M.
N.
O.
P.
P1.
Q.
R.

Titles and References
Disclosure of Accounting Policies
Comparative Financial Statements
Accounting Changes and Error Corrections
Risks and Uncertainties
Contingencies and Commitments
Environmental Remediation Liabilities
Related-Party Transactions and Economic Dependency
Employee Stock Ownership Plans
Employers’ Disclosures About Pensions and Other Postretirement
Benefits
Employers’ Disclosures for Defined Benefit Pension and Other
Postretirement Benefits
Consolidations
Financial Instruments
Foreign Currency
Impairment of Long-Lived Assets to Be Held and Used
Long-Lived Assets and Disposal Groups to Be Disposed Of
Transfers and Servicing of Financial Assets and Securitizations
Accounting for Servicing Financial Assets
Nonmonetary Transactions
Subsequent Events
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Financial Statements and Notes Checklist
Place ✓ by
Sections Applicable

S.
T.
U.
V.
W.
X.
Y.

Costs Associated With Exit or Disposal Activities
Business Combinations
Segment Information
Postemployment Benefits
Stock Compensation Plans
Asset Retirement Obligations
Demutualizations and Formations of Mutual Insurance Holding
Companies
Z.
Guarantees
AA. Fair Value Measurements

• Auditors’ Reports Checklist

_________
_________
_________
_________
_________
_________
_________
_________
_________
_________

• Supplemental Information for Life Insurance Companies That Are
Securities and Exchange Commission Registrants

_________

Note: Reminder—A “no” answer is indicative of a potential GAAP departure. The reason for the “no” answer and the resolution of the matter
should be documented in the working papers.
Yes
_____

No
_____

N/A
_____

For classified balance sheets, are assets and liabilities segregated into
current and noncurrent classifications, with totals presented for current assets and current liabilities?
[ARB 43, Ch. 3A, pars. 2–8; SFAS 78, pars. 5 and 13; SFAS 6, par. 15;
FIN 8, par. 3; TB 79-3, par. 2]

_____

_____

_____

Are assets not expected to be realized during the current operating
cycle classified as noncurrent?
[ARB 43, Ch. 3A, pars. 5–6]

_____

_____

_____

Are valuation allowances for assets shown as deductions from their
related assets with appropriate disclosure?
[APB 12, par. 3]

_____

_____

_____

_____

_____

_____

Balance Sheet
A. General
1.

2.

3.

B. Cash
1.

Is restricted cash appropriately segregated from cash available for
current operations?
[ARB 43, Ch. 3A, par. 6]

2.

Are restrictions on cash appropriately disclosed?
[SFAS 5, pars. 18–19]

_____

_____

_____

3.

Is the policy for determining cash equivalents disclosed?
[SFAS 95, par. 10]

_____

_____

_____

4.

If the company has material bank overdrafts or material balance of
undelivered checks as of the balance sheet date, are:
a. Bank overdrafts presented as a separate caption within current
liabilities?
b. Undelivered checks classified as accounts payable?
[Generally Accepted]

_____

_____

_____

_____

_____

_____
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Yes
_____

No
_____

N/A
_____

Practice Tip
Be sure that the amount of cash and cash equivalents displayed on the balance sheet equals the amount of
cash and cash equivalents displayed on the statement of cash flows.
C. Investment Securities
1.

2.

3.

Are there separate captions for each of the following investment
categories:
a. Fixed-maturity securities?

_____

_____

_____

b. Mortgage loans on real estate?

_____

_____

_____

c. Investment real estate?

_____

_____

_____

d. Policy loans?

_____

_____

_____

e. Other long-term investments?
[AAG, App. B]

_____

_____

_____

Are the carrying amounts of investment securities on deposit with
regulatory authorities disclosed?
[AAG, App. C, par. 1]

_____

_____

_____

Are debt and equity securities classified as (a) held-to-maturity, (b)
available-for-sale, or (c) trading?
[SFAS 115, par. 6]

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: If SFAS 159, The Fair Value Option for Financial Assets and Financial
Liabilities—Including an amendment of FASB Statement No. 115 has not been
adopted, answer question 4. If it has been adopted, answer question 4a.
For effective date information go to section AA, “Fair Value Measurements” of this checklist.
4.

If an enterprise presents a classified statement of financial position,
are all individual held-to-maturity securities, individual availablefor-sale securities, and individual trading securities reported as either
current or noncurrent, as appropriate, under the provisions of ARB
43, Chapter 3A, “Working Capital—Current Assets and Current Liabilities”?
[SFAS 115, par. 17, as amended by SFAS 135]

4a. If an enterprise reports its investments in available-for-sale securities
and trading securities separately from similar assets that are subsequently measured using another measurement attribute on the face
of the statement of financial position, does the entity either (a) present
the aggregate of those fair value and non-fair-value amounts in the
same line item and parenthetically disclose the amount of fair value
included in the aggregate amount or (b) present two separate line
items to display the fair value and non-fair-value carrying amounts?
If an enterprise presents a classified statement of financial position,
are all individual held-to-maturity securities, individual availablefor-sale securities, and individual trading securities reported as either
current or noncurrent, as appropriate, under the provisions of ARB
43, Chapter 3A, “Working Capital—Current Assets and Current Liabilities”?
[SFAS 115, par. 17, as amended by SFAS 135 and SFAS 159]
Copyright © 2008
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Yes
_____

No
_____

N/A
_____

Practice Tip
Presentation of individual amounts for trading securities, held-to-maturity securities, and available-for-sale
securities on the face of the balance sheet is not required as long as the information is provided in the notes
to the financial statements.
5.

For securities classified as available-for-sale, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:
a. Aggregate fair value?

_____

_____

_____

b. Total gains for securities with net gains in accumulated other
comprehensive income?

_____

_____

_____

_____

_____

_____

a. Aggregate fair value?

_____

_____

_____

b. Gross unrecognized holding gains or losses?

_____

_____

_____

c. Net carrying amount?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The proceeds from sales of available-for-sale securities and gross
realized gains and losses that have been included in earnings as a
result of those sales?

_____

_____

_____

b. The basis on which the cost of a security sold or the amount
reclassified out of accumulated other comprehensive income into
earnings was determined (that is, specified identification, average
cost, or other method used)?

_____

_____

_____

c. The gross gains and losses included in earnings from transfers of
securities from the available-for-sale category to the trading category?

_____

_____

_____

c. Total losses for securities with net losses in accumulated other
comprehensive income?
[SFAS 115, par. 19]
6.

For securities classified as held-to-maturity, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:

d. Gross gains and losses in accumulated other comprehensive income for any derivatives that hedged the forecasted acquisition of
the held-to-maturity securities?
[SFAS 115, par. 19]
7.

For investments in debt securities classified as available-for-sale or
held-to-maturity:
a. Is disclosure made about their contractual maturities as of the date
of the latest balance sheet presented (maturity information may be
combined in appropriate groupings)?
b. If securities not due at a single date (such as mortgage-backed
securities) are allocated over several maturity groupings, is the
basis for allocation disclosed?
[SFAS 115, par. 20]

8.

For each period for which an income statement is presented, are the
following disclosed:

d. The amount of the net unrealized holding gain or loss on availablefor-sale securities for the period that has been included in accumulated other comprehensive income and the amount of gains and
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. Net carrying amount of the sold or transferred security?

_____

_____

_____

b. The net gain or loss in accumulated other comprehensive income
for any derivative that hedged the forecasted acquisition of the
held-to-maturity security?

_____

_____

_____

c. Related realized or unrealized gain or loss?

_____

_____

_____

d. The circumstances leading to the decision to sell or transfer the
security?
[SFAS 115, par. 22]

_____

_____

_____

(1) The aggregate related fair value of investments with unrealized losses?

_____

_____

_____

(2) The aggregate amount of unrealized losses (that is, the
amount by which cost exceeds fair value)?

_____

_____

_____

losses reclassified out of accumulated other comprehensive income into earnings for the period?
e. The portion of trading gains and losses for the period that relates
to trading securities still held at the reporting date?
[SFAS 115, par. 21]
9.

For any sales of or transfers from securities classified as held-tomaturity, are the following disclosed for each period for which an
earnings statement is presented:

Note: The disclosure requirements in questions 10–12 below are effective
for reporting periods beginning after December 15, 2005. Earlier application is permitted.
10. For all investments in an unrealized loss position, including those that
fall within the scope of EITF 99-20, Recognition of Interest Income and
Impairment on Purchased and Retained Beneficial Interests in Securitized
Financial Assets, for which other-than-temporary impairments have
not been recognized, does an investor disclose the following in its
annual financial statements:
a. As of each date for which a statement of financial position is
presented, quantitative information, aggregated by category of
investment—each category of investment that the investor discloses in accordance with SFAS 115, Accounting for Certain Investments in Debt and Equity Securities and SFAS 124, Accounting for
Certain Investments Held by Not-for-Profit Organizations (refer to
paragraph 4(b) in FSP FAS 115-1 and FAS 124-1, The Meaning of
Other-Than-Temporary Impairment and Its Application to Certain Investments) and cost-method investments—in tabular form:

Notes: The disclosures in (1) and (2) above should be segregated by those
investments that have been in a continuous unrealized loss position for
less than 12 months and those that have been in a continuous unrealized
loss position for 12 months or longer.
The reference point for determining how long an investment has been in
a continuous unrealized loss position is the balance sheet date of the
reporting period in which the impairment is identified. For entities that do
not prepare interim financial information, the reference point would be
(continued)
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

(1) The nature of the investment(s)?

_____

_____

_____

(2) The cause(s) of the impairment(s)?

_____

_____

_____

(3) The number of investment positions that are in an unrealized
loss position?

_____

_____

_____

(4) The severity and duration of the impairment(s)?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The aggregate carrying amount of all cost-method investments?

_____

_____

_____

b. The aggregate carrying amount of cost-method investments that
the investor did not evaluate for impairment?

_____

_____

_____

_____

_____

_____

_____

_____

_____

the annual balance sheet date of the period during which the impairment
was identified. The continuous unrealized loss position ceases upon either
(a) the recognition of an other-than-temporary impairment or (b) the
investor becoming aware of a recovery of fair value up to (or beyond) the
cost of the investment during the period.
b. As of the date of the most recent statement of financial position,
additional information (in narrative form) that provides sufficient
information to allow financial statement users to understand the
quantitative disclosures and the information that the investor
considered (both positive and negative) in reaching the conclusion
that the impairment(s) are not other than temporary? These disclosures could include:

(5) Other evidence considered by the investor in reaching its
conclusion that the investment is not other-than-temporarily
impaired, including, for example, industry analyst reports,
sector credit ratings, volatility of the security’s fair value,
and/or any other information that the investor considers
relevant?
[FSP FAS 115-1 and FAS 124-1, par. 17]
11. Are individually significant unrealized losses generally not aggregated?
[FSP FAS 115-1 and FAS 124-1, par. 17]
12. For cost-method investments, does an investor disclose the following
additional information, if applicable, as of each date for which a
statement of financial position is presented in its annual financial
statements:

c. The fact that the fair value of a cost-method investment is not
estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value
of the investment, and:
(1) The investor determined, in accordance with paragraphs 14–
15 of SFAS 107, Disclosures about Fair Value of Financial Instruments, that it is not practicable to estimate the fair value of the
investment? or
(2) The investor is exempt from estimating fair value under SFAS
126, Exemption from Certain Required Disclosures about Financial
Instruments for Certain Nonpublic Entities?
[FSP FAS 115-1 and FAS 124-1, par. 18]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The name of each investee and their percentage of ownership of
common stock?

_____

_____

_____

b. The accounting policies of the investor with respect to investments
in common stock?

_____

_____

_____

c. The difference between the amount at which an investment is
carried and the amount of underlying equity in net assets?

_____

_____

_____

Note: FSP FAS 115-1 and FAS 124-1 includes a tabular example of the
quantitative disclosures (see Appendix A of the FSP) as referred to in
question 10a above.
13. Are mortgage loans that are purchased at a discount or premium
reported at amortized cost with an allowance for uncollectible
amounts, if any?
[SFAS 60, par. 47]
14. Are changes in the allowance for uncollectible amounts relating to
mortgage loans reported in income as prescribed in SFAS 114, Accounting by Creditors for Impairment of a Loan?
[SFAS 60, par. 47, as amended by SFAS 114, par. 23]
15. Are real estate investments (except those held for sale) reported at cost
less accumulated depreciation?
[SFAS 60, par. 48, as amended; AAG, par. 11.93]
16. Are reductions in the carrying amounts of real estate investments
resulting from the application of SFAS 144, Accounting for the Impairment or Disposal of Long-Lived Assets, included in realized gains and
losses?
[SFAS 60, par. 48, as amended]
17. For those entities that enter into options with no intrinsic value at
acquisition in order to purchase securities accounted for under SFAS
115, is disclosure made of the accounting policy for the premium paid
(time value) to acquire the option that is classified as held-to-maturity
or available-for-sale disclosed?
[EITF 96-11]
18. Are mortgage loans that are acquired at par value reported at outstanding principal balances?
[SFAS 60, par. 47]
19. Are adjustments to deferred acquisition costs (DAC) and other assets
and liabilities as a result of including unrealized gains or losses as part
of shareholders equity in accordance with SFAS 115 disclosed?
[AAG, App. C, par. 4]
D. Investments Accounted for by the Equity Method
1.

2.

Are investments in common stock shown in the balance sheet of the
investor as a single amount, and is the investor’s share of earnings or
losses of the investee shown in the income statement as a single
amount (except for extraordinary items or prior period adjustments)?
[APB 18, par. 19]
Are the following disclosures made for investments in common stock
accounted for by the equity method:
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Yes
_____

No
_____

N/A
_____

d. The accounting treatment of the difference described in c?

_____

_____

_____

e. For investments in common stock for which a quoted market price
is available, the aggregate value of each identified investment
based on the quoted market price? (Note: This is not required for
investments in common stock of subsidiaries.)

_____

_____

_____

f. For investments in common stock, corporate joint ventures, or
other investments which are in the aggregate material in relation
to the financial position or results of operations of an investor,
summarized information as to assets, liabilities, and results of
operation of the investees as appropriate?

_____

_____

_____

_____

_____

_____

a. The name of such investee?

_____

_____

_____

b. The reasons why the equity method is not considered appropriate?
[APB 18, par. 20, fn. 13]

_____

_____

_____

a. The name of such investee?

_____

_____

_____

b. The reasons why the equity method is considered appropriate?
[APB 18, par. 20, fn. 13]

_____

_____

_____

_____

_____

_____

_____

_____

_____

g. Material effects of conversions of outstanding convertible securities, exercises, or contingent issuances?
[APB 18, par. 20]
3.

4.

5.

6.

If the reporting entity holds 20 percent or more of the voting stock of
a significant investee corporation but does not account for the investment using the equity method, are the following disclosed:

If the reporting entity holds less than 20 percent of the voting stock of
a significant investee corporation and accounts for the investment
using the equity method, are the following disclosed:

Upon loss of significant influence, has the investor recorded the
proportionate share of an investee’s equity adjustments for other
comprehensive income as offset against the carrying value of the
investment at the time significant influence is lost?
[FSP APB 18-1, par. 4]
To the extent that the offset results in a carrying value of the investment that is less than zero has the investor (a) reduced the carrying
value of the investment to zero and (b) recorded the remaining balance
in income?
[FSP APB 18-1, par. 4]

Note: FSP APB 18-1, Accounting by an Investor for Its Proportionate Share of
Accumulated Other Comprehensive Income of an Investee Accounted for under
the Equity Method in Accordance with APB Opinion No. 18 upon a Loss of
Significant Influence, does not provide guidance for entities that have
historically not recorded their proportionate share of an investee’s equity
adjustments for other comprehensive income. These entities should refer
to paragraph 25 of SFAS 154, Accounting Changes and Error Corrections—a
replacement of APB Opinion No. 20 and FASB Statement No. 3, for the
appropriate guidance. FSP APB 18-1 also does not provide guidance on
the measurement and recognition of a gain or loss on the sale of all or a
portion of the underlying investment.
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7.

8.

9.

Does the life insurance entity disclose any contingent obligations or
commitments for additional funding or guarantees of obligations of
the investee?
[AAG, par. 11.99]
Is the selected policy disclosed for determining the amount of equity
method losses when previous losses have reduced the common stock
investment account to zero?
[EITF 99-10]
If an equity method investor reports a change to (or the elimination
of) a previously existing difference between the reporting period of
an investor and the reporting period of an equity method investee in
the investor’s consolidated financial statements as described in EITF
06-9, Reporting a Change in (or the Elimination of) a Previously Existing
Difference between the Fiscal Year-End of a Parent Company and That of a
Consolidated Entity or between the Reporting Period of an Investor and That
of an Equity Method Investee, has the change been reported as a change
in accounting principle in accordance with the provisions of SFAS 154,
excluding retrospective application if it is impracticable to do so?
[EITF 06-9, par. 4]

10. If the provisions of EITF 06-9 are applicable to the financial statements
of an investor in an equity method investee, are the disclosures
required by SFAS 154 made?
[EITF 06-9, par. 5]
11. If the organization has investments that would have been accounted
for under the equity method if the organization had not chosen to
apply the fair value option in SFAS 159 or in paragraph 16 of SFAS
133, Accounting for Derivative Instruments and Hedging Activities, has it
disclosed for each period for which a statement of financial position
is presented the information required by paragraph 20 of APB 18, The
Equity Method of Accounting for Investments in Common Stock, excluding
the disclosures in paragraphs 20(a)(3), 20(b), and 20(e) of that APB?
[SFAS 159, par. 18f]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Practice Tip
The significance of an investment to the investor’s financial position and results of operations should be
considered in evaluating the extent of disclosures relating to the financial position and results of operations
of an investee.
E. Impairment of a Loan
1.

Is the allowance deducted from the related assets?
[APB 12, par. 3]

2.

Is the following information disclosed, either in the body of the
financial statements or in the accompanying notes for impaired
loans:11

_____

_____

_____

_____

_____

_____

a. As of the date of each balance sheet presented:
(1) Total recorded investment in the impaired loans at the end of
each period and the amount of the recorded investment for
which there is a related allowance for loan losses?
Copyright © 2008
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Yes
_____

No
_____

N/A
_____

(2) The amount of the allowance?

_____

_____

_____

(3) The amount of the recorded investment for which no allowance for loan losses was recorded?

_____

_____

_____

(4) The company’s policy for recognizing interest on impaired
loans, including how cash receipts are recorded?

_____

_____

_____

(1) Average recorded investments?

_____

_____

_____

(2) Related amount of interest income recognized using the cash
basis method of accounting during the time within the period
the loans were impaired?

_____

_____

_____

(3) If practicable, the amount of interest income recognized using
the cash basis method of accounting during the time within
the period the loans were impaired?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Is the discount or premium presented as a deduction from or
addition to the face amount of the note?

_____

_____

_____

b. Does the disclosure include the effective interest rate and face
amount of the note?

_____

_____

_____

b. For each period for which a statement of income is presented:

(4) The activity in the allowance for loan losses related to impaired loans including the following:
(i) Opening balance?
(ii) Additions charged to operations?
(iii) Direct write-down charged against the allowance?
(iv) Recovery of amounts previously charged off?
(v) Ending balance?
[SFAS 114, par. 20, as amended by SFAS 118, par. 6]
3.

F.

When a loan is restructured in a troubled debt restructuring (as
defined in SFAS 15, Accounting by Debtors and Creditors for Troubled
Debt Restructurings) into two (or more) loan agreements, are the
restructured loans considered separately when assessing the applicability of the disclosures described in question 2 above?
[EITF 96-22]

Accounts and Notes Receivable and Agents’ Balances
1.

Are premiums due reported as assets?
[AAG, Table 3.1]

2.

Are deferred premiums offset against liabilities for future policy
benefits?
[AAG, Table 3.1 and par. 7.19]

3.

Are hypothecation or other pledging of receivables disclosed?
[SFAS 5, pars. 18–19]

4.

Are accounts and notes receivable from officers, employees, and
affiliated entities shown separately with appropriate disclosures?
[ARB 43, Ch. 1A, par. 5]

5.

If a note is noninterest bearing or has an inappropriate stated interest
rate:
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. The basis of accounting for loans, trade receivables, and lease
financings, including those classified as held for sale?

_____

_____

_____

b. The method used in determining the lower of cost or fair value of
nonmortgage loans held for sale (that is aggregate or individual
asset basis)?

_____

_____

_____

c. The method for recognizing interest income on loan and trade
receivables, including the entity’s policy for treatment of related
fees and costs and the method of amortizing net deferred fees or
costs?

_____

_____

_____

d. The classification and method of accounting for interest-only
strips, loans, other receivables, or retained interests in securitizations that can be contractually prepaid or otherwise settled in a
way that the holder would not recover substantially all of its
recorded investment?

_____

_____

_____

e. The accounting policies and methodology the entity used to estimate its allowance for loan losses, allowance for doubtful accounts, any liability for off-balance sheet credit losses, and any
related charges for loan, trade receivable or other credit losses,
including a description of the factors that influenced management’s judgment?

_____

_____

_____

f. The policy for placing loans (and trade receivables if applicable)
on nonaccrual status (or discontinuing accrual of interest) and
recording payments received on nonaccrual loans (and trade receivables if applicable), and the policy for resuming accrual of
interest?

_____

_____

_____

g. The policy for charging off uncollectible loans and receivables?

_____

_____

_____

_____

_____

_____

c. Is amortization of discount or premium reported as interest in the
income statement?
[APB 21, par. 16]
6.

Is the unamortized balance of loan origination, commitment, and
other fees and costs and purchase premiums and discounts that is
being recognized as an adjustment of yield reported as part of the loan
balance to which it relates?
[SFAS 91, par. 21]

Note: Regarding SOP 01-6, Accounting by Certain Entities (Including Entities With Trade Receivables) That Lend to or Finance the Activities of Others
(AICPA, Technical Practice Aids, ACC sec. 10,850), questions 7–15 below
apply to organizations that (1) extend credit to customers (constituents)
to encourage them to purchase products and services, (2) make mortgage
loans, or (3) make secured or unsecured loans to constituents (for example,
tenant loans). This checklist includes only the disclosure requirements for
the more common activities within the scope of SOP 01-6. If the organization purchases or sells loans or servicing rights, forecloses on a loan, or
engages in other more complex lending activities, the disclosure requirements of SOP 01-6 not included herein also should be considered.
7.

Does the accounting policy note include the following:

h. The policy for determining past due or delinquency status (that is,
whether that status is based on most recent payment or on contractual terms)?
[SOP 01-6, par. 13a–c (ACC 10,850.13)]
Copyright © 2008

FSP §20,300.03

78

2-08

20,312

19

Financial Statements and Notes Checklist

8.

9.

The aggregate amount of gains or losses on sales of loans or trade
receivables (including adjustments to record loans held for sale at the
lower of cost or fair value) presented separately in the financial
statement or disclosed in the notes?
[SOP 01-6, par. 13d (ACC 10,850.13)]
Loans or trade receivables may be presented on the balance sheet as
aggregated amounts. However,
a. Loans or trade receivables held for sale should be presented on the
balance sheet in a separate balance sheet category.
b. Major categories of loans or trade receivables should be presented
separately either in the balance sheet or in the notes.
c. The allowance for credit losses, the allowance for doubtful accounts, and, as applicable, any unearned income, any unamortized premiums and discounts, and any net unamortized deferred
fees and costs, should be disclosed in the financial statements.
[SOP 01-6, par. 13e (ACC 10,850.13)]

10. Are foreclosed and repossessed assets classified as a separate balance
sheet amount or included in other assets on the balance sheet with
separate disclosures in the notes?
[SOP 01-6, par. 13f (ACC 10,850.13)]
11. Are certain returned or repossessed assets, such as inventory, subsequently to be utilized by the entity in operations, not classified
separately?
[SOP 01-6, par. 13f (ACC 10,850.13)]
12. Is the recorded investment in loans (and trade receivables if applicable) on nonaccrual status as of each balance sheet date disclosed in the
notes to the financial statements?
[SOP 01-6, par. 13g (ACC 10,850.13)]
13. Is the recorded investment in loans (and trade receivables if applicable) past due ninety days or more and still accruing interest disclosed?
[SOP 01-6, par. 13g (ACC 10,850.13)]
14. Is the carrying amount of securities deposited disclosed if insurance
subsidiaries are required to deposit securities with state regulatory
authorities?
[SOP 01-6, par. 13h (ACC 10,850.13)]
15. Is the carrying amount of loans, trade receivables, securities and
financial instruments that serve as collateral for borrowings disclosed
pursuant to paragraphs 18–19 of SFAS 5, Accounting for Contingencies?
[SOP 01-6, par. 13i (ACC 10,850.13)]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Notes: SOP 03-3, Accounting for Certain Loans or Debt Securities Acquired in
a Transfer (AICPA, Technical Practice Aids, ACC sec. 10,880), addresses
accounting for differences between contractual cash flows and cash flows
expected to be collected from an investor’s initial investment in loans or
debt securities (loans) acquired in a transfer if those differences are attributable, at least in part, to credit quality.
Readers may also refer to AICPA Technical Practice Aid Technical Questions and Answers (TIS) section 2130.09–.37 (AICPA, Technical Practice
Aids) for additional nonauthoritative guidance pertaining to various topics on the application of SOP 03-3.
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

(1) The outstanding balance and related carrying amount at the
beginning and end of the period?

_____

_____

_____

(2) The amount of accretable yield at the beginning and end of
the period, reconciled for additions, accretion, disposals of
loans, and reclassifications to or from nonaccretable difference during the period?

_____

_____

_____

(3) For loans acquired during the period, the contractually required payments receivable, cash flows expected to be collected, and fair value at the acquisition date?

_____

_____

_____

(4) For those loans within the scope of SOP 03-3 for which the
income recognition model in SOP 03-3 is not applied in
accordance with paragraph 6, the carrying amount at the
acquisition date for loans acquired during the period and the
carrying amount of all loans at the end of the period?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

16. Do the notes to financial statements describe how prepayments are
considered in the determination of contractual cash flows and cash
flows expected to be collected?
[SOP 03-3, par. 14 (ACC 10,880.14)]
17. Is information about loans meeting the scope criteria of paragraph 3
of SOP 03-3 included in the disclosures required by paragraphs 20(a)–
20(b) of SFAS 114, if the condition in paragraph 16 of SFAS 115 or
paragraph 8(a) of SFAS 5 (as discussed in paragraphs 7(a)–8(a) of SOP
03-3) is met?
[SOP 03-3, par. 15 (ACC 10,880.15)]
18. In addition to disclosures required by other GAAP, for each balance
sheet presented, does an investor disclose the following information
about loans within the scope of SOP 03-3:
a. Separately for both those loans that are accounted for as debt
securities and those loans that are not accounted for as debt
securities:

b. Further, for those loans that are not accounted for as debt securities, does an investor disclose:
(1) The amount of (a) any expense recognized pursuant to paragraph 8(a) of SOP 03-3 and (b) any reductions of the allowance
recognized pursuant to paragraph 8(b)(1) of SOP 03-3 for each
period for which an income statement is presented?
(2) The amount of the allowance for uncollectible accounts at the
beginning and end of the period?
[SOP 03-3, par. 16 (ACC 10,880.16)]
G. Reinsurance Receivables
1.

2.

Are fronting arrangements treated as reinsurance arrangements for
purposes of disclosures required by SFAS 60, Accounting and Reporting
by Insurance Enterprises and SFAS 113, Accounting and Reporting for
Reinsurance of Short-Duration and Long-Duration Contracts?
[SFAS 113, par. 6]
Are the following disclosed in relation to ceded insurance transactions:
a. Nature of the transaction(s)?
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3.

4.

5.

6.

7.

Yes
_____

No
_____

N/A
_____

b. Purpose of the transaction(s)?

_____

_____

_____

c. Effect of the transaction(s)?

_____

_____

_____

d. The fact that the insurer is not relieved of its primary obligation to
the policyholder in a reinsurance transaction?
[SFAS 113, par. 27a]

_____

_____

_____

Are the following disclosed for short-duration reinsurance contracts
on both a written and an earned basis:
a. Premiums from direct business?

_____

_____

_____

b. Reinsurance assumed?

_____

_____

_____

c. Reinsurance ceded?
[SFAS 113, par. 27b]

_____

_____

_____

Are the following disclosed for long-duration reinsurance contracts:
a. Premiums and amounts assessed against policyholders from direct business?

_____

_____

_____

b. Reinsurance assumed?

_____

_____

_____

c. Reinsurance ceded?

_____

_____

_____

d. Premiums and amounts earned?
[SFAS 113, par. 27b]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Are the methods used for income recognition on reinsurance contracts
disclosed?
[SFAS 113, par. 27c]
Are concentrations of credit risk associated with reinsurance receivables and prepaid reinsurance premiums disclosed for a ceding enterprise under the provisions of paragraph 15A of SFAS 107, as amended
by SFAS 133?
[SFAS 113, par. 28; SFAS 133, par. 533]
Are the following items reported separately as assets for those companies participating in ceding transactions:
a. Estimated reinsurance receivables arising from ceding transactions?
b. Amounts paid to the reinsurer relating to the unexpired portion
of reinsured contracts (prepaid reinsurance premiums)?
[SFAS 113, par. 14]

8.

9.

Are amounts receivable and payable between the ceding company
and an individual reinsurer offset only when a right of offset exists as
defined in FIN 39, Offsetting of Amounts Related to Certain Contracts—an
interpretation of APB Opinion No. 10 and FASB Statement No. 105?
[SFAS 113, par. 15]
Are the amounts of earned premiums ceded and recoveries recognized under reinsurance contracts reported in the statements of earnings as separate line items or disclosed in the notes?
[SFAS 113, par. 16; AAG, par. 12.30]

H. Lease Finance Receivables
1.

Do disclosures include:
a. Appropriate components of the net investment in the leases as of
the date of each balance sheet presented?
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b. Future minimum lease payments to be received for each of the five
succeeding fiscal years as of the date of the latest balance sheet
presented?
c. Total contingent rentals included in income for each period for
which a statement of income is presented?
[SFAS 13, par. 23a, as amended by SFAS 91, par. 25d]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

2.

Are leasing arrangements described?
[SFAS 13, pars. 23 and 29; SFAS 91, par. 25; SFAS 98, pars. 17–19]

_____

_____

_____

3.

Are leveraged leases appropriately accounted for and reported?
[SFAS 13, pars. 41–47, as amended by FSP FAS 13-2]

_____

_____

_____

a. The nature of the change in accounting principle?

_____

_____

_____

b. The cumulative effect of the change on retained earnings in the
statement of financial position as of the date of adoption?
[FSP FAS 13-2, par. 14]

_____

_____

_____

_____

_____

_____

a. The nature of costs capitalized?

_____

_____

_____

b. The method of amortizing these costs?

_____

_____

_____

c. The amount of these costs amortized for the period?
[AAG, App. C, par. 7; SFAS 60, par. 60c]

_____

_____

_____

Note: In July 2006, the Financial Accounting Standards Board (FASB)
issued FSP FAS 13-2, Accounting for a Change or Projected Change in the
Timing of Cash Flows Relating to Income Taxes Generated by a Leveraged Lease
Transaction. The guidance in the FSP shall be applied to fiscal years
beginning after December 15, 2006. Earlier application is permitted as of
the beginning of an entity’s fiscal year, provided that the entity has not
yet issued financial statements, including financial statements for any
interim period, for that fiscal year. Only tax positions that meet the
more-likely-than-not recognition threshold at the date of adoption of the
FSP shall be reflected in the financial statements. In addition, all recognized tax positions in a leveraged lease must be measured in accordance
with FIN 48, Accounting for Uncertainty in Income Taxes—an interpretation
of FASB Statement No. 109 at the date of adoption of the FSP. If, at the date
of adoption, the application of FIN 48 causes a change in the recognition
or measurement of the tax position, that change shall be considered a
change of an important assumption as of the date of adoption of the FSP.
The cumulative effect of applying the provisions of the FSP shall be
reported as an adjustment to the beginning balance of retained earnings
as of the beginning of the period in which this FSP is adopted. The
disclosure requirements of the FSP shall be applied as of the most recent
statement of financial position or income statement presented.
4.

Is the following disclosed by the lessor in the fiscal year of adoption:

Note: Financial statements of subsequent periods from the date of adoption need not repeat these disclosures.
I.

Deferred Acquisition Costs
1.

2.

Are unamortized acquisition costs classified in the balance sheet as
assets?
[AAG, par. 10.25]
Are the following disclosed relating to deferred acquisition costs:
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. A description of the company’s accounting policy?

_____

_____

_____

b. An analysis of the PVP asset account for each year for which an
income statement is presented, including the PVP balance at the
beginning of the year, the amount of PVP additions during the
year arising from acquisitions of insurance entities, the amount of
interest accrued on the unamortized PVP balance during the year,
the interest accrual rate, the amount of amortization during the
year, the amount of any write-offs during the year attributable to
impairment and how those write-offs were determined, and the
PVP balance at the end of the year?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Depreciation expense for each period for which an income statement is presented?

_____

_____

_____

b. Balances of major classes of depreciable assets, by nature or function, at the balance sheet date?

_____

_____

_____

c. Accumulated depreciation, either by major classes of depreciable
assets or in total, at the balance sheet date?

_____

_____

_____

d. A general description of the method or methods used in computing depreciation for major classes of depreciable assets?
[APB 12, par. 5]

_____

_____

_____

Are pledged assets and material commitments for property expenditures disclosed?
[SFAS 5, pars. 18–19]

_____

_____

_____

_____

_____

_____

d. The accounting policy applied to internal replacements, including
whether or not the company has availed itself of the alternative
application guidance in paragraphs 18–19 of SOP 05-1, Accounting
by Insurance Enterprises for Deferred Acquisition Costs in Connection
With Modification or Exchanges of Insurance Contracts (AICPA, Technical Practice Aids, ACC sec. 10,920), and if so, for which kinds of
internal replacement transactions?
[SOP 05-1, par. 28 (ACC 10,920.28)]
3.

4.

Is the fact that the company considers anticipated investment income
in determining if a premium deficiency relating to short-duration
contracts exists disclosed?
[SFAS 60, par. 60e]
If a public company acquires a life insurance entity accounted for as
a purchase and the acquirer recognizes an asset for the present value
of future profits (PVP), is the following disclosed:

c. The estimated amount or percentage of the end of the year PVP
balance to be amortized during each of the next five years?
[AAG, App. C, par. 8]
J.

Property and Equipment
1.

Is the carrying basis of property and equipment disclosed?
[AAG, App. B; APB 12, par. 5]

2.

For depreciable assets, does disclosure include:

3.

4.

For any accounting period in which interest costs are capitalized, is
the total amount of interest cost incurred during the period, and the
amount thereof that is capitalized, disclosed?
[SFAS 34, par. 21b]
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5.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. The gross amount of assets recorded under capital leases as of the
date of each balance sheet presented by major classes according to
nature or function (this information may be combined with the
comparable information for owned assets)?

_____

_____

_____

b. Future minimum lease payments as of the date of the latest balance
sheet presented, in the aggregate and for each of the next five fiscal
years, with separate deductions from the total for executory costs,
including any profit thereon that is included in the minimum lease
payments and for the amount of the imputed interest necessary to
reduce the net minimum lease payments to present value?

_____

_____

_____

c. The total of minimum sublease rentals to be received in the future
under noncancelable subleases as of the date of the latest balance
sheet presented?

_____

_____

_____

_____

_____

_____

(1) Assets recorded under capital leases?

_____

_____

_____

(2) Accumulated amortization of capital leases?

_____

_____

_____

(3) Obligations under capital leases?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Is the amount of interest cost incurred and charged to expense during
the period disclosed for an accounting period in which no interest cost
is capitalized?
[SFAS 34, par. 21a]

Note: Subsequent to the adoption of SFAS 143, Accounting for Asset Retirement Obligations, the following consensus does not apply to obligations
for asbestos removal that are within the scope of SFAS 143.
6.

For an existing property with an asbestos problem, are the costs
incurred to treat the problem, if charged to expense, not classified as
an extraordinary item?
[EITF 89-13]

K. Lessee Leases
1.

Is the following information disclosed with respect to capital leases:

d. Total contingent rentals actually incurred for each period for
which an income statement is presented?
[SFAS 13, par. 16]
e. Separate identification of:

(4) Amount of amortization of capital lease assets or the fact that
the amortization of capital lease assets is included in depreciation expense?
[SFAS 13, par. 13]
2.

Are the following disclosed for operating leases that have initial or
remaining noncancelable lease terms in excess of one year:
a. Future minimum rental payments required, as of the date of the
latest balance sheet presented, in the aggregate, and for each of the
five succeeding fiscal years?
b. The total of minimum rentals to be received in the future under
noncancelable subleases as of the date of the latest balance sheet
presented?
[SFAS 13, par. 16]
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3.

4.

5.

6.

7.

8.

9.

For all operating leases, do disclosures include rental expense for each
period for which an income statement is presented, with separate
amounts for minimum rentals, contingent rentals, and sublease rentals (rental payments under leases with terms of a month or less that
are not renewed need not be included)?
[SFAS 13, par. 16c]
Do disclosures include a general description of the lessee’s leasing
arrangements including, but not limited to, the following:
a. The basis on which contingent rental payments are determined?
b. The existence and terms of renewal or purchase options and
escalation clauses?
c. Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing?
[SFAS 13, par. 16]
Is the nature and extent of leasing transactions with related parties
disclosed?
[SFAS 13, par. 29]
If there is a modification of lease terms and the increase in lease
payments is a termination penalty, is the accounting policy disclosed
in accordance with APB 22?
[EITF 95-17; APB 22, pars. 12–14]
Do the financial statements of a seller-lessee include a description of
the terms of the sale-leaseback transaction including future commitments, obligations, provisions, or circumstances that require or result
in the seller-lessee’s continuing involvement?
[SFAS 98, par. 17]
If a sale-leaseback transaction is accounted for using the deposit
method or as a financing arrangement, are the following disclosures
made:
a. The obligation for future minimum lease payments as of the date
of the latest balance sheet presented in the aggregate and for each
of the five succeeding fiscal years?
b The total of minimum sublease rentals, if any, to be received in the
future under noncancelable subleases in the aggregate and for
each of the five succeeding fiscal years?
[SFAS 98, par. 18]
When rental costs incurred during and after a construction period are
for the right to control the use of a leased asset during and after
construction of a lessee asset, are the rental costs included in income
from continuing operations?
[FSP FAS 13-1, par. 6]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

L. Other Assets
Note: If SFAS 142, Goodwill and Other Intangible Assets, has not been
adopted, the following questions do apply. See section M for the disclosures required after the effective date of SFAS 142. SFAS 142 is required
to be applied at the beginning of an entity’s fiscal year and to be applied
to all goodwill and other intangible assets recognized in its financial
statements at that date.
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1.

2.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

(1) The total amount assigned and the amount assigned to any
major intangible asset class?

_____

_____

_____

(2) The amount of any significant residual value, in total and by
major intangible asset class?

_____

_____

_____

Do disclosures include the method and period of amortization of
intangible assets?
[APB 22, par. 13]
For an unidentified intangible asset arising as a result of the fair value
of liabilities assumed in a purchase method business combination
exceeding fair value of tangible and identified intangible assets acquired in a combination initiated after September 30, 1982, is the
method and period of amortization disclosed?
[APB 17, par. 30]

M. Intangible Assets and Goodwill (Only applicable if the provisions of
SFAS 142 are being applied to the financial statements.)
Note: SFAS 142 is not applicable to goodwill and other intangible assets
arising from combinations between mutual enterprises until FASB completes its deliberation with respect to application of the purchase method
by those entities. Goodwill and intangible assets acquired in a combination between two or more mutual enterprises for which the acquisition
date is after June 30, 2001, shall continue to be accounted for in accordance
with APB 17.
1.

2.

3.

4.

5.

6.

At a minimum, are all intangible assets aggregated and presented as
a separate line item in the statement of financial position? (This
requirement does not preclude presentation of individual intangible
assets or classes of intangible assets as separate line items.)
[SFAS 142, par. 42]
Are amortization expense and impairment losses for intangible assets
presented in income statement line items within continuing operations as deemed appropriate for each entity?
[SFAS 142, par. 42]
Is the aggregate amount of goodwill presented as a separate line item
in the statement of financial position?
[SFAS 142, par. 43]
Is the aggregate amount of goodwill impairment losses presented as
a separate line item in the income statement before the subtotal income
from continuing operations (or similar caption) unless a goodwill impairment loss is associated with a discontinued operation?
[SFAS 142, par. 43]
Is a goodwill impairment loss associated with a discontinued operation included (on a net-of-tax basis) within the results of discontinued
operations?
[SFAS 142, par. 43]
For intangible assets acquired either individually or with a group of
assets, is the following information disclosed in the notes to the
financial statements in the period of acquisition:
a. For intangible assets subject to amortization:
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Yes
_____

No
_____

N/A
_____

(3) The weighted-average amortization period, in total and by
major intangible asset class?

_____

_____

_____

b. For intangible assets not subject to amortization, the total amount
assigned and the amount assigned to any major intangible asset
class?

_____

_____

_____

_____

_____

_____

(1) The gross carrying amount and accumulated amortization, in
total and by major intangible asset class?

_____

_____

_____

(2) The aggregate amortization expense for the period?

_____

_____

_____

(3) The estimated aggregate amortization expense for each of the
five succeeding fiscal years?

_____

_____

_____

b. For intangible assets not subject to amortization, the total carrying
amount and the carrying amount for each major intangible asset
class?

_____

_____

_____

(1) The aggregate amount of goodwill acquired?

_____

_____

_____

(2) The aggregate amount of impairment losses recognized?

_____

_____

_____

(3) The amount of goodwill included in the gain or loss on
disposal of all or a portion of a reporting unit?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. A description of the impaired intangible asset and the facts and
circumstances leading to the impairment?

_____

_____

_____

b. The amount of the impairment loss and the method for determining fair value?

_____

_____

_____

c. The caption in the income statement in which the impairment loss
is aggregated?

_____

_____

_____

c. The amount of research and development assets acquired and
written off in the period and the line item in the income statement
in which the amounts written off are aggregated?
[SFAS 142, par. 44]
7.

Has the following information been disclosed in the financial statements or the notes to the financial statements for each period for which
a statement of financial position is presented:
a. For intangible assets subject to amortization:

c. The changes in the carrying amount of goodwill during the period
including:

8.

9.

If the entity reports segment information in accordance with SFAS
131, Disclosures about Segments of an Enterprise and Related Information,
is the above information about goodwill provided in total and for each
reportable segment and are any significant changes in the allocation
of goodwill by reportable segment disclosed?
[SFAS 142, par. 45]
If any portion of goodwill has not yet been allocated to a reporting
unit at the date the financial statements are issued, is that unallocated
amount and the reasons for not allocating that amount disclosed?
[SFAS 142, par. 45]

10. For each impairment loss recognized related to an intangible asset, is
the following information disclosed in the notes to the financial
statements that include the period in which the impairment loss is
recognized:
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

a. A description of the facts and circumstances leading to the impairment?

_____

_____

_____

b. The amount of the impairment loss and the method of determining
the fair value of the associated reporting unit (whether based on
quoted market prices, prices of comparable businesses, a present
value or other valuation technique, or a combination thereof)?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees?

_____

_____

_____

b. The basis of presentation for separate account assets and liabilities
and related separate account activity?

_____

_____

_____

c. The aggregate fair value of assets, by major investment asset
category, supporting separate accounts with additional insurance
benefits and minimum investment return guarantees as of each
date for which a statement of financial position is presented?

_____

_____

_____

_____

_____

_____

a. The separate account is legally recognized. That is, the separate
account is established, approved, and regulated under special
rules such as state insurance laws, federal securities laws, or
similar foreign laws?

_____

_____

_____

b. The separate account assets supporting the contract liabilities are
legally insulated from the general account liabilities of the insurance enterprise (that is, the contract holder is not subject to insurer
default risk to the extent of the assets held in the separate account)?

_____

_____

_____

d. If applicable, the segment in which the impaired intangible asset
is reported under SFAS 131?
[SFAS 142, par. 46]
11. For each goodwill impairment loss recognized, is the following information disclosed in the notes to the financial statement that include
the period in which the impairment loss is recognized:

c. If a recognized impairment loss is an estimate that has not yet been
finalized (refer to SFAS 142, paragraph 22), that fact and the
reasons therefore and, in subsequent periods, the nature and
amount of any significant adjustments made to the initial estimate
of the impairment loss?
[SFAS 142, par. 47]
N. Separate Account Assets
1.

2.

Are separate account assets reported as summary totals in the financial statements?
[SFAS 60, par. 54]
Has the insurance company disclosed the following information regarding separate accounts:

d. The amount of gains and losses recognized on assets transferred
to separate accounts for the periods presented?
[SOP 03-1, par. 38 (ACC 10,870.38); AAG, App. C, par. 5]
3.

If the separate account arrangement meets all of the following conditions, have the portion of separate account assets representing contract holder funds been measured at fair value and reported in the
insurance enterprise’s financial statements as a summary total, with
an equivalent summary total reported for related liabilities:

Copyright © 2008

FSP §20,300.03

78

2-08

20,322

29

Financial Statements and Notes Checklist
Yes
_____

No
_____

N/A
_____

c. The insurer must, as a result of contractual, statutory, or regulatory requirements, invest the contract holder’s funds within the
separate account as directed by the contract holder in designated
investment alternatives or in accordance with specific investment
objectives or policies?

_____

_____

_____

d. All investment performance, net of contract fees and assessments,
must as a result of contractual, statutory, or regulatory requirements be passed through to the individual contract holder. Contracts may specify conditions under which there may be a
minimum guarantee, but not a ceiling, because a ceiling would
prohibit all investment performance from being passed through
to the contract holder?

_____

_____

_____

_____

_____

_____

a. The present values of initial expected recoveries that will be reimbursed under the insurance or reinsurance contracts that have
been recorded as an adjustment to incurred losses?

_____

_____

_____

b. Any adjustment of amounts initially recognized for expected recoveries? (The individual components of the adjustment [meaning
interest accrual, the present value of additional expected recoveries, and the present value of reductions in expected recoveries]
should be disclosed separately.)

_____

_____

_____

_____

_____

_____

_____

_____

_____

For the portion of separate account arrangements meeting these criteria, the related investment performance (including interest, dividends, realized gains and losses, and changes in unrealized gains and
losses) and the corresponding amounts credited to the contract holder
should be offset within the same statement of operations line item
netting to zero. Contract fees and assessments should be reported in
accordance with SFAS 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and
Losses from the Sale of Investments, paragraph 19. Any liabilities related
to minimum guarantees and insurance benefit liabilities under the
contracts in excess of the fair value of separate account assets representing contract holder funds should be recognized as general account liabilities.
[SOP 03-1, par. 11 (ACC 10,870.11); SFAS 97, par. 19]
O. Deposit Accounting
1.

2.

Has a description of the contracts accounted for as deposits and the
separate amounts of total deposit assets and total deposit liabilities
reported in the statement of financial position been disclosed?
[SOP 98-7, par. 18 (ACC 10,760.18); AAG, App. C, par. 25]
Has the following information regarding the changes in the recorded
amount of the deposit arising from an insurance or reinsurance contract that transfers only significant underwriting risk been disclosed:

c. The amortization expense attributable to the expiration of coverage provided under the contract?
[SOP 98-7, par. 19 (ACC 10,760.19); AAG, App. C, par. 25]
P. Policy Liabilities
1.

Is the basis for estimating the liabilities for unpaid claims and claim
adjustment expenses disclosed?
[SFAS 60, par. 60a; AAG, App. C, par. 10a]
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2.

3.

4.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. The balance in the liability for unpaid claims and claim adjustment
expenses at the beginning and end of the period presented with,
if net balances are presented, separate disclosure of the related
amount of reinsurance recoverable?

_____

_____

_____

b. Incurred claims and claim adjustment expenses with separate
disclosure of the provision of insured events of the current period
and for increases or decreases in the provision for insured events
of prior fiscal years?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The relative percentage?

_____

_____

_____

b. The method of accounting for policyholders’ dividends?

_____

_____

_____

c. The amount of dividends?

_____

_____

_____

d. The amount of any additional income allocated to participating
policyholders?
[SFAS 60, par. 60g; AAG, App. C, par. 19]

_____

_____

_____

Are the methods and assumptions used in estimating the liability for
future policy benefits and the average rate of assumed investment
yields in effect for the current year disclosed?
[SFAS 60, par. 60b; AAG, App. C, par. 13]
Is the carrying amount of liabilities for unpaid claims and claim
adjustment expenses relating to short-duration contracts that are
presented at present value in the financial statements and the range
of interest rates used to discount those liabilities disclosed?
[SFAS 60, par. 60d; AAG, App. C, par. 10b]
For each fiscal year for which an income statement is presented, is the
following information about the liability for unpaid claims and claim
adjustment expenses disclosed:

c. Payments of claims and claim adjustment expenses with separate
disclosure of payments of claims and claim adjustment expenses
attributable to insured events of the current fiscal year and to
insured events of the prior period?
[SOP 94-5, par. 10 (ACC 10,630.10); AAG, App. C, par. 11]
5.

If changes in incurred claims and claim adjustment expenses recognized in the income statement are attributable to insured events of
prior periods, are the following disclosed in the financial statements:
a. The reasons for the change?
b. Whether additional premiums or return premiums have been
accrued as a result of the prior-period effects?
[SOP 94-5, par. 10 (ACC 10,630.10), as amended by SOP 01-5 (ACC
10,840); AAG, App. C, par. 12]

6.

7.

Is the fact that the company considers anticipated investment income
in determining if a premium deficiency relating to short-duration
contracts exists disclosed?
[SFAS 60, par. 60e; AAG, App. C, par. 10c]
For participating insurance, does disclosure include:
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Yes
_____

No
_____

N/A
_____

Are premiums from participating insurance contracts reported as
revenue in the statement of income when due from policyholders?
[SOP 95-1, par. 12 (ACC 10,650.12)]

_____

_____

_____

Are death and surrender benefits incurred reported as expense in the
statement of income?
[SOP 95-1, par. 13 (ACC 10,650.13)]

_____

_____

_____

10. Are annual policyholder dividends reported separately as an expense
in the statement of income?
[SOP 95-1, par. 14 (ACC 10,650.14)]

_____

_____

_____

a. The methods and assumptions used in estimating the liability for
future policy benefits?

_____

_____

_____

b. The average rate of assumed investment yields used in estimating
expected gross margins?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: SOP 95-1, Accounting for Certain Insurance Activities of Mutual Life
Insurance Enterprises (AICPA, Technical Practice Aids, ACC sec. 10,650),
applies to life insurance contracts that have both of the following
characteristics:21
• They are long-duration participating contracts that are expected to
pay dividends to policyholders based on actual experience of the
insurance enterprise.
• Annual policyholder dividends are paid in a manner that identifies
divisible surplus and distributes that surplus in approximately the
same proportion as the contracts are considered to have contributed
to divisible surplus (commonly referred to in actuarial literature as
the contribution principle).
8.

9.

11. Are the following disclosed in the financial statements with respect to
participating contracts:

c. The nature of acquisition costs capitalized, the method of amortizing those costs, and the amount of those costs amortized for the
period?
[SOP 95-1, par. 24 (ACC 10,650.24); AAG, App. C, par. 20]
12. Has the entity disclosed a description of the liability valuation methods and assumptions used in estimating the liabilities for additional
insurance benefits and minimum guarantees?
[SOP 03-1, par. 38 (ACC 10,870.38); AAG, App. C, par. 13]
13. Have the following been disclosed in relation to minimum guarantees:
a. The separate account liability balances subject to various types of
benefits (for example, guaranteed minimum death benefit, guaranteed minimum income benefit, guaranteed minimum accumulation benefit)? Disclosures within these categories of benefits for
the types of guarantees provided may also be appropriate (for
example, return of net deposits, return of net deposits accrued at
a stated rate, return of highest anniversary value).
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b. The amount of liability reported for additional insurance benefits,
annuitization benefits and other minimum guarantees, by type of
benefit, for the most recent balance sheet date and the incurred and
paid amounts for all periods presented?
c. For contracts for which an additional liability is disclosed in
paragraph b above, net amount at risk and weighted average
attained age of contract holders?
[SOP 03-1, par. 38 (ACC 10,870.38); AAG, App. C, par. 13]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Q. Income Taxes
1.

2.

3.

4.

5.

Are deferred tax assets and liabilities determined for each tax-paying
component (an individual company or group of companies that is
consolidated for tax purposes) in each tax jurisdiction presented
separately?
[SFAS 109, par. 17]
Are the components of the net deferred tax liability or asset recognized in the balance sheet disclosed as follows:
a. The total of all deferred tax liabilities?
b. The total of all deferred tax assets?
c. The total valuation allowance for deferred tax assets?
[SFAS 109, par. 43]
Is the net change during the year in the total valuation allowance
disclosed?
[SFAS 109, par. 43]
Is the following information disclosed whenever a deferred tax liability is not recognized because of the exceptions to comprehensive
recognition of deferred taxes for any of the areas addressed by APB
23, Accounting for Income Taxes—Special Areas (as amended by SFAS
109, Accounting for Income Taxes):
a. A description of the types of temporary differences for which a
deferred tax liability is not recognized and the types of events that
would cause those temporary differences to become taxable?
b. The cumulative amount of each type of temporary differences?
c. The amount of the unrecognized deferred tax liability for temporary differences related to investments in foreign subsidiaries and
foreign corporate joint ventures that are essentially permanent in
duration if determination of that liability is practicable, or a statement that determination is not practicable?
d. The amount of the deferred tax liability for temporary differences
other than those in c. above (that is, undistributed domestic earnings, the bad debt reserve for tax purposes of a U.S. savings and
loan association or other qualified thrift lender, the policyholders’
surplus of a life insurance enterprise, and the statutory reserve
funds of a U.S. steamship enterprise) that is not recognized in
accordance with the provisions of paragraphs 31–32 of SFAS 109?
[SFAS 109, par. 44]
In a classified balance sheet:
a. Are deferred tax assets and deferred tax liabilities classified as
current or noncurrent based on the classification of the related
asset or liability for financial reporting?
[SFAS 109, par. 41]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

(1) All current deferred tax liabilities and assets?

_____

_____

_____

(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Obligations for items that entered the operating cycle?

_____

_____

_____

b. Collections received in advance of the performance of services?

_____

_____

_____

c. Debts that arise from operations directly related to the operating
cycle?

_____

_____

_____

d. Other liabilities whose regular and ordinary liquidation is likely
to occur within a relatively short time period?

_____

_____

_____

b. Are deferred tax assets or liabilities not related to an asset or
liability for financial reporting (including those related to carryforwards) classified according to the expected reversal date of the
temporary difference?
[SFAS 109, pars. 41 and 288p]
c. Is the valuation allowance for a particular tax jurisdiction allocated
between current and noncurrent deferred tax assets for that tax
jurisdiction on a pro rata basis?
[SFAS 109, par. 41]
d. Are the following items offset and presented as a single amount
for a particular taxpaying component and within a particular
taxpaying jurisdiction:

6.

Do the financial statements include disclosure of the following:
a. Disclosures relating to “Policyholders’ Surplus” as defined in the
Internal Revenue Code and as prescribed by APB 23?
b. The portion of retained earnings in excess of statutory unassigned
surplus upon which no income tax provisions have been made and
the reasons therefor?
[AAG, App. C, par. 14]

7.

If the reporting entity is a public enterprise:
a. Is the approximate tax-effect of each type of temporary difference
and carryforward that gives rise to a significant portion of deferred
tax liabilities and deferred tax assets (before valuation allowances)
disclosed?
b. If the reporting entity is not subject to income taxes because its
income is taxed directly to its owners, is that fact and the net
differences between the tax bases and reported amounts of the
enterprises’ assets and liabilities disclosed?
[SFAS 109, par. 43]

8.

If the reporting entity is a nonpublic enterprise, are the types of
temporary differences and carryforwards that give rise to a significant
portion of deferred tax liabilities and deferred tax assets (before
valuation allowances) disclosed?
[SFAS 109, par. 43]

R. Current Liabilities, Notes Payable, and Long-Term Debt
1.

For classified balance sheets, do current liabilities include:
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e. Obligations that, by their terms, are due on demand or will be due
within one year (or operating cycle, if longer) from the balance
sheet date, even though liquidation may not be expected within
that period?
[ARB 43, Ch. 3A, pars. 7–8; SFAS 78, par. 5]
2.

3.

4.

Do current liabilities exclude short-term obligations that the provider
intends to refinance on a long-term basis, provided the provider has
demonstrated the ability to consummate the long-term financing?
[SFAS 6, pars. 8–14; FIN 8, pars. 2–4]
Is there adequate disclosure of interest rates, maturities, and other
terms and conditions provided in loan agreements and bond indentures (such as assets pledged as collateral, and covenants to reduce
debt and maintain working capital)?
[FASCON 5, par. 11; SFAS 5, par. 18]
Are the following disclosed for each of the five years following the
date of the latest balance sheet presented:
a. The aggregate amount of payments for unconditional purchase
obligations that meet the criteria of SFAS 47, Disclosure of LongTerm Obligations, and that are recognized on the purchaser’s balance sheet?
b. The combined aggregate amount of maturities and sinking fund
requirements for all long-term borrowings?
c. The amount of redemption requirements for all issues of capital
stock that are redeemable at fixed or determinable prices on fixed
or determinable dates, separately by issue or combined?
[SFAS 47, par. 10]

5.

Are conversion features appropriately accounted for and disclosed?
[APB 14, par. 12]

6.

If a note is noninterest bearing or has an inappropriate stated interest
rate:
a. Is the discount or premium presented as a deduction from or
addition to the face amount of the note?
b. Does the disclosure include the effective interest rate and face
amount of the note?
c. Is amortization of the discount or premium reported as interest
expense?
d. Are issue costs reported in the balance sheet as deferred charges?
[APB 21, par. 16]

7.

8.

If a short-term obligation is to be excluded from current liabilities in
a classified balance sheet, do disclosures include:
a. A general description of the financing agreement?
b. The terms of any new obligation incurred or expected to be incurred, or equity securities issued or expected to be issued as a
result of the refinancing?
[SFAS 6, par. 15]
Are long-term debt agreements subject to a subjective acceleration
clause disclosed unless the likelihood of the acceleration of the due
date is remote?
[FTB 79-3]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____
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9.

Yes
_____

No
_____

N/A
_____

a. Description of the principal changes in terms, the major features
of settlement, or both?

_____

_____

_____

b. Aggregate gain on restructuring of payables?

_____

_____

_____

c. Aggregate net gain or loss on transfers of assets recognized during
the period?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. A general description of the transaction?

_____

_____

_____

b. The amount of debt that is considered extinguished at the end of
the period so long as that debt remains outstanding?
[SFAS 140, par. 17(b)]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

For a troubled debt restructuring occurring during the current period,
do disclosures include:

d. Per-share amount of the aggregate gain on restructuring of payables?
[SFAS 15, par. 25, as amended by SFAS 145, par. 7b]
10. For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the
carrying amount of restructured payables?
b. Total amounts that are contingently payable, if applicable, and
conditions under which those amounts would become payable or
forgiven?
[SFAS 15, par. 26]
11. If there is an early extinguishment of debt, is the difference between
reacquisition price and carrying amount identified as income in the
period of extinguishment as gain or loss?
[APB 26, pars. 20–21]
12. Is the following disclosed if debt was considered to be extinguished
by in-substance defeasance under the provisions of SFAS 76, Extinguishment of Debt, prior to the effective date of SFAS 125, Accounting
for Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities:

13. If assets are set aside after January 1, 1997 solely for satisfying scheduled payments of a specific obligation, is disclosure made describing
the nature of restrictions placed on those assets?
[SFAS 140, par. 17(c)]
14. Are long-term obligations that are or will be callable by the creditor,
either because the debtor’s violation of the debt agreement at the
balance sheet date makes the obligation callable, or because the violation (if not cured within a specified grace period) will make the
obligation callable, classified as current unless one of the following
conditions is met:
a. The creditor waives or subsequently loses the right to demand
repayment for more than one year (or operating cycle, if longer)
from the balance sheet date?
b. The obligation contains a grace period within which the debtor
may cure the violation and it is probable that the violation will be
cured within that period, thus preventing the obligation from
becoming callable?
[SFAS 78, par. 5]
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15. If a covenant on a long-term loan agreement is not met, and thus, the
lender has the right to call the debt, and the lender waives that right
for a period of greater than one year but retains the future covenant
requirements, is the debt classified as noncurrent unless both of the
following are met:
a. The covenant violation occurred at the balance sheet date or would
have occurred absent a loan modification?
b. It is probable the company will not be able to comply with the
covenant at a measurement date within the next 12 months?
[EITF 86-30]
16. Are borrowings outstanding under a revolving credit agreement that
includes both a subjective acceleration clause and a requirement to
maintain a lock-box arrangement, whereby remittances from the
borrower’s customers reduce the debt outstanding, classified as shortterm obligations?
[EITF 95-22]
17. In accordance with PB 15, Accounting by the Issuer of Surplus Notes, are
surplus notes classified as debt in the financial statements of the
issuer, and are existing disclosure requirements for debt instruments
complied with?
[AAG, par. 14.15, App. C, par. 15]
18. In accordance with PB 15, is the Insurance Commissioner’s role and
ability to approve or disapprove any interest or principal payments
disclosed?
[AAG, par. 14.15, App. C, par. 16]
19. If the reclassification to earnings of the amount in accumulated comprehensive income resulting from a cash flow hedge of debt is required under SFAS 133 when the debt is extinguished, is the
reclassified amount not classified as extraordinary?
[EITF 00-9]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

S. Other Liabilities
1.

2.

Are liabilities appropriately accrued and reported for employees’
compensation for future absences, including sabbatical leaves described in EITF 06-2, Accounting for Sabbatical Leave and Other Similar
Benefits Pursuant to FASB Statement No. 43?
[SFAS 43, par. 6; EITF 06-2, par. 5]
For insurance-related assessments:
a. If amounts relating to insurance-related assessments have been
discounted pursuant to the provisions of SOP 97-3, Accounting by
Insurance and Other Enterprises for Insurance-Related Assessments
(AICPA, Technical Practice Aids, ACC sec. 10,710), has the entity
disclosed in the financial statements the undiscounted amounts of
the liability and any related asset for premium tax offsets or policy
surcharges as well as the discount rate used?
b. If amounts have not been discounted, has the entity disclosed in
the financial statements the amounts of the liability, any related
asset for premium tax offsets or policy surcharges, the periods
over which the assessments are expected to be paid, and the period
over which the recorded premium tax offsets or policy surcharges
are expected to be realized?
[SOP 97-3, par. 27 (ACC 10,710.27); AAG, App. C, par. 26]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

T. Shareholders’ Equity
1.

For each class of stock, do disclosures include the number of shares
authorized, issued, and outstanding, and par or stated value per share?
[Generally Accepted]

2.

Are classes of capital stock presented in order of priority in liquidation?
[Generally Accepted]

3.

Do the financial statements include a description, in summary form,
sufficient to explain the pertinent rights and privileges of the various
securities outstanding (for example, dividend and liquidation preferences, participation rights, call prices and dates, conversion or exercise prices or rates and pertinent dates, sinking fund requirements,
unusual voting rights, and significant terms of contracts to issue
additional shares)?
[SFAS 129, par. 4]

4.

5.

6.

Do disclosures include the number of shares issued upon conversion,
exercise, or satisfaction of required conditions during at least the most
recent annual fiscal period and any subsequent interim period presented?
[SFAS 129, par. 5]
For preferred stock that has a preference in involuntary liquidation
considerably in excess of par or stated value of the shares, is the
liquidation preference disclosed in the equity section of the balance
sheet in the aggregate, either parenthetically or “in short,” rather than
on a per share basis or in the notes to the financial statements?
[SFAS 129, par. 6]
Are the following disclosed on the face of the balance sheet or in the
notes:
a. The aggregate or per share amounts at which preferred stock may
be called or are subject to redemption through sinking-fund operations or otherwise?
b. The aggregate and per share amounts of arrearages in cumulative
preferred dividends?
[SFAS 129, par. 7]

7.

8.

For redeemable stock, do disclosures include the amount of redemption requirements, separately by issue or combined, for all issues of
capital stock that are redeemable at fixed or determinable prices on
fixed or redeemable dates in each of the five years following the date
of the latest balance sheet?
[SFAS 129, par. 8]
Do disclosures for contingently convertible securities include the
significant quantitative and qualitative terms of the conversion features to enable users of the financial statements to understand the
circumstances of the contingency and the potential impact of conversion, including:
a. Events or changes in circumstances that would cause the contingency to be met and any significant features necessary to understand the conversion rights and the timing of those rights (for
example, the periods in which (1) the contingency might be met
and (2) the securities may be converted if the contingency is met)?
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b. The conversion price and the number of shares into which the
security is potentially convertible?
c. Events or changes in circumstances, if any, that could adjust or
change the contingency, conversion price, or number of shares,
including significant terms of those changes?
d. The manner of settlement upon conversion and any alternative
settlement methods (for example, cash, shares, or a combination)?
[FSP 129-1, par. 4]
9.

Do disclosures indicate whether the shares that would be issued if the
contingently convertible securities were converted are included in the
calculation of diluted EPS, and the reasons why or why not?
[FSP 129-1, par. 5]

10. Are appropriations of retained earnings for loss contingencies clearly
identified and included in shareholders’ equity?
[SFAS 5, par. 15]
11. Are restrictions on payment of dividends disclosed?
[SFAS 5, pars. 18–19]
12. After completion of a quasi-reorganization, is a new retained earnings
account established and dated with the date being disclosed in subsequent financial statements until it is no longer deemed significant?31
[ARB 43, Ch. 7A, par. 10; ARB 46; SFAS 111, par. 8(a)3]
13. Are the carrying basis, cost and number of shares of any treasury stock
held by the reporting entity disclosed?
[Generally Accepted]
14. If treasury stock is purchased for purposes other than retirement or if
ultimate disposition has not yet been decided, is its cost:
a. Shown separately as a deduction from the total of capital stock,
additional paid-in capital, and retained earnings? or
b. Accorded the accounting treatment appropriate for retired stock?
[APB 6, par. 12b]
15. If state laws relating to acquisition of stock restrict the availability of
retained earnings for payment of dividends or other significant effects, is appropriate disclosure made?
[APB 6, par. 13]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Notes: If SFAS 158, Employers’ Accounting for Defined Benefit Pension and
Other Postretirement Plans—an amendment of FASB Statements No. 87, 88,
106, and 132(R), has not been adopted answer question 16, if it has been
adopted answer question 17:
The statement provides different effective dates for the recognition and
related disclosure provisions and for the required change to a fiscal year-end
measurement date. Also, the effective date of the recognition and disclosure provisions differs for an employer that is an issuer of publicly traded
equity securities from one that is not. Readers should refer to the full text
of the statement to understand the various effective dates.
(continued)
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The amount of statutory capital and surplus?

_____

_____

_____

b. The amount of statutory capital and surplus necessary to satisfy
regulatory requirements (based on current operations) if significant in relation to the statutory capital and surplus?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

See section J1, “Employers’ Disclosures for Defined Benefit Pension and
Other Postretirement Plans” of the “Other Financial Statement Disclosures”
section of this checklist for additional disclosures and effective dates.
16. If an additional liability required to be recognized pursuant to SFAS
87, Employers’ Accounting for Pensions, paragraph 36, exceeds unrecognized prior-service cost, is the excess (which would represent a net
loss not yet recognized as net periodic pension cost) reported in other
comprehensive income, net of any tax benefits that result from considering such losses as temporary differences, for purposes of applying the provisions of SFAS 87, paragraph 37 and SFAS 109, paragraph
287?
[SFAS 87, par. 37]
17. If the asset or liability that is recognized pursuant to SFAS 87, paragraph 35, results in a temporary difference, as defined in SFAS 109, is
the deferred tax effects of any temporary differences recognized in
income tax expense or benefit for the year and allocated to various
financial statement components, including other comprehensive income, pursuant to paragraphs 35–39 of SFAS 109?
[SFAS 87, par. 37, as amended by SFAS 158]
18. For treasury shares purchased at a stated price significantly in excess
of current market price, is the allocation of amounts paid and the
accounting treatment for such amounts disclosed?
[FTB 85-6, pars. 1–3]
19. Is the following information relating to stockholders’ equity, statutory
capital and surplus, and the effects of statutory accounting practices
on the ability to pay dividends to stockholders disclosed:

c. The nature of statutory restrictions on the payment of dividends
and the amount of retained earnings that is not available for the
payment of dividends to stockholders?
[SFAS 60, par. 60h; AAG, App. C, par. 17]
20. If the company receives a note rather than cash as a contribution to its
equity, is the note classified as a reduction of stockholders’ equity
unless (in the very limited circumstance) there is substantial evidence
of ability and intent to pay within a reasonably short period of time?
[EITF 85-1]

Income Statement
A. Premium Revenue
1.

Are premiums from universal life contracts no longer included in
revenue but recorded in the balance sheet policyholder accounts?
[SFAS 97, par. 59]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The accounting policy selected from the two alternatives in paragraph 26 of SOP 93-7, Reporting on Advertising Costs (AICPA,
Technical Practice Aids, ACC sec. 10,590), for reporting advertising,
indicating whether such costs are expensed as incurred or the first
time the advertising takes place?

_____

_____

_____

b. A description of the direct-response advertising reported as assets
(if any), the accounting policy, and the amortization period?

_____

_____

_____

c. The total amount charged to advertising expense for each income
statement presented, with separate disclosure of amounts, if any,
representing a write-down to net realizable value and the reasons
for such a write-down?

_____

_____

_____

d. The total amount of advertising reported as assets in each balance
sheet?
[SOP 93-7, par. 49 (ACC 10,590.49)]

_____

_____

_____

Are payments to policyholders that represent a return of policyholder
balances not reported as expenses in the statement of earnings?
[AAG, par. 9.30; SFAS 97, par. 21]

_____

_____

_____

_____

_____

_____

B. Investment Income
1.

Are amounts of interest income, loan origination, commitment, amortization amounts, and other fees and costs recognized as an adjustment of yield reported as part of interest income?
[SFAS 91, par. 22; AAG, par. 11.69]

2.

Is investment income presented net of investment expenses?
[SFAS 97, par. 23]

3.

Are realized gains and losses on all investments (except investments
that are classified as trading securities and those that are accounted
for as either hedges of net investments in foreign operations or cash
flow hedges as described in SFAS 133) reported in the statement of
income as a component of other income, on a pretax basis?
[SFAS 97, par. 28]

4.

For all three categories of investments under SFAS 115, is interest and
dividend income, including amortization of premium and discount,
included in earnings?
[AAG, par. 11.12]

C. Other Income
1.

Is amortization of other fees, such as commitment fees that are being
amortized on a straight-line basis over the commitment period or
included in income when the commitment expires, reported as service
fee income?
[SFAS 91, par. 22]

D. Benefits and Expenses
1.

2.

3.

Do disclosures for advertising costs include:

Do amounts reported as expenses include benefit claims in excess of
the related policyholder balances, expenses of contract administration, interest accrued to policyholders, and amortization of capitalized acquisition costs?
[AAG, par. 9.30]
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4.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. Current tax expense or benefit?

_____

_____

_____

b. Deferred tax expense or benefit (exclusive of the effects of other
components listed below)?

_____

_____

_____

c. Investment tax credits?

_____

_____

_____

d. The benefits of operating loss carryforwards?

_____

_____

_____

e. Tax expense that results from allocating certain benefits, either
directly to contributed capital or to reduce goodwill or other
noncurrent intangible assets, of an acquired company?

_____

_____

_____

f. Adjustments of a deferred tax liability or asset for enacted changes
in tax laws or rates or a change in the tax status of the enterprise?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Are depreciation and other related charges or credits related to real
estate investments recorded as investment expense or operating expense depending on the balance sheet classification of the underlying
assets?
[AAG, par. 11.93; SFAS 60, par. 48]

E. Income Taxes
1.

2.

Are the types of significant temporary differences and carryforwards
disclosed?
[SFAS 109, par. 43]
Are the following significant components of income tax expense
attributable to continuing operations for each year presented disclosed in the financial statements or notes thereto:

g. Adjustments of the beginning-of-the-year balance of a valuation
allowance because of a change in circumstances that causes a
change in judgment about the realizability of the related deferred
tax asset in future years?
[SFAS 109, par. 45a–h]
h. The amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes?
i. Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to
reduce goodwill or other noncurrent intangible assets of an acquired entity or directly to contributed capital?
[SFAS 109, pars. 45 and 48]
3.

4.

5.

Is the amount of income tax expense or benefit allocated to continuing
operations and the amounts separately allocated to other items (in
accordance with the provisions of paragraphs 35–39 of SFAS 109)
disclosed for each year for which those items are presented?
[SFAS 109, par. 46]
If the company is a public enterprise, do the financial statements
disclose a reconciliation using percentages or dollar amounts of (i) the
reported amount of income tax expense attributable to continuing
operations for the year to (ii) the amount of income tax expense that
would result from applying domestic federal statutory tax rates to
pretax income from continuing operations?
[SFAS 109, par. 47]
If the company is a public enterprise, is the estimated amount and the
nature of each significant reconciling item disclosed?
[SFAS 109, par. 47]
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6.

7.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

If an entity is involved in the sale or purchase of tax benefits through
tax leases, are the accounting policies or practices followed for those
transactions disclosed in accordance with APB 22, Disclosure of Accounting Polices? Do the disclosures include the following:

_____

_____

_____

a. The method of accounting for those transactions?

_____

_____

_____

b. The methods of recognizing revenue?
c. The method of allocating income tax benefits and asset costs to
current and future periods?
[FTB 82-1, par. 4]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

If the company is a nonpublic enterprise, is the nature of significant
reconciling items disclosed (a numerical reconciliation may be omitted)?
[SFAS 109, par. 47]
If the company is a member of a group that files a consolidated tax
return, are the following items disclosed in its separately issued
financial statements:
a. The aggregate amount of current and deferred tax expense for
each statement of income presented and the amount of any taxrelated balances due to or from affiliates as of the date of each
statement of financial position presented?
b. The principal provisions of the method by which the consolidated
amount of current and deferred tax expense is allocated to members of the group and the nature and effect of any changes in that
method (and in determining related balances to or from affiliates)
during the years for which the disclosures in question a above are
presented?
[SFAS 109, par. 49a–b]

8.

9.

If material and unusual or infrequent to the entity, are the nature and
financial effects of transactions involving the sale or purchase of tax
benefits through tax leases disclosed on the face of the income statement or, alternatively, in the notes to the financial statements in
accordance with APB 30, Reporting the Results of Operations?
[FTB 82-1, par. 6]

10. Are disclosures included if significant contingencies exist with respect
to the sale or purchase of tax benefits through tax leases in accordance
with SFAS 5?
[FTB 82-1, par. 7]
11. Are disclosures included for any change in the method of accounting
for sales or purchases of tax benefits through tax leases that significantly affects comparability if comparative financial statements are
presented in accordance with paragraph 2 of Chapter 2A of ARB 43?
[FTB 82-1, par. 7]
12. Does an enterprise that previously recognized the qualified production activities deduction, associated with the American Jobs Creation
Act of 2004, as a tax rate reduction restate its financial statements in
accordance with paragraph 27 of APB 20, Accounting Changes, to
reflect the deduction as a special deduction as prescribed in paragraphs 231–232 of SFAS 109, and provide the disclosures required by
paragraph 28 of APB 20 and paragraph 14 of SFAS 3, Reporting
Accounting Changes in Interim Financial Statements, if applicable?
[FTB TB 82-1, par. 7 (I27.506)]
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Yes
_____

No
_____

N/A
_____

a. A summary of the repatriation provision as it applies to the
enterprise, including the status of the enterprise’s evaluation of the
effects of the repatriation provision as well as the evaluation’s
expected completion date?

_____

_____

_____

b. If the entity makes decisions in stages, the effect on income tax
expense (or benefit) for any amounts that have been recognized
under the repatriation provision? For annual financial statements,
any effect should be shown separately in the same place (either on
the face of the income statement or in the footnotes) that the
amounts of current and deferred taxes are disclosed for the period.

_____

_____

_____

c. The range of reasonably possible amounts of unremitted earnings
that is still being considered for repatriation as a result of the
repatriation provision and the related potential range of income
tax effects of such repatriation? If the related range of income tax
effects of such repatriation cannot be reasonably estimated at the
time of issuance of its financial statements, an enterprise shall
provide a statement to that effect.

_____

_____

_____

_____

_____

_____

_____

_____

_____

13. Is the following information disclosed for an enterprise that has not
yet completed its evaluation of the repatriation provision, associated
with the American Jobs Creation Act of 2004 (“Act”), for purposes of
applying SFAS 109 for each period for which financial statements
covering periods affected by the Act are presented:

d. Pro forma financial data for any effect of the repatriation provision
(at a minimum, the effect on income tax expense (or benefit)) if the
enterprise decides on a plan for reinvestment or repatriation of
foreign earnings (as a result of the repatriation provision) subsequent to the date of its financial statements but prior to the
issuance of those financial statements?
[FSP 109-2]
14. Is the following information provided in an enterprise’s financial
statements for the period in which it completes its evaluation of the
repatriation provision, associated with the American Jobs Creation
Act of 2004:
a. The total effect on income tax expense (or benefit) for amounts that
have been recognized under the repatriation provision? For annual financial statements, any effect should be shown separately
in the same place (either on the face of the income statement or in
the footnotes) that the amounts of current and deferred taxes are
disclosed for the period.
[FSP 109-2]
Notes: In June 2006, FIN 48 was issued. The interpretation is effective for
fiscal years beginning after December 15, 2006. Readers should refer to
paragraphs 23–24 of the interpretation for transition requirements. For
additional guidance readers may refer to a practice guide developed by
the staff of the AICPA Accounting Standards, Audit and Attest Standards,
and Tax Teams entitled “Accounting for Uncertain Tax Positions Under
FIN 48” to help practitioners implement FIN 48, “Accounting for Uncertain Tax Positions.” FIN 48 interprets SFAS 109.
In January 2008, FASB recommended that the effective date of FIN 48 for
nonissuers be deferred to fiscal years beginning after December 15, 2007.
Auditors would be advised to monitor the final effective date.
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

(1) The gross amounts of the increases and decreases in unrecognized tax benefits as a result of tax positions taken during a
prior period?

_____

_____

_____

(2) The gross amounts of increases and decreases in unrecognized tax benefits as a result of tax positions taken during the
current period?

_____

_____

_____

(3) The amounts of decreases in the unrecognized tax benefits
relating to settlements with taxing authorities?

_____

_____

_____

(4) Reductions to unrecognized tax benefits as a result of a lapse
of the applicable statute of limitations?

_____

_____

_____

b. The total amount of unrecognized tax benefits that, if recognized,
would affect the effective tax rate?

_____

_____

_____

c. The total amounts of interest and penalties recognized in the
statement of operations and the total amounts of interest and
penalties recognized in the statement of financial position?

_____

_____

_____

(1) The nature of the uncertainty?

_____

_____

_____

(2) The nature of the event that could occur in the next 12 months
that would cause the change?

_____

_____

_____

(3) An estimate of the range of the reasonably possible change or
a statement that an estimate of the range cannot be made?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

15. Does an enterprise disclose its policy on classification of interest and
penalties in accordance with paragraph 19 of FIN 48 in the footnotes
to the financial statements?
[FIN 48, par. 20]
16. Does an enterprise disclose the following at the end of each annual
reporting period presented:
a. A tabular reconciliation of the total amounts of unrecognized tax
benefits at the beginning and end of the period, which shall
include at a minimum:

d. For positions for which it is reasonably possible that the total
amounts of unrecognized tax benefits will significantly increase or
decrease within 12 months of the reporting date:

e. A description of tax years that remain subject to examination by
major tax jurisdictions?
[FIN 48, par. 21]
17. If an enterprise presents a classified statement of financial position,
does the entity classify a liability associated with an unrecognized tax
benefit as a current liability (or the amount of a net operating loss
carryforward or amount refundable is reduced) to the extent the
enterprise anticipates payment (or receipt) of cash within one year or
the operating cycle, if longer? Furthermore, has the liability for unrecognized tax benefits (or reduction in amounts refundable) not been
combined with deferred tax liabilities or assets?
[FIN 48, par. 17]
18. Is a liability that has been recognized as a result of applying FIN 48,
not classified as a deferred tax liability unless it arises from a taxable
temporary difference?
[FIN 48, par. 18]
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F.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Extraordinary Items, Unusual Items, Infrequent Items
1.

2.

3.

4.

5.

6.

7.

Do extraordinary items meet both criteria of (1) unusual nature and
(2) infrequency of occurrence?
[APB 30, par. 20]
Are extraordinary items segregated and shown (including applicable
income taxes) following income before extraordinary items and before net income?
[APB 30, par. 11]
Are descriptive captions and amounts (including applicable income
taxes) presented for individual extraordinary events or transactions,
preferably on the face of the income statement?
[APB 30, par. 11]
Do disclosures include descriptions of an extraordinary event or
transaction and the principal items entering into determination of
extraordinary gain or loss?
[APB 30, par. 11]
Are the income taxes applicable to extraordinary events disclosed on
the face of the statement of operations or in related notes?
[APB 30, par. 11]
Is each adjustment in the current period of an element of an extraordinary item that was reported in a prior period separately disclosed
as to year of origin, nature, and amount and classified separately in
the current period as an extraordinary item?
[SFAS 16, par. 16c]
Are material events or transactions that are either unusual in nature
or of infrequent occurrence, but not both (and therefore not meeting
criteria for extraordinary items):
a. Reported as a separate component of income from continuing
operations?
b. Accompanied by disclosure of the nature and financial effects of
each event?
[APB 30, par. 26]

8.

Is the following information disclosed in the notes to the financial
statements in the period(s) in which business interruption (BI) insurance recoveries are recognized:
a. The nature of the event resulting in business interruption losses?
b. The aggregate amount of BI insurance recoveries recognized during the period and the line item(s) in the statement of operations
in which those recoveries are classified (including amounts reported as an extraordinary item pursuant to APB 30)?
[EITF 01-13]

G. Earnings Per Share
Note: SFAS 128, Earnings per Share, applies only to entities with publicly
held common stock or potential common stock.
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1.

2.

3.

4.

5.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. A reconciliation of the numerators and denominators of the basic
and diluted per share computations for income from continuing
operations?

_____

_____

_____

b. The effect that has been given to preferred dividends in arriving
at income available to common shareholders’ in computing basic
EPS?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

If the reporting entity has a simple capital structure (only common
stock outstanding), are basic per share amounts for income from
continuing operations and for net income presented on the face of the
income statement for all periods for which an income statement or
summary of earnings is presented?
[SFAS 128, pars. 36 and 38]
If the reporting entity has other than a simple capital structure, are
basic and diluted per share amounts for income from continuing
operations and for net income presented on the face of the income
statement with equal prominence for all periods for which an income
statement or summary of earnings is presented? (Note: If diluted EPS
data are reported for at least one period, they should be reported for
all periods presented, even if they are the same amounts as basic EPS.)
[SFAS 128, pars. 36 and 38]
If discontinued operations, extraordinary items, or the cumulative
effect of accounting changes are reported in the period, are the basic
and diluted per share amounts for those line items presented on the
face of the income statement or in the notes?
[SFAS 128, par. 37]
If per share amounts not required to be presented by SFAS 128 are
disclosed, are they disclosed only in the notes and do the disclosures
indicate whether the per share amounts are pretax or net of tax?
[SFAS 128, par. 37]
Are the following disclosed for each period for which an income
statement is presented:

c. Securities (including those issuable pursuant to contingent stock
agreements) that could potentially dilute basic EPS in the future
that were not included in the computation of diluted EPS because
to do so would have been antidilutive for the period(s) presented?
[SFAS 128, par. 40]
6.

7.

For the latest period for which an income statement is presented, do
disclosures include a description of any transaction that occurs after
the end of the most recent period but before issuance of the financial
statements that would have changed materially the number of common shares or potential common shares outstanding at the end of the
period if the transaction had occurred before the end of the period?
[SFAS 128, par. 41]
If the number of common shares outstanding increases as a result of
a stock dividend or stock split or decreases as a result of a reverse stock
split, the computations of basic and diluted EPS should be adjusted
retroactively for all periods presented to reflect that change in capital
structure. If per share computations reflect such changes in the number of shares, is that fact disclosed?
[SFAS 128, par. 54]
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8.

9.

If changes in common stock resulting from stock dividends, stock
splits, or reverse stock splits occur after the close of the period but
before issuance of the financial statements, the per share computations for those and any prior-period financial statements presented
should be based on the new number of shares. If per share computations reflect such changes in the number of shares, is that fact disclosed?
[SFAS 128, par. 54]
When prior earnings per share amounts have been restated in compliance with an accounting standard requiring restatement, is the
effect of the restatement, expressed in per share terms, disclosed in
the period of restatement?
[SFAS 128, par. 57]

10. Are prior period earnings per share amounts presented for comparative purposes restated to conform to the consensus guidance in EITF
03-6, Participating Securities and the Two-Class Method under FASB
Statement No. 128, Earnings per Share?
[EITF 03-6]
11. For contingently convertible instruments outstanding at the date of
adoption of EITF 04-8, The Effect of Contingently Convertible Instruments
on Diluted Earnings per Share and whose terms have not been modified
since the date of issuance, are prior-period diluted earnings per share
restated to conform to the guidance in the consensus for comparative
purposes?
[EITF 04-8]
12. For contingently convertible instruments outstanding at the date of
adoption of EITF 04-8 and whose terms have been modified, are
prior-period diluted earnings per share restated to conform to the
guidance in the consensus for comparative purposes based on the
modified terms of the instrument at the date of adoption of EITF 04-8?
[EITF 04-8]
13. For contingently convertible instruments that have been stock settled
(stock settled would include conversion) prior to the date of adoption
of EITF 04-8, are all prior-period diluted earnings per share restated
to conform to the guidance in the consensus for comparative purposes?
[EITF 04-8]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

H. Comprehensive Income
1.

2.

3.

Are all components of comprehensive income reported in the financial statements in the period in which they are recognized?
[SFAS 130, par. 14]
Is a total amount for comprehensive income displayed in the financial
statement where the components of other comprehensive income are
reported?
[SFAS 130, par. 14]
Is an amount for net income displayed and included as a component
of comprehensive income?
[SFAS 130, pars. 15 and 22]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: If SFAS 158 is not effective, answer question 4, if it is effective, go
to question 5 below.
4.

5.

6.

7.

8.

9.

Are items included in other comprehensive income classified separately into foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt
and equity securities?
[SFAS 130, par. 17]
Are items included in other comprehensive income classified separately into foreign currency items, gains or losses associated with
pension or other postretirement benefits, prior service costs or credits
associated with pension or other postretirement benefits, transition
assets or obligations associated with pension or other postretirement
benefits, and unrealized gains and losses on certain investments in
debt and equity securities?
[SFAS 130, par. 17, as amended by SFAS 158]
Are reclassification adjustments made that avoid double counting in
comprehensive income of items that are displayed as part of net
income for a period that also had been displayed as part of other
comprehensive income in that period or other periods presented on
the face of the financial statement in which comprehensive income is
reported or disclosed in the notes?
[SFAS 130, par. 20, as amended by SFAS 158]
Are comprehensive income and its components displayed in a financial statement that is displayed with the same prominence as the other
financial statements? (Note: SFAS 130, Reporting Comprehensive Income encourages but does not require that the components of other
comprehensive income and total comprehensive income be displayed
below the total for net income in a statement that reports results of
operations or in a separate statement of comprehensive income that
begins with net income.)
[SFAS 130, pars. 22–23]
Are the components of other comprehensive income displayed either
net of related tax effects, or before related tax effects with one amount
shown for the aggregate tax effect related to the total of other comprehensive income items?
[SFAS 130, par. 24]
Is the amount of income tax expense or benefit allocated to each
component of other comprehensive income (including reclassification adjustments) displayed on the face of the statement in which
those components are displayed or disclosed in the notes to the
financial statements?
[SFAS 130, par. 25]

10. Is the total of other comprehensive income for a period transferred to
a component of equity that is displayed separately from retained
earnings and additional paid-in-capital in the balance sheet with a
descriptive title such as accumulated other comprehensive income?
[SFAS 130, par. 26]
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11. Are accumulated balances for each classification within accumulated other comprehensive income disclosed on the face of the balance
sheet, in the statement of changes in shareholders’ equity, or in the
notes?
[SFAS 130, par. 26]
12. Has the enterprise reported a total for comprehensive income in
condensed financial statements of interim periods?
[SFAS 130, par. 27]
13. Has the entity displayed as a separate classification within other
comprehensive income the net gain or loss on derivative instruments
designated and qualifying as cash flow hedging instruments that are
reported in comprehensive income pursuant to paragraphs 30 and 41
of SFAS 133?
[SFAS 133, par. 46]
14. As part of the disclosures of accumulated other comprehensive income, pursuant to paragraph 26 of SFAS 130, has the entity separately
disclosed the beginning and ending accumulated derivative gain or
loss, the related net change associated with current period hedging
transactions, and the net amount of any reclassification into earnings?
[SFAS 133, par. 47]
I.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Other
1.

2.

3.

4.

5.

Are the following excluded from determination of net income or
results of operations under all circumstances:
a. Adjustments or charges or credits resulting from transactions in
the company’s own capital stock?
b. Transfers to and from accounts properly designated as appropriated retained earnings?
c. Adjustments made pursuant to a quasi reorganization?
[APB 9, par. 28]
Is the amount of revenue and expense recognized from advertising
barter transactions disclosed for each income statement period presented?
[EITF 99-17]
If the entity engages in advertising barter transactions for which the
fair value is not determinable within the limits of EITF 99-17, Accounting for Advertising Barter Transactions, is information regarding the
volume and type of advertising surrendered and received (such as the
number of equivalent pages, the number of minutes, or the overall
percentage of advertising volume) disclosed for each income statement period presented?
[EITF 99-17]
At a minimum, is a description of the nature and amounts of losses
and costs recognized as a result of the September 11 events and the
amount of related insurance recoveries (if any) recognized disclosed
in the notes to the financial statements in all periods affected by the
September 11, 2001 attacks?
[EITF 01-10]
Are losses and costs incurred as a result of the September 11, 2001
attacks classified as part of income from continuing operations?
[EITF 01-10]

Copyright © 2008

78

2-08

20,343

FSP §20,300.03

50

Life and Health Insurance Entities

6.

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Does a vendor disclose the following in regard to revenue arrangements with multiple deliverables:
a. Its accounting policy for recognition of revenue from multipledeliverable arrangements (for example, whether deliverables are
separable into units of accounting)?
b. The description and natures of such arrangements, including performance, cancellation, termination, or refund-type provisions?
[EITF 00-21]

7.

Yes
_____

Is the income statement classification of the expense associated with
a “free” product or service delivered at the time of sale of another
product or service classified as cost of sales?
[EITF 01-9]

Notes: EITF 06-3, How Taxes Collected from Customers and Remitted to
Governmental Authorities Should Be Presented in the Income Statement (That
Is, Gross Versus Net Presentation), provides guidance on the presentation
of taxes in the income statement. The Task Force reached a consensus that
the disclosures required under EITF 06-3 should be applied retrospectively to interim and annual financial statements for all periods presented,
if those amounts are significant. The disclosure of those taxes described
under the consensus can be made on an aggregate basis. The Task Force
observed that since EITF 06-3 requires only the presentation of additional
disclosures, at the date of adoption an entity would not be required to
reevaluate its existing policies related to taxes assessed by a governmental
authority that are imposed concurrently on a specific revenue-producing
transaction between a seller and a customer. An entity that chooses to
reevaluate its existing policies and elects to change the presentation of
taxes within the scope of EITF 06-3 must follow the requirements of SFAS
154, which provides that an entity may voluntarily change its accounting
principles only to adopt a preferable accounting principle.
The consensuses in EITF 06-3 should be applied to financial reports for
interim and annual reporting periods beginning after December 15, 2006.
Earlier application is permitted.
8.

Is the accounting policy decision regarding the presentation of taxes
within the scope of EITF 06-3 Issue 1 on either a gross basis (included
in revenues and costs) or a net basis (excluded from revenues) disclosed pursuant to APB 22?
[EITF 06-3, par. 4]

Note: An entity is not required to reevaluate its existing policies related
to taxes assessed by a governmental authority as a result of this consensus.
9.

For any such taxes that are reported on a gross basis, does the entity
disclose the amounts of those taxes in interim and annual financial
statements for each period for which an income statement is presented
if those amounts are significant?
[EITF 06-3, par. 4]

Note: The disclosure of those taxes can be done on an aggregate basis.
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: The AICPA has released a series of questions and answers also
known as a Technical Practice Aid. TIS section 5400.05, “Accounting and
Disclosures Guidance for Losses From Natural Disasters—Nongovernmental Entities,” identifies certain issues that may arise in accounting for
losses from natural disasters and lists relevant accounting literature for
nongovernmental entities to consider in addressing those financial reporting issues.

Statement of Changes in Shareholders’ Equity
1.

Are changes in the separate accounts of shareholders’ equity disclosed?
[APB 12, par. 10]

2.

Are changes in the number of shares of equity securities disclosed?
[APB 12, par. 10]

3.

If prior-period adjustments have been recorded during the current
year, are their resulting effects (both gross and net of applicable
income taxes and including the amounts of income tax applicable to
the prior period adjustments) appropriately disclosed:
a. For single-period statements, does the disclosure indicate the
effects of such restatement on the balance of retained earnings at
the beginning of the period and on the net income of the immediately preceding period?
b. If financial statements of more than one period are presented, does
disclosure include the effects for each of the periods presented in
the statements?
[APB 9, par. 26]
Practice Tip

Disclosure of restatements in annual reports issued subsequent to the first such post-revision disclosure
would ordinarily not be required.
4.

If the reporting entity is a publicly traded company and if interim
financial data and disclosures are not separately reported for the
fourth quarter, are accounting changes made during the fourth quarter, disposals of segments of a business (components of an entity, if
SFAS 144 is effective), extraordinary, unusual, or infrequently occurring items recognized in the fourth quarter, and the aggregate effect
of year end adjustments that are material to the results of that quarter
disclosed in a note to the financial statements?
[APB 28, par. 31]

_____

_____

_____

_____

_____

_____

_____

_____

_____

Statement of Cash Flows
1.

2.

Is a statement of cash flows presented as a basic financial statement
(for each period for which a statement of income is presented) if
financial statements present both financial position and results of
operations?
[SFAS 95, par. 3]
Are cash receipts and cash payments from operating activities shown
separately on the statement of cash flows?
[SFAS 95, pars. 27–28]

Copyright © 2008

78

2-08

20,345

FSP §20,300.03

52

Life and Health Insurance Entities
Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Cash receipts from sales of goods or services?

_____

_____

_____

b. Cash receipts from interest and dividends?

_____

_____

_____

c. All other cash receipts that do not stem from transactions defined
as investing or financing activities?

_____

_____

_____

d. Cash payments to suppliers and employees, such as benefits paid
to policyholders, surrender benefits, and dividends paid to policyholders?

_____

_____

_____

e. Cash payments to governments for taxes, duties, fines, and other
fees or penalties and the cash that would have been paid for
income taxes if increases in the value of equity instruments issued
under share-based payment arrangements that are not included
in the cost of goods or services recognizable for financial reporting
purposes also had not been deductible in determining taxable
income? (This is the same amount reported as a financing cash
inflow pursuant to paragraph 19(e) of SFAS 95, Statement of Cash
Flows.)

_____

_____

_____

f. Cash payments to lenders and other creditors for interest?

_____

_____

_____

g. Payments to settle lawsuits?

_____

_____

_____

h. Contributions to charities?

_____

_____

_____

i. Cash flows from purchases, sales, and maturities of trading securities?

_____

_____

_____

j. All other cash payments that do not stem from transactions defined as investing or financing activities?
[SFAS 95, pars. 22–23, as amended by SFAS 123(R)]

_____

_____

_____

Is cash payment made to settle an asset retirement obligation classified in the statement of cash flows as an operating activity?
[EITF 02-6]

_____

_____

_____

Are cash receipts and cash payments from investing activities shown
separately on statement of cash flows?
[SFAS 95, par. 31]

_____

_____

_____

a. Are cash receipts and cash payments resulting from purchases and
sales of securities classified as trading securities as discussed in
SFAS 115, classified as operating cash flows?
[SFAS 102, par. 8, as amended by SFAS 115, as amended by SFAS
145]
b. Are cash receipts and cash payments from purchases and sales of
securities and other assets acquired for resale and carried at market value in a trading account classified as operating cash flows?
[SFAS 102, par. 8, as amended by SFAS 115]
c. Are cash receipts and cash payments resulting from purchases,
acquisitions and sales of loans, if those loans are acquired specifically for resale and are carried at market value or the lower of cost
or market, classified as operating cash flows?
[SFAS 102, par. 9]
3.

4.

5.

6.

Are cash receipts and cash payments for the following transactions
classified as cash flows from operating activities:

Are cash receipts and cash payments for the following transactions
classified as cash flows from investing activities:
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Financial Statements and Notes Checklist
Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

10. Is the change in cash and cash equivalents shown?
[SFAS 95, pars. 7 and 26]

_____

_____

_____

11. Is the policy for defining cash equivalent disclosed?
[SFAS 95, par. 10]

_____

_____

_____

Receipts from collections or sales of loans?
Receipts from sales of property, plant, and equipment?
Loans to others?
Payments to acquire property, plant, and equipment?
Receipts from sales of equity instruments of other enterprises
exclusive of those carried in the trading account?
f. Payments to acquire equity instruments of other enterprises, exclusive of those carried in a trading account?
[SFAS 95, pars. 16–17, as amended by SFAS 102, as amended by
SFAS 115]
a.
b.
c.
d.
e.

7.

8.

9.

Are cash receipts and cash payments from financing activities shown
separately on the statement of cash flows?
[SFAS 95, par. 31]
Are cash receipts and cash payments for the following transactions
classified as cash flows from financing activities:
a. Proceeds from issuing equity instruments?
b. Proceeds from issuing bonds, mortgages, and notes, and from
other short- or long-term borrowing?
c. Repayment of amounts borrowed?
d. Dividend payments to stockholders?
e. Acquisition of treasury stock?
f. Other principal payments to creditors who have extended longterm credit?
g. Debt issue costs?
h. Proceeds received from derivative instruments and distributions
to counterparties of derivative instruments that include financing
elements at inception?
[SFAS 95, pars. 19–20, as amended by SFAS 149; EITF 95-13]
i. Cash retained as a result of the tax deductibility of increases in the
value of equity instruments issued under share-based payment
arrangements that are not included in the cost of goods or services
that is recognizable for financial reporting purposes? For this
purpose, excess tax benefits shall be determined on an individual
award (or a portion thereof) basis. (Note: This item is only effective
if the provisions of SFAS 123(R), Share-Based Payment are effective.)
[SFAS 123(R), par. 68a]
If applicable, is the effect of exchange rate changes on cash balances
held in foreign currencies shown separately on statement of cash
flows?
[SFAS 95, par. 25]

Practice Tip
Any change in policy for determining which items are treated as cash equivalents is a change in accounting
principle.
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Yes
_____

No
_____

N/A
_____

12. Are noncash investing and financing activities, such as converting
debt to equity, summarized in a separate schedule?
[SFAS 95, par. 32]

_____

_____

_____

13. If the direct method is used, is a separate schedule provided to
reconcile net income to net cash flow from operating activities?
[SFAS 95, par. 30]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Cash collected from customers, including lessees, licensees, and
the like?

_____

_____

_____

b. Interest and dividends received?

_____

_____

_____

c. Other operating cash receipts, if any?

_____

_____

_____

d. Cash paid to employees and other suppliers of goods or services,
including suppliers of insurance, advertising, and the like?

_____

_____

_____

e. Interest paid?

_____

_____

_____

f. Income taxes paid and, separately, the cash that would have been
paid for income taxes if increases in the value of equity instruments issued under share-based payment arrangements that are
not recognizable as a cost of goods or services for accounting
purposes also had not been deductible in determining taxable
income (paragraph 19(e) of SFAS 95)?

_____

_____

_____

_____

_____

_____

_____

_____

_____

14. If the indirect method is used:
a. Is the same amount for net cash flow from operating activities
reported indirectly, by adjusting net income to reconcile it to net
cash flow from operating activities?
b. Is the reconciliation of net income to net cash flows from operating
activities reported, either within the statement of cash flows or
provided in a separate schedule (the reconciliation should separately report all major reconciling items pertaining to operating
activities)?
[SFAS 95, pars. 29–30]
15. If the indirect method is used, are the amounts of interest paid (net of
amounts capitalized) and income taxes paid during the period(s)
disclosed?
[SFAS 95, par. 29]
16. Are the following classes of operating cash receipts and payments for
life insurance companies using the direct method, at a minimum,
separately disclosed:

g. Other operating cash payments, if any?
[SFAS 95, par. 27, as amended by SFAS 123(R)]
17. If an other-than-insignificant financing element is present at inception, other than a financing element inherently included in an at-themarket derivative instrument with no prepayments (that is, the
forward points in an at-the-money forward contract), does the borrower report all cash inflows and outflows associated with that derivative instrument in a manner consistent with financing activities as
described in paragraphs 18–20 of SFAS 95?
[SFAS 133, par. 45A, as amended by SFAS 149, par. 18]
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Financial Statements and Notes Checklist
Yes
_____

No
_____

N/A
_____

a. Balance sheet?

_____

_____

_____

b. Statement of income (operations)?

_____

_____

_____

c. Statement of retained earnings or changes in shareholders’ equity?

_____

_____

_____

d. Statement of cash flows?

_____

_____

_____

e. Description of accounting policies?

_____

_____

_____

f. Notes to the financial statements?
[Generally Accepted]

_____

_____

_____

2.

Are the financial statements suitably titled?
[Generally Accepted]

_____

_____

_____

3.

Does each statement include a general reference indicating that the
notes are an integral part of the financial statement presentation?
[Generally Accepted]

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Is a selection from existing acceptable alternatives?

_____

_____

_____

b. Are principles and methods peculiar to the industry in which the
reporting entity operates, even if such principles and methods are
predominantly followed in that industry?

_____

_____

_____

_____

_____

_____

_____

_____

_____

Is the company’s accounting policy with respect to vendor’s sales
incentive arrangements disclosed?
[EITF 03-10]

_____

_____

_____

Do mutual life insurance companies disclose the principles and methods used to account for marketable securities and insurance activities?
[FIN 40, par. 5]

_____

_____

_____

General
A. Titles and References
1.

For a full presentation in conformity with GAAP, are the following
financial statements presented:

B. Disclosure of Accounting Policies
1.

2.

3.

Is a description of all significant accounting policies of the reporting
company presented as an integral part of the financial statements?
[APB 22, par. 8]
Do the summary or notes identify and describe all significant accounting principles followed by the reporting entity and the methods of
applying those principles that materially affect the determination of
financial position, cash flows, and results of operations?
[APB 22, par. 12]
Do those principles and methods identified in question 2 include all
instances in which there:

c. Are unusual or innovative applications of GAAP?
[APB 22, par. 12]
4.

5.

6.

Does disclosure of significant accounting policies include appropriate
reference to details presented elsewhere (in the statements and notes
thereto) so duplication of details is avoided?
[APB 22, par. 14]
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7.

Yes
_____

No
_____

N/A
_____

a. If an insurance enterprise’s risk-based capital would have triggered a regulatory event had it not used a permitted practice, is
that fact disclosed in the financial statements?

_____

_____

_____

b. A description of the prescribed or permitted statutory accounting
practice by insurance enterprises at the date each financial statement is presented?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Statutory accounting practices?

_____

_____

_____

b. Describe how this basis differs from GAAP?
[SOP 95-5, par. 20 (AUD 14,310.20)]

_____

_____

_____

_____

_____

_____

_____

_____

_____

If (a) state prescribed statutory accounting practices differ from NAIC
statutory accounting practices or (b) permitted state statutory accounting practices differ from either state prescribed statutory accounting
practices or NAIC statutory accounting practices, is the following
information about the use of prescribed or permitted statutory accounting practices (individually or in the aggregate) results in reported statutory surplus or risk-based capital that is significantly
different from the statutory surplus or risk-based capital that would
have been reported had NAIC statutory accounting practices been
followed, disclosed:

c. The related monetary effect on statutory surplus of using an
accounting practice that differs from either state prescribed statutory accounting practices or NAIC statutory accounting practices
by insurance enterprises at the date each financial statement is
presented?41
[SOP 94-5, par. 8 (ACC 10,630.08), as amended by SOP 01-5 (ACC
10,840)]
8.

9.

Are managements’ policies and methodologies for estimating a liability for unpaid claims and claim adjustment expenses for difficult-toestimate liabilities such as for claims for toxic waste cleanup,
asbestos-related illnesses, or other environmental remediation exposures disclosed?
[SOP 94-5, par. 11 (ACC 10,630.11), as amended by SOP 01-5 (ACC
10,840)]
Do the notes to the accompanying insurance enterprise’s statutory
financial statements contain a summary of significant accounting
policies that discuss the following:

10. For general-use statutory financial statements, are the effects of the
differences between statutory accounting practices and GAAP, if
quantified, disclosed?
[SOP 95-5, par. 20 (AUD 14,310.20)]
11. Has the insurance company disclosed its accounting policy for internal
replacements, including whether or not the company has availed itself
of the alternative application guidance in paragraphs 18–19 of SOP
05-1, and if so, for which types of internal replacement transactions?
[SOP 05-1, par. 28 (ACC 10,920.28)]
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Financial Statements and Notes Checklist
Yes
_____

No
_____

N/A
_____

a. The nature of the costs deferred?

_____

_____

_____

b. The method of amortizing those costs?
[SOP 03-1, par. 39 (ACC 10,870.39); AAG, App. C, par. 9]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

12. Has the insurance company disclosed its accounting policy for sales
inducements, including:

13. For sales inducements, are the amount of costs deferred and amortized for each of the periods presented and the unamortized balance
as of each balance sheet date disclosed?
[SOP 03-1, par. 39 (ACC 10,870.39); AAG, App. C, par. 9]
14. Has the insurance company disclosed its accounting policy for separate accounts, including:
a. The general nature of the contracts reporting in separate accounts,
including the extent and terms of minimum guarantees?
b. The basis of presentation for separate account assets and liabilities
and related separate account activity?
[SOP 03-1, par. 38 (ACC 10,870.38); AAG, App. C, par. 5]
15. Has the insurance company included a description of the liability
valuation methods and assumptions used in estimating the liabilities
for additional insurance benefits and minimum guarantees?
[SOP 03-1, par. 38 (ACC 10,870.38); AAG, App. C, par. 13]
16. If consolidated statements are presented; is the consolidation policy
disclosed?
[ARB 51, par. 5; APB 22, par. 13]
C. Comparative Financial Statements
1.

Are comparative statements considered?
[ARB 43, Ch. 2A, pars. 1–2]

2.

Are the notes and other disclosures included in the financial statements of the preceding year(s) presented, repeated, or at least referred
to, to the extent that they continue to be of significance?
[ARB 43, Ch. 2A, par. 2]

3.

If changes occurred in the manner of or basis for presenting corresponding items for two or more periods, are appropriate explanations
of the changes disclosed?
[ARB 43, Ch. 2A, par. 3, as amended by APB 20]

D. Accounting Changes and Error Corrections51
Change in Accounting Principle
1.

Is the following disclosed in the fiscal period in which a change in
accounting principle is made:
a. The nature of and reason for the change in accounting principle,
including an explanation of why the newly adopted accounting
principle is preferable?
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Yes
_____

No
_____

N/A
_____

(1) A description of the prior-period information that has been
retrospectively adjusted, if any?

_____

_____

_____

(2) The effect of the change on income from continuing operations, net income (or other appropriate captions of changes in
the applicable net assets or performance indicator), any other
affected financial statement line item, and any affected per
share amounts for the current period and any prior periods
retrospectively adjusted? Presentation of the effect on financial statement subtotals and totals other than income from
continuing operations and net income (or other appropriate
captions of changes in the applicable net assets or performance indicator) is not required.

_____

_____

_____

(3) The cumulative effect of the change on retained earnings or
other components of equity or net assets in the statement of
financial position as of the beginning of the earliest period
presented?

_____

_____

_____

(4) If retrospective application to all prior periods (paragraph 7
of SFAS 154) is impracticable, disclosure of the reasons therefore, and a description of the alternative method used to
report the change (paragraphs 8–9 of SFAS 154)?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

b. The method of applying the change, and:

c. If indirect effects of a change in accounting principle are recognized:
(1) A description of the indirect effects of a change in accounting
principle, including the amounts that have been recognized
in the current period, and the related per share amounts, if
applicable?
(2) Unless impracticable, the amount of the total recognized
indirect effects of the accounting change and the related per
share amounts, if applicable, that are attributable to each
prior period presented?
[SFAS 154, par. 17]
Note: Financial statements of subsequent periods need not repeat the
disclosures required by this paragraph.
[SFAS 154, par. 17]
2.

3.

If a change in accounting principle has no material effect in the period
of change but is reasonably certain to have a material effect in later
periods, are the disclosures required by question 1a above provided
whenever the financial statements of the period of change are presented?
[SFAS 154, par. 17]
In the fiscal year in which a new accounting principle is adopted, does
financial information reported for interim periods after the date of
adoption include disclosure of the effect of the change on income from
continuing operations, net income (or other appropriate captions of
changes in the applicable net assets or performance indicator), and
related per share amounts, if applicable, for those post-change
interim periods?
[SFAS 154, par. 18]

Copyright © 2008

FSP §20,300.03

78

2-08

20,352

59

Financial Statements and Notes Checklist

4.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. The cumulative effect of the change to the new accounting principle on periods prior to those presented reflected in the carrying
amounts of assets and liabilities as of the beginning of the first
period presented?

_____

_____

_____

b. The cumulative effect of the change on retained earnings or on
other components of equity or net assets in the statement of
financial position?

_____

_____

_____

_____

_____

_____

a. A description of the prior-period information that has been
retrospectively adjusted?

_____

_____

_____

b. The effect of the change on income from continuing operations,
net income (or other appropriate captions of changes in the applicable net assets or performance indicator), any other affected
financial statement line item, and any affected per share amounts
for any prior periods retrospectively adjusted?

_____

_____

_____

If a public company that regularly reports interim information makes
an accounting change during the fourth quarter of its fiscal year and
does not report the data specified by paragraph 30 of APB 28, in a
separate fourth-quarter report or in its annual report, does the entity
include disclosure of the effects of the accounting change on interimperiod results, as required by paragraph 17 of SFAS 154, in a note to
the annual financial statements for the fiscal year in which the change
is made?
[SFAS 154, par. 16]

Note: EITF 06-2. The task force reached a consensus that the issue should
be effective for fiscal years beginning after December 15, 2006. An entity
should apply the consensus reached in the issue through either (a) a
change in accounting principle through a cumulative effect adjustment to
retained earnings or to other components of equity or net assets in the
statement of financial position at the beginning of the year of adoption or
(b) a change in accounting principle through retrospective application to
all prior periods. Earlier adoption of this guidance is permitted as of the
beginning of an entity’s fiscal year provided that the entity has not yet
issued financial statements, including interim financial statements, for
any period of that fiscal year.
5.

6.

If an entity chooses to apply the consensus in EITF 06-2 as a change
in accounting principle through a cumulative-effect adjustment to
retained earnings, does the entity disclose the cumulative effect of the
change on retained earnings or other components of equity or net
assets in the statement of financial position?
[EITF 06-2, par. 7]
If an entity chooses to apply the consensus in EITF 06-2 as a change
in accounting principle through retrospective application to all prior
periods, does the entity include the recognition of:

c. Adjustments to financial statements for each individual prior
period presented to reflect the period-specific effects of applying
the new accounting principle?
[EITF 06-2, par. 8]
7.

If an entity chooses to apply the consensus reached in this EITF 06-2
as a change in accounting principle through retrospective application
to all prior periods, are the following disclosed:
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c. The cumulative effect of the change on retained earnings or on
other components of equity or net assets in the statement of
financial position as of the beginning of the earliest period presented?
[EITF 06-2, par. 9]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Change in Accounting Estimate
8.

9.

Is the effect on income from continuing operations, net income (or
other appropriate captions of changes in the applicable net assets or
performance indicator), and any related per share amounts of the
current period disclosed for a change in estimate that affects several
future periods, such as a change in service lives of depreciable assets?
Disclosure of those effects is not necessary for estimates made each
period in the ordinary course of accounting for items such as uncollectible accounts or inventory obsolescence; however, if the effect of
a change in the estimate is material, is it disclosed?
[SFAS 154, par. 22]
When an entity effects a change in estimate by changing an accounting
principle, are the disclosures required by questions 1–3 above made?
[SFAS 154, par. 22]

10. If a change in estimate does not have a material effect in the period of
change but is reasonably certain to have a material effect in later
periods, is a description of that change in estimate disclosed whenever
the financial statements of the period of change are presented?
[SFAS 154, par. 22]
Change in the Reporting Entity
11. When there has been a change in the reporting entity, does the
financial statements of the period of the change describe the nature of
the change and the reason for it?
a. Is the effect of the change on income before extraordinary items,
net income (or other appropriate captions of changes in the applicable net assets or performance indicator), other comprehensive
income, and any related per share amounts disclosed for all periods presented?
[SFAS 154, par. 24]
Note: Financial statements of subsequent periods need not repeat the
disclosures required by this paragraph.
[SFAS 154, par. 24]
12. If a change in reporting entity does not have a material effect in the
period of change but is reasonably certain to have a material effect in
later periods, is the nature of and reason for the change disclosed
whenever the financial statements of the period of change are presented?
[SFAS 154, par. 24]
Note: Paragraphs 51–58 of SFAS 141, Business Combinations, describe the
manner of reporting and the disclosures required for a business combination.
[SFAS 154, par. 24]
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Yes
_____

No
_____

N/A
_____

13. When financial statements are restated to correct an error, does the
entity disclose that its previously issued financial statements have
been restated, along with a description of the nature of the error? Does
the entity also disclose the following:

_____

_____

_____

a. The effect of the correction on each financial statement line item
and any per share amounts affected for each prior period presented?

_____

_____

_____

_____

_____

_____

14. In addition, does the entity make the disclosures of prior-period
adjustments and restatements required by paragraph 26 of APB 9,
Reporting the Results of Operations?

_____

_____

_____

a. The effects, in total and by class, of the correction on change in net
assets for each of the periods presented?

_____

_____

_____

_____

_____

_____

Correction of an Error in Previously Issued Financial Statements

b. The cumulative effect of the change on retained earnings or other
appropriate components of equity or net assets in the statement of
financial position, as of the beginning of the earliest period presented?
[SFAS 154, par. 26]

b. For single period financial statements, the effects, in total and by
class, of the correction on change in net assets of the preceding
year?
[APB 9, par. 26; SFAS 154, par. 26]
Note: Financial statements of subsequent periods need not repeat the
disclosures required by this paragraph. An entity that issues interim
financial statements shall provide the required disclosures in the financial
statements of both the interim period of the change and the annual period
of the change.
[SFAS 154, par. 26]

Notes: EITF 06-6, Debtor’s Accounting for a Modification (or Exchange) of
Convertible Debt Instruments, applies to modifications or exchanges of debt
instruments occurring in interim or annual reporting periods beginning
after board ratification (November 29, 2006). The scope of this issue
includes modifications and exchanges of debt instruments that (a) either
add or eliminate an embedded conversion option or (b) affect the fair value
of an existing embedded conversion option. Earlier application of this issue
is permitted for modifications or exchanges of debt instruments in periods
for which financial statements have not yet been issued. Retrospective
application to previously issued financial statements is not permitted. The
guidance in this issue supersedes EITF 05-7, Accounting for Modifications
to Conversion Options Embedded in Debt Instruments and Related Issues. If
EITF 06-6 is applicable to the financial statements, skip question 15.
EITF 05-7 should be applied to future modifications of debt instruments
beginning in the first interim or annual reporting period beginning after
December 15, 2005. Early application of this guidance is permitted in
periods for which financial statements have not yet been issued. At
the September 28, 2005 meeting, the board ratified the consensus
reached by the task force in this issue.
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15. If the scope of EITF 05-7 applies, are the disclosures required by SFAS
154 made excluding those disclosures that require the effects of retroactive application?
[EITF 05-7, par. 8]
16. For debt instruments that were converted (or extinguished) in prior
periods that fall within the scope of EITF 00-27, Application of Issue No.
98-5 to Certain Convertible Instruments, but are still presented in the
financial statements, has the entity retrospectively applied SFAS 154
and recorded SFAS 109 temporary differences as adjustments to
paid-in-capital?
[EITF 05-8, par. 6]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Investments in Real Estate Ventures
Notes: For general partners of all new partnerships formed and for
existing partnerships for which the partnership agreements are modified,
the guidance in FSP SOP 78-9-1, Interaction of AICPA Statement of Position
78-9 and EITF Issue No. 04-5 is effective after June 29, 2005. For general
partners in all other partnerships, the guidance in FSP 78-9 is effective no
later than the beginning of first reporting period in fiscal years beginning
after December 15, 2005, and the application of either Transition Method
A or Transition Method B, described in FSP SOP 78-9-1 is permitted.
For more information on the accounting and reporting for real estate
ventures, readers should refer to SOP 78-9, Accounting for Investments in
Real Estate Ventures (AICPA, Technical Practice Aids, ACC sec. 10,240), as
amended by FSP SOP 78-9-1. Readers may also refer to the AICPA checklist,
Checklist Supplement and Illustrative Financial Statements for Real Estate
Ventures (product no. 008978kk).
17. Upon the application of Transition Method A of FSP SOP 78-9-1, does
the entity disclose in the year of adoption the effect on the opening
balance sheet of adopting the new accounting principle?
[FSP SOP 78-9-1, par. 8]
18. Upon the application of Transition Method B of FSP SOP 78-9-1, if the
entity applies the guidance in FSP SOP 78-9-1 through retrospective
application, does it apply the guidance in paragraphs 7–8 and 10 of
SFAS 154, and the disclosures required by paragraph 17 of SFAS 154?
[FSP SOP 78-9-1, par. 10]
E. Risks and Uncertainties
Notes: The guidance in FSP SOP 94-6-1, Terms of Loan Products That May
Give Rise to a Concentration of Credit Risk, is effective for interim and annual
periods ending after December 19, 2005. An entity shall provide the
disclosures required by SFAS 107 for products that are determined to
represent a concentration of credit risk in accordance with the guidance
in question 1 of the FSP for all periods presented.
[FSP SOP 94-6-1, par. 17]
Question 2 of the FSP references only existing effective literature; therefore, no effective date or transition guidance is required.
[FSP SOP 94-6-1, par. 18]
(continued)
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

The type and extent of information provided shall be determined by
whether the entity is the originator, holder, investor, guarantor, or servicer
and also by the significance of the loan product(s) to the reporting entity.
[FSP SOP 94-6-1, par. 9 (question 2)]
1.

2.

3.

4.

Is a description of the major products and services the entity sells or
provides and the principal markets, including the location of those
markets, disclosed?
[SOP 94-6, par. 10 (ACC 10,640.10); FSP SOP 94-6-1, par. 10]
If the company operates in more than one business, are the relative
importance of its operations in each business and the basis for the
determination (for example, assets, revenues, or earnings) disclosed?
[SOP 94-6, par. 10 (ACC 10,640.10); FSP SOP 94-6-1, par. 10]
Is an explanation that the preparation of financial statements in
conformity with GAAP requires the use of management’s estimates
included in the financial statements?
[SOP 94-6, par. 11 (ACC 10,640.11); FSP SOP 94-6-1, par. 10]
Is the disclosure regarding an estimate made when known information available prior to the issuance of the financial statements indicates that both of the following criteria have been met:
a. It is at least reasonably possible that the estimate of the effect on
the financial statements of a condition, situation, or set of circumstances that existed at the date of the financial statements will
change in the near term due to one or more future confirming
events?
b. The effect of the change will be material?
[SOP 94-6, par. 13 (ACC 10,640.13); FSP SOP 94-6-1, par. 10]

5.

6.

7.

Does the disclosure in question 4 above, indicate the nature of the
uncertainty and include an indication that it is reasonably possible
that a change in estimate will occur in the near term?61
[SOP 94-6, par. 14 (ACC 10,640.14); FSP SOP 94-6-1, par. 10]
If the estimate in question 4 above involves a loss contingency covered
by SFAS 5, do disclosures include an estimate of the possible loss or
range of loss, or state that such an estimate cannot be made?72
[SOP 94-6, pars. 13–14 (ACC 10,640.13–14); FSP SOP 94-6-1, pars.
10–11]
Is disclosure of the concentrations described in paragraph 22 of SOP
94-6, Disclosure of Certain Significant Risks and Uncertainties (AICPA,
Technical Practice Aids, ACC sec. 10,640), made if, based on information known to management before the financial statements are issued,
the criteria in paragraph 21 of SOP 94-6 are met?
[SOP 94-6, pars. 21–22 (ACC 10,640.21–.22); FSP SOP 94-6-1, pars.
10–11]
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If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are
encouraged but not required.
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See footnote 6.
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8.

For those concentrations of labor subject to collective bargaining
agreements and concentrations of operations located outside of the
company’s home country that meet the criteria of paragraph 21 of SOP
94-6, are the following disclosed:
a. The percentage of labor force covered by a collective agreement
and the percentage of the labor force covered by a collective
bargaining agreement that will expire in one year?
b. The carrying amounts of net assets and the geographic areas in
which they are located for operations located outside the company’s home country?
[SOP 94-6, par. 24 (ACC 10,640.24); FSP SOP 94-6-1, pars. 10–11]

9.

Have the optional disclosures in paragraphs 14–15 of SOP 94-6 been
considered?
[SOP 94-6, pars. 14–15 (ACC 10,640.14–.15)]

10. Are major categories of loans, including unusual risk concentrations
disclosed, such as:
a. Commercial, financial, and agricultural?

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

b. Real estate construction?

_____

_____

_____

c. Real estate mortgage?

_____

_____

_____

d. Installment loans to individuals?

_____

_____

_____

e. Lease financing?

_____

_____

_____

f. Foreign?

_____

_____

_____

g. Loans in process?

_____

_____

_____

h. Other?
[FSP SOP 94-6-1, par. 11]

_____

_____

_____

_____

_____

_____

b. Loans with a high loan-to-value ratio?

_____

_____

_____

c. Multiple loans on the same collateral that, when combined, result
in a high loan-to-value ratio?

_____

_____

_____

d. Option ARMS or similar products that may expose the borrower
to future increases in repayments?

_____

_____

_____

e. An initial interest rate that is below the market interest rate for the
initial period of a loan term and that may increase significantly
when that period ends?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

11. Are major concentrations of loan products whose contractual features
may increase credit risk disclosed, such as:
a. Negative amortization?

f. Interest only loans?
[FSP SOP 94-6-1, pars. 2 and 7; SFAS 107, par. 15A]
12. Are foreign loans, foreign nonaccrual loans, and foreign operations,
if any of these foreign activities exceed a material percentage of
activities, disclosed?
[FSP SOP 94-6-1, par. 7; SFAS 107, par. 15A]
F.

Yes
_____

Contingencies and Commitments (See also section Z, “Guarantees”.)
1.

Is the nature and amount of significant accrued loss contingencies not
related to life insurance disclosed as necessary to keep the financial
statements from being misleading?
[SFAS 5, par. 9]
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2.

3.

4.

5.

6.

7.

8.

9.

Yes
_____

No
_____

N/A
_____

a. Nature of the contingency?

_____

_____

_____

b. Estimate of possible loss or range of loss, or a statement that such
estimate cannot be made?
[SFAS 5, par. 10]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

(1) Torts?

_____

_____

_____

(2) Theft of, damage to, expropriation of, or destruction of assets?

_____

_____

_____

(3) Business interruption?

_____

_____

_____

(4) Errors or omissions?

_____

_____

_____

For loss contingencies not accrued, do disclosures indicate:

Is the nature and amount of guarantees disclosed (for example, obligations under standby letters of credit, guarantees to repurchase loans
that are sold)?
[SFAS 5, par. 12; FIN 45, par. 13]
Are gain contingencies adequately disclosed with care to avoid any
misleading implications about likelihood of realization?
[SFAS 5, par. 17]
Is there adequate disclosure of commitments, such as those for capital
expenditures, for purchase or sale of securities under financial futures
contracts, and for funding of loans and unused letters of credit?
[SFAS 5, pars. 18–19]
If the company as guarantor “lends” its creditworthiness to another
party (borrower) for a fee, is the guarantee disclosed in a note, if
material?
[EITF 85-20]
If exposure to loss exists in excess of the amount accrued for a loss
contingency, do disclosures include the excess amount or state that
no estimate is possible?
[SFAS 5, par. 10]
When, after considering management’s plans, the auditor concludes
there is substantial doubt about the entity’s ability to continue as a
going concern for a reasonable period of time, is adequate disclosure
of the situation made in the financial statements?
[AU 341.10; AAG, par. 5.137c]
Is a description of contingencies resulting from the September 11
events that have not yet been recognized in the financial statements
but that are reasonably expected to impact the entity’s financial
statements in the near term disclosed in the notes to the financial
statements in all periods affected by the September 11, 2001 attacks?
[EITF 01-10]

Note: SFAS 5 states that it does not discourage disclosure of uninsured
risks in appropriate circumstances. AcSEC believes that, though operational criteria have not been developed for such disclosures as stated in
SFAS 5, they should be encouraged rather than simply not discouraged.
10. For publicly held entities and entities with public accountability, such
as governments, are circumstances disclosed in which:
a. They are exposed to risks of future material loss related to:
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Yes
_____

No
_____

N/A
_____

(5) Injuries to employees? or

_____

_____

_____

(6) Acts of God? and

_____

_____

_____

_____

_____

_____

11. Does each reporting entity decide the matters to be disclosed, depending on its circumstances? The following are some of the matters
reporting entities may consider for disclosure:

_____

_____

_____

a. The actual and potential effects of losses from such risks on the
entities historical or planned operations, including exposure to
losses from claims, curtailment of research and development or
manufacturing, or contraction or cessation of other activities, such
as discontinuance of a product line?

_____

_____

_____

b. Comparison of current insurance coverage by major categories of
risk to coverage in prior periods, without necessarily quantifying
such coverage or change in coverage?

_____

_____

_____

c. Recent claims experience?

_____

_____

_____

d. A description of the reporting entity’s risk management programs?
(Encouraged, but not required.)
[EITF 03-8]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

b. Those risks have not been transferred to unrelated third parties
through insurance? (Encouraged, but not required.)
[EITF 03-8]

Note: Disclosure of this kind is experimental. Its location in a financial
report, therefore, depends on the judgment of those preparing the financial report.
G. Environmental Remediation Liabilities
Note: SOP 96-1, Environmental Remediation Liabilities (AICPA, Technical
Practice Aids, ACC sec. 10,680), does not provide guidance on recognizing
liabilities of insurance companies for unpaid claims.
1.

Is there disclosure of the following accounting policies:
a. Whether accruals for environmental remediation liabilities are
measured on a discounted basis?
b. The policy concerning the timing of recognition of recoveries?
(Encouraged, but not required.)
[SOP 96-1 (Ch. 7, pars. 152–153) (ACC 10,680.152–.153)]

2.

Do the financial statements disclose the event, situation, or set of
circumstances that triggered recognition of loss contingencies that
arose out of the reporting entity’s environmental remediation-related
obligations? (Encouraged, but not required.)
[SOP 96-1 (Ch. 7, par. 153) (ACC 10,680.153)]

Recognized Losses and Recoveries of Losses, and Reasonably Possible
Loss Exposures
3.

With respect to recorded accruals for environmental remediation loss
contingencies and assets for third-party recoveries related to environmental remediation obligations, are the following disclosed:
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Yes
_____

No
_____

N/A
_____

a. The nature of the accruals, if such disclosure is necessary for the
financial statements not to be misleading, and, in situations where
disclosure of the nature of the accruals is necessary, the total
amount accrued for the remediation obligation, if such disclosure
is also necessary for the financial statements not to be misleading?

_____

_____

_____

b. If any portion of the accrued obligation is discounted, the undiscounted amount of the obligation and the discount rate used in the
present-value determinations?

_____

_____

_____

_____

_____

_____

a. The nature of the reasonably possible loss contingency, that is, a
description of the reasonably possible remediation obligation, and
an estimate of the possible loss exposure or the fact that such an
estimate cannot be made?

_____

_____

_____

b. If the criteria of SOP 94-6 are met with respect to estimated loss (or
gain) contingencies, an indication that it is at least reasonably
possible that a change in the estimate will occur in the near term?

_____

_____

_____

c. The estimated time frame of disbursements for recorded amounts
if expenditures are expected to continue over the long term?
(Encouraged, but not required.)

_____

_____

_____

d. The estimated time frame for realization of recognized probable
recoveries, if realization is not expected in the near term? (Encouraged, but not required.)

_____

_____

_____

e. If the criteria of SOP 94-6 are met with respect to the accrued
obligation, to any recognized asset for third-party recoveries, or to
reasonably possible loss exposures or disclosed gain contingencies, the factors that cause the estimate to be sensitive to change?
(Encouraged, but not required.)

_____

_____

_____

f. If an estimate of the probable or reasonably possible loss or range
of loss cannot be made, the reasons why it cannot be made?
(Encouraged, but not required.)

_____

_____

_____

(1) The total amount accrued for the site?

_____

_____

_____

(2) The nature of any reasonably possible loss contingency or
additional loss, and an estimate of the possible loss or the fact
that an estimate cannot be made and the reasons why it
cannot be made?

_____

_____

_____

c. If the criteria of SOP 94-6 (it is at least reasonably possible that an
estimate of the effect on the financial statements of a matter that
existed at the balance sheet date will change in the near term and
the effect of the change would be material to financial statements)
are met with respect to the accrued obligation or to any recognized
asset for third-party recoveries, an indication that it is at least
reasonably possible that a change in the estimate of the obligation
or of the asset will occur in the near term?
[SOP 96-1 (Ch. 7, par. 161) (ACC 10,680.161)]
4.

With respect to reasonably possible loss contingencies, including
reasonably possible loss exposures in excess of the amount accrued,
are the following disclosed:

g. If information about the reasonably possible loss or the recognized
and additional reasonably possible loss for an environmental
remediation obligation related to an individual site is relevant to
an understanding of the financial position, cash flows, or results
of operations of the entity, the following with respect to the site:
(Encouraged, but not required.)
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Yes
_____

No
_____

N/A
_____

(3) Whether other potentially responsible parties are involved
and the entity’s estimated share of the obligation?

_____

_____

_____

(4) The status of regulatory proceedings?

_____

_____

_____

(5) The estimated time frame for resolution of the contingency?
[SOP 96-1 (Ch. 7, pars. 162–163) (ACC 10,680.162–.163)]

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The amount recognized for environmental remediation loss contingencies in each period?

_____

_____

_____

b. The amount of any recovery from third parties that is credited to
environmental remediation costs in each period?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Probable But Not Reasonably Estimable Losses
5.

6.

If the reporting entity’s probable but not reasonably estimable environmental remediation obligations may be material, are the nature of
the probable contingency (that is, a description of the remediation
obligation) and the fact that a reasonable estimate cannot currently be
made disclosed?
[SOP 96-1 (Ch. 7, par. 166) (ACC 10,680.166)]
Is the estimated time frame for resolution of the uncertainty as to the
amount of the loss disclosed? (Encouraged, but not required.)
[SOP 96-1 (Ch. 7, par. 166) (ACC 10,680.166)]

Environmental Remediation Costs Recognized Currently
7.

Is the amount of environmental remediation costs recognized in the
income statement disclosed in the following detail: (Encouraged, but
not required.)

c. The income statement caption in which environmental remediation costs and credits are included?
[SOP 96-1 (Ch. 7, par. 170) (ACC 10,680.170)]
Other Matters
8.

9.

Do the financial statements include a contingency conclusion that addresses the estimated total unrecognized exposure to environmental
remediation and other loss contingencies? (Optional.)
[SOP 96-1 (Ch. 7, par. 171) (ACC 10,680.171)]
Is there a description of the general applicability and impact of
environmental laws and regulations upon their business and how the
existence of such laws and regulations may give rise to loss contingencies for future environmental remediation? (Optional.)
[SOP 96-1 (Ch. 7, par. 172) (ACC 10,680.172)]

10. Are applicable disclosures about environmental obligations (and recoveries) related to the attacks of September 11 disclosed in the notes
to the financial statements in all periods affected by the September 11,
2001 attacks, pursuant to SOP 96-1?
[EITF 01-10]
H. Related-Party Transactions and Economic Dependency
1.

For related-party transactions, do disclosures include:
a. The nature of the relationship(s) involved (for example, parent,
subsidiary, and affiliate companies, officers, stockholders, etc.)?
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Yes
_____

No
_____

N/A
_____

b. A description of the transactions, including transactions to which
no amounts or nominal amounts were ascribed, for each of the
periods for which an income statement is presented, and such
other information deemed necessary to an understanding of the
effects of the transactions on the financial statements?

_____

_____

_____

c. The dollar amounts of transactions for each of the periods for
which an income statement is presented and the effects of any
change in the method of establishing the terms from that used in
the preceding period?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. A description of the plan, the basis for determining contributions,
including the employee groups covered, and the nature and effect
of significant matters affecting comparability of information for all
periods presented?

_____

_____

_____

(1) For leveraged ESOPs and pension reversion ESOPs, does the
description include the basis for releasing shares and how
dividends on allocated and unallocated shares are used?

_____

_____

_____

b. A description of the accounting policies followed for ESOP transactions, including the method of measuring compensation, the
classification of dividends on ESOP shares, and the treatment of
ESOP shares for EPS computations?

_____

_____

_____

(1) If the entity has both old ESOP shares for which it does not
adopt the guidance in SOP 93-6, Employers’ Accounting for
Employee Stock Ownership Plans (AICPA, Technical Practice
Aids, ACC sec. 10,580), and new ESOP shares for which the
guidance in SOP 93-6 is required, are the accounting policies
for both blocks of shares disclosed?

_____

_____

_____

c. The amount of compensation cost recognized during the period?

_____

_____

_____

d. The number of allocated shares, committed-to-be-released shares,
and suspense shares held by the ESOP at the balance sheet date?

_____

_____

_____

(1) If the entity has both old ESOP shares for which it does not
adopt the guidance in SOP 93-6 and new ESOP shares for
which the guidance in SOP 93-6 is required, is the above
disclosure made separately for both blocks of shares?

_____

_____

_____

d. Amounts due from or to related parties as of the date of each
balance sheet presented and, if not otherwise apparent, the terms
and manner of settlement?
[SFAS 57, par. 2]
2.

I.

Is the nature of a controlled relationship disclosed, even though there
are no transactions between the enterprises, if the reporting company
and one or more other enterprises are under common ownership or
management control, and the existence of the control could result in
operating results or financial position of the reporting company being
significantly different from those that would have resulted if the
company were autonomous?
[SFAS 57, par. 4]

Employee Stock Ownership Plans
1.

If an employer sponsors an employee stock ownership plan (ESOP),
do the employer’s disclosures include:
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e. The fair value of unearned ESOP shares at the balance sheet date
for shares accounted for under SOP 93-6?81
f. The existence and nature of any repurchase obligation, including
disclosure of the fair value of the shares allocated as of the balance
sheet date, which are subject to a repurchase obligation?92
[SOP 93-6, par. 53 (ACC 10,580.53)]
2.

3.

4.

5.

6.

J.

Are all the items listed in question 1 above disclosed even if the
employer with an ESOP does not adopt SOP 93-6 for shares held by
the ESOP on December 31, 1992?
[SOP 93-6, par. 55 (ACC 10,580.55)]
For leveraged ESOPs and for nonleveraged ESOPs where the assets
from the pension plan are used by the ESOP to purchase shares, when
the employer reports the issuance of shares or the sale of treasury
shares to the ESOP, is the charge to unearned ESOP shares presented
as a separate item in the balance sheet as a contra-asset account?
[SOP 93-6, pars. 13 and 46 (ACC 10,580.13 and .46)]
If the employer sponsors an ESOP with an indirect loan, is the outside
loan reported as a liability and the receivable from the ESOP not
reported on the employer’s balance sheet?
[SOP 93-6, par. 26 (ACC 10,580.26)]
If the employer sponsors an ESOP with an employer loan, is the
ESOP’s note payable and the employer’s note receivable from the
ESOP not reported in the employer’s balance sheet?
[SOP 93-6, par. 27 (ACC 10,580.27)]
If SOP 76-3, Accounting Practices for Certain Employee Stock Ownership
Plans (AICPA, Technical Practice Aids, ACC sec. 10,130) is still being
followed for ESOP shares purchased before December 31, 1992 and if
the reporting entity has guaranteed the debt of an ESOP or made a
commitment to make future contributions to the ESOP sufficient to
meet debt service requirements, are the compensation element and
the interest element of annual contributions reported separately, and
are the interest rate and debt terms disclosed in the notes to the
financial statements?
[SOP 76-3, par. 10 (ACC 10,130.10)]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Employers’ Disclosures About Pensions and Other Postretirement
Benefits103
In September 2006 FASB issued SFAS 158, which amends SFAS 87, Employers’ Accounting for Pensions, 88, Employers’ Accounting for Settlements
and Curtailments of Defined Benefit Pension Plans and for Termination Benefits,
106, Employers’ Accounting for Postretirement Benefits Other Than Pensions,
and 132(R), Employers’ Disclosures about Pensions and Other Postretirement
Benefits—an amendment of FASB Statements No. 87, 88, and 106. If SFAS 158
has been adopted, questions 1–19 below do not apply and readers should
refer to section J1. The Other Matters questions 20–24 still apply.
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9

Employers may wish to disclose additional information about the obligation, particularly information about the timing of
payments.
[SOP 93-6, par. 95 (ACC 10,580.95)]
3

10
EITF 03-4, Determining the Classification and Benefit Attribution Method for a “Cash Balance” Pension Plan, states that cash balance
plans should be considered a defined benefit plan.
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Yes
_____

No
_____

N/A
_____

a. The benefit obligation, fair value of plan assets, and funded status
of the plan?
[SFAS 132(R), par. 8a]

_____

_____

_____

b. Employer contributions, participant contributions, and benefits
paid?
[SFAS 132(R), par. 8b]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Reduced Disclosure Requirements for Nonpublic Entities
Note: A nonpublic entity is not required to disclose the information
required by paragraphs 5(a)–(c), 5(m), and 5(o)–(r) of SFAS 132(R). See the
related disclosure questions below.
1.

For a nonpublic entity111 that sponsors one or more defined benefit
pension plans or one or more other defined benefit postretirement
plans, has the following information been disclosed, separately for
pension plans and other postretirement benefit plans:

c. Information about plan assets:
(1) For each major category of plan assets which shall include,
but is not limited to, equity securities, real estate, and all other
assets, the percentage of the fair value of total plan assets held
as of the measurement date used for each statement of financial position presented?
[SFAS 132(R), par. 8c(1)]
(2) A narrative description of investment policies and strategies,
including target allocation percentages or range of percentages for each major category of plan assets presented on a
weighted-average basis as of the measurement date(s) of the
latest statement of financial position presented, if applicable,
and other factors that are pertinent to an understanding of the
policies or strategies such as investment goals, risk management practices, permitted and prohibited investments including the use of derivatives, diversification, and the
relationship between plan assets and benefit obligations?
[SFAS 132(R), par. 8c(2)]
(3) A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assumption, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?
[SFAS 132(R), par. 8c(3)]
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Note: The changes made in italics are from FSP FAS 126-1, Applicability of Certain Disclosure and Interim Reporting Requirements for
Obligors for Conduit Debt Securities, which clarifies the definition of a public entity in certain accounting standards to include entities that
are conduit bond obligors for conduit debt securities that are traded in a public market. The guidance should be applied prospectively
in fiscal periods beginning after December 15, 2006. An entity may elect to retrospectively apply the guidance to all prior periods. If an
entity issues interim financial statements, the FSP should be applied to the first interim period after the date of adoption. A nonpublic
entity is any entity other than one (a) whose debt or equity securities trade in a public market either on a stock exchange (domestic or
foreign) or in the over-the-counter market including securities quoted only locally or regionally, (b) that is a conduit bond obligor for
conduit debt securities that are traded in a public market (a domestic or foreign stock exchange or an over-the-counter market,
including local or regional markets), (c) that makes a filing with a regulatory agency in preparation for the sale of any class of debt or
equity securities in a public market, or (d) that is controlled by an entity covered by (a), (b) or (c).
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: Disclosure of additional asset categories and additional information about specific assets within a category is encouraged if that information is expected to be useful in understanding the risks associated with
each asset category and the overall expected long-term rate of return on
assets.
[SFAS 132(R), par. 8c(4)]
d. For defined benefit pension plans, the accumulated benefit obligation?
[SFAS 132(R), par. 8d]
e. The benefits (as of the date of the latest statement of financial
position presented) expected to be paid in each of the next five
fiscal years, and in the aggregate for the five fiscal years thereafter?
(The expected benefits should be estimated based on the same
assumptions used to measure the company’s benefit obligation at
the end of the year and should include benefits attributable to
estimated future employee service.)
[SFAS 132(R), par. 8e]
f. The employer’s best estimate, as soon as it can be reasonably
determined, of contributions expected to be paid to the plan
during the next fiscal year beginning after the date of the latest
statement of financial position presented? (Estimated contributions may be presented in the aggregate combining (a) contributions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions.)
[SFAS 132(R), par. 8f]
g. The amounts recognized in the statements of financial position,
including net pension and other postretirement benefit prepaid
assets or accrued liabilities and any intangible asset and the
amount of accumulated other comprehensive income recognized
pursuant to paragraph 37 of SFAS 87, as amended?
[SFAS 132(R), par. 8g]
h. The amount of net periodic benefit cost recognized and the
amount included within other comprehensive income arising
from a change in the minimum pension liability recognized pursuant to paragraph 37 of SFAS 87, as amended?
[SFAS 132(R), par. 8h]
i. On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rates, rates of
compensation increase (for pay-related plans), and expected longterm rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost?
[SFAS 132(R), par. 8i]
j. The measurement date(s) used to determine pension and other
postretirement benefit measurements for the pension plans and
other postretirement benefit plans that make up at least the majority of plan assets and benefit obligations?
[SFAS 132(R), par. 8j]
k. The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
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FSP §20,300.03

78

2-08

20,366

73

Financial Statements and Notes Checklist

eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?
[SFAS 132(R), par. 8k]
l. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related parties and the plan during the period?
[SFAS 132(R), par. 8l]
m. The nature and effect of significant nonroutine events, such as
amendments, combinations, divestitures, curtailments, and settlements?
[SFAS 132(R), par. 8m]
2.

3.

Are amounts related to the employer’s results of operations disclosed
for each period for which a statement of income is presented?
[SFAS 132(R), par. 8]
Are amounts related to the employer’s statement of financial position
disclosed as of the measurement date used for each statement of
financial position presented?
[SFAS 132(R), par. 8]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Disclosures in Interim Financial Reports
4.

If the entity is publicly traded, does it disclose the following information in its interim financial statements that include a statement of
income:
a. The amount of net periodic benefit cost recognized, for each period
for which a statement of income is presented, showing separately
the service cost component, the interest cost component, the expected return on plan assets for the period, the amortization of the
unrecognized transition obligation or transition asset, the amount
of recognized gains or losses, the amount of prior service cost
recognized, and the amount of gain or loss recognized due to a
settlement or curtailment?
b. The total amount of the employer’s contributions paid, and expected to be paid, during the current fiscal year, if significantly
different from amounts previously disclosed pursuant to paragraph 5(g) of SFAS 132, Employers’ Disclosures about Pensions and
Other Postretirement Benefits—an amendment of FASB Statements No.
87, 88, and 106? (Estimated contributions may be presented in the
aggregate combining (a) contributions required by funding regulations or laws, (b) discretionary contributions, and (c) noncash
contributions.)
[SFAS 132(R), par. 9]

5.

If the entity is nonpublic, does it disclose in interim periods, for which
a complete set of financial statements is presented, the total amount
of the employer’s contributions paid, and expected to be paid, during
the current fiscal year, if significantly different from amounts previously disclosed pursuant to paragraph 8(f) of SFAS 132? (Estimated
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

(1) The amount of any unamortized prior service cost?

_____

_____

_____

(2) The amount of any unrecognized net gain or loss (including
asset gains and losses not yet reflected in market-related
value)?

_____

_____

_____

(3) The amount of any remaining unamortized, unrecognized
net obligation or net asset existing at the initial date of application of SFAS 87 or SFAS 106?

_____

_____

_____

(4) The net pension or other postretirement benefit, prepaid
assets, or accrued liabilities?

_____

_____

_____

_____

_____

_____

contributions may be presented in the aggregate combining (a) contributions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions.)
[SFAS 132(R), par. 10]
Pensions and Other Postretirement Benefits
6.

If an employer sponsors one or more defined benefit pension plans or
one or more defined benefit postretirement plans, has the following
information been provided separately for pension plans and other
postretirement benefit plans:
a. A reconciliation of beginning and ending balances of the benefit
obligation121 showing separately, if applicable, the effects during
the period attributable to each of the following: service cost, interest cost, contributions by plan participants, actuarial gains and
losses, foreign currency exchange rate changes,132 benefits paid,
plan amendments, business combinations, divestitures, curtailments, settlements, and special termination benefits?
[SFAS 132(R), par. 5a]
b. A reconciliation of beginning and ending balances of the fair value
of plan assets showing separately, if applicable, the effects during
the period attributable to each of the following: actual return on
plan assets, foreign currency exchange rate changes,143 contributions by the employer, contributions by plan participants, benefits
paid, business combinations, divestitures, and settlements?
[SFAS 132(R), par. 5b]
c. The funded status of the plans, the amounts not recognized in the
statement of financial position, and the amounts recognized in the
statement of financial position, including:

(5) Any intangible asset and the amount of accumulated other
comprehensive income recognized pursuant to paragraph 37
of SFAS 87, as amended?
[SFAS 132(R), par. 5c]
d. Information about plan assets:
Copyright © 2008
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For defined benefit pension plans, the benefit obligation is the projected benefit obligation—the actuarial present value as of a date
of all benefits attributed by the pension benefit formula to employee service rendered prior to that date. For defined benefit
postretirement plans, the benefit obligation is the accumulated postretirement benefit obligation—the actuarial present value of
benefits attributed to employee service rendered to a particular date.
2

13
The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation
whose functional currency is not the reporting currency pursuant to SFAS 52, Foreign Currency Translation.
3

14

Refer to footnote 13.
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Yes
_____

No
_____

N/A
_____

(1) For each major category of plan assets, which shall include,
but is not limited to, equity securities, debt securities, real
estate, and all other assets, the percentage of the fair value of
total plan assets held as of the measurement date used for
each statement of financial position presented?

_____

_____

_____

(2) A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assumption, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?

_____

_____

_____

(3) A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assumption, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

(4) Disclosure of additional asset categories and additional information about specific assets within a category is encouraged
if that information is expected to be useful in understanding
the risks associated with each asset category and the overall
expected long-term rate of return on assets?
[SFAS 132(R), par. 5d]
e. For defined benefit pension plans, the accumulated benefit obligation?
[SFAS 132(R), par. 5e]
f. The benefits (as of the date of the latest statement of financial
position presented) expected to be paid in each of the next five
fiscal years, and in the aggregate for the five fiscal years thereafter?
The expected benefits should be estimated based on the same
assumptions used to measure the company’s benefit obligation at
the end of the year and should include benefits attributable to
estimated future employee service.
[SFAS 132(R), par. 5f]
g. The employer’s best estimate, as soon as it can reasonably be
determined, of contributions expected to be paid to the plan
during the next fiscal year beginning after the date of the latest
statement of financial position presented? Estimated contributions may be presented in the aggregate combining (a) contributions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions.
[SFAS 132(R), par. 5g]
h. The amount of net periodic benefit cost recognized, showing
separately the service cost component, the interest cost component, the expected return on plan assets for the period, the amortization of the unrecognized transition obligation or transition
asset, the amount of recognized gains and losses, the amount of
prior service cost recognized, and the amount of gain or loss
recognized due to a settlement or curtailment?
[SFAS 132(R), par. 5h]
Copyright © 2008

78

2-08

20,369

FSP §20,300.03

76

Life and Health Insurance Entities

i. The amount included within other comprehensive income for the
period arising from a change in the additional minimum pension
liability recognized pursuant to paragraph 37 of SFAS 87, as
amended?
[SFAS 132(R), par. 5i]
j. On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rates, rates of
compensation increase (for pay-related plans), and expected longterm rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost?
[SFAS 132(R), par. 5j]
k. The measurement date(s) used to determine pension and other
postretirement benefit measurements for the pension plans and
other postretirement benefit plans that make up at least the majority of plan assets and benefit obligations?
[SFAS 132(R), par. 5k]
l. The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?
[SFAS 132(R), par. 51]
m. The effect of a one-percentage-point increase and the effect of a
one-percentage-point decrease in the assumed health care cost trend
rates on (1) the aggregate of the service and interest cost components of net periodic postretirement health care benefit cost and
(2) the accumulated postretirement benefit obligation for health
care benefits? (For purposes of this disclosure, all other assumptions
shall be held constant, and the effects shall be measured based on
the substantive plan that is the basis for the accounting.)
[SFAS 132(R), par. 5m]
n. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related parties and the plan during the period?
[SFAS 132(R), par. 5n]
o. If applicable, any alternative amortization method used to amortize prior service amounts or unrecognized net gains and losses
pursuant to paragraphs 26 and 33 of SFAS 87 or paragraphs 53 and
60 of SFAS 106?
[SFAS 132(R), par. 5o]
p. If applicable, any substantive commitment such as past practice
or a history of regular benefit increases, used as the basis for
accounting for the benefit obligation?
[SFAS 132(R), par. 5p]
q. If applicable, the cost of providing special or contractual termination benefits recognized during the period and a description of the
nature of the event?
[SFAS 132(R), par. 5q]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

Are amounts related to the employer’s results of operations disclosed
for each period for which an income statement is presented?
[SFAS 132(R), par. 5]

_____

_____

_____

Are amounts related to the employer’s statement of financial position
disclosed for each balance sheet presented?
[SFAS 132(R), par. 5]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

r. An explanation of any significant change in the benefit obligation
or plan assets not otherwise apparent in the other disclosures
required by SFAS 132?
[SFAS 132(R), par. 5r]
7.

8.

Employers With Two or More Plans
9.

Are the disclosures required by SFAS 132 aggregated for all of an
employer’s defined benefit pension plans and for all of an employer’s
other defined benefit postretirement plans unless disaggregating in
groups is considered to provide useful information or is otherwise
required by paragraph 6 of SFAS 132 and paragraph 7 of SFAS 132?
[SFAS 132(R), par. 6]

10. Unless otherwise stated, are disclosures as of the measurement date
for each statement of financial position presented?
[SFAS 132(R), par. 6]
11. Does the disclosure of amounts recognized in the statement of financial position present prepaid benefit costs and accrued benefit liabilities separately?
[SFAS 132(R), par. 6]
Note: Disclosures about pension plans with assets in excess of the accumulated benefit obligation generally may be aggregated with disclosures
about pension plans with accumulated benefit obligations in excess of
assets. The same aggregation is permitted for other postretirement benefit
plans.
[SFAS 132(R), par. 6]
12. If aggregate disclosures are presented, does the employer disclose:
a. The aggregate benefit obligation and aggregate fair value of plan
assets for plans with benefit obligations in excess of plan assets as
of the measurement date of each statement of financial position
presented?
b. The aggregate pension accumulated benefit obligation and aggregate fair value of plan assets for pension plans with accumulated
benefit obligations in excess of plan assets?
[SFAS 132(R), par. 6]
13. If a U.S. reporting entity combines disclosures about pension plans or
other postretirement benefit plans outside the United States with
those for U.S. plans, are the benefit obligations of the plans outside
the United States not significant relative to the total benefit obligation
and do those plans not use significantly different assumptions?
[SFAS 132(R), par. 7]
Note: A foreign reporting entity that prepares financial statements in
conformity with U.S. GAAP shall apply the proceeding guidance to its
domestic and foreign plans.
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Defined Contribution Plans
14. Does the employer disclose the amount of cost recognized for defined
contribution pension plans and for other defined contribution postretirement benefit plans for all periods presented separately from the
amount of cost recognized for defined benefit plans?
[SFAS 132(R), par. 11]
15. Do the disclosures include a description of the nature and effect of any
significant changes during the period affecting comparability, such as
a change in the rate of employer contributions, a business combination, or a divestiture?
[SFAS 132(R), par. 11]
Note: The AICPA staff, helped by industry experts, released two questions and answers, commonly referred to as Technical Practice Aids
(TPAs), on accounting and disclosures for single employer and multiemployer employee benefit plans related to the Medicare Prescription Drug,
Improvement and Modernization Act of 2003 (the Medicare Act):
• TIS section 6931.05, “Accounting and Disclosure Requirements for
Single-Employer Employee Benefit Plans Related to the Medicare
Prescription Drug, Improvement and Modernization Act of 2003”
• TIS section 6931.06, “Accounting and Disclosure Requirements for
Multiemployer Employee Benefit Plans Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003”
These TPAs provide accounting and disclosure guidance for both single
employer and multiemployer plans relating to the effects of the Medicare
Act. Practitioners are encouraged to incorporate this guidance as soon as
practicable. These Technical Practice Aids are available on the AICPA’s
Web site at www.aicpa.org/Professional+Resources/Accounting+and+
Auditing/Accounting+Standards/recent_tpas.aspx.
Multiemployer Plans
16. Has the employer disclosed the amount of contributions to multiemployer plans for each annual period for which a statement of income
is presented?
[SFAS 132(R), par. 12]
17. If the employer chooses to disclose total contributions to multiemployer plans without disaggregating the amounts attributable to pension plans and other postretirement benefit plans, do the disclosures
include a description of the nature and effect of any changes affecting
comparability, such as a change in the rate of employer contributions,
a business combination, or a divestiture?
[SFAS 132(R), par. 12]
18. In some situations, withdrawal from a multiemployer plan may result
in an employer having an obligation to the plan for a portion of the
unfunded benefit obligation of the pension plans and other postretirement benefit plans. If withdrawal under circumstances that would
give rise to an obligation is either probable or reasonably possible,
have the provisions of SFAS 5 been applied (SFAS 87, paragraph 70)?
[SFAS 132(R), par. 13]
19. If it is either probable or reasonably possible that (a) an employer
would withdraw from the plan under circumstances that would
give rise to an obligation or (b) an employer’s contribution to the fund
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The reduction in the APBO for the subsidy related to benefits
attributed to past service?

_____

_____

_____

b. The effect of the subsidy on the measurement of net periodic
postretirement benefit cost for the current period? That effect
includes (1) any amortization of the actuarial experience gain in a
as a component of the net amortization called for by paragraph 59
of SFAS 106, (2) the reduction in current period service cost due to
the subsidy, and (3) the resulting reduction in interest cost on the
APBO as a result of the subsidy.

_____

_____

_____

_____

_____

_____

would be increased during the remainder of the contract period to
make up a shortfall in the funds necessary to maintain the negotiated
level of benefit coverage (a “maintenance of benefits” clause), has the
employer applied the provisions of SFAS 5 (SFAS 106, paragraph 83)?
[SFAS 132(R), par. 13]
Other Matters
20. If the matters addressed in EITF 03-2, Accounting for the Transfer to the
Japanese Government of the Substitutional Portion of Employee Pension
Fund Liabilities, apply, are the disclosure requirements of that EITF
issue complied with?
[EITF 03-2]
21. If the matters addressed in EITF 06-10, Accounting for Collateral Assignment Split-Dollar Life Insurance, relating to benefits that extend into
postretirement periods apply, are the disclosure requirements of that
EITF issue complied with?
[EITF 06-10]
22. Until an employer is able to determine whether benefits provided by
its plan are actuarially equivalent, does it disclose the following in
financial statements for interim or annual periods:
a. The existence of the Act?
b. The fact that measures of the accumulated postretirement benefit
obligation (APBO) or net periodic postretirement benefit cost do
not reflect any amount associated with the subsidy because the
employer is unable to conclude whether the benefits provided by
the plan are actuarially equivalent to Medicare Part D under the
Act?
[FSP 106-2]
23. In interim and annual financial statements for the first period in which
an employer includes the effects of the subsidy in measuring the
APBO and the first period in which an employer includes the effects
of the subsidy in measuring net periodic postretirement benefit cost,
does it disclose the following:

c. Any other disclosures required by paragraph 5(r) of SFAS 132(R),
Employers’ Disclosures about Pensions and Other Postretirement Benefits? Paragraph 5(r) of SFAS 132(R) requires disclosure of “an
explanation of any significant change in the benefit obligation or
plan assets not otherwise apparent in the other disclosures required by this Statement.”
[FSP 106-2]
24. For purposes of the disclosures required by paragraphs 5(a) and 5(f)
of SFAS 132(R), does an employer disclose gross benefit payments
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. A description of the prior-period information that has been
retrospectively adjusted?

_____

_____

_____

b. The effect of the change in accounting principle on income from
continuing operations, net income (or other appropriate captions
of changes in the applicable net assets or performance indicator),
any other affected financial statement caption, and any affected
per share amounts for any prior periods retrospectively adjusted?

_____

_____

_____

_____

_____

_____

(paid and expected, respectively), including prescription drug benefits, and separately, the gross amount of the subsidy receipts (received
and expected, respectively)?
[FSP 106-2]
Note: The consensus in EITF 06-4, Accounting for Deferred Compensation
and Postretirement Benefit Aspects of Endorsement Split-Dollar Life Insurance
Arrangements, was ratified at the September 20, 2006 meeting and is
effective for fiscal years beginning after December 15, 2007, with earlier
application permitted. Entities should recognize the effects of applying
the consensus in this issue through either (a) a change in accounting
principle through a cumulative-effect adjustment to retained earnings or
to other components of equity or net assets in the statement of financial
position as of the beginning of the year of adoption or (b) a change in
accounting principle through retrospective application to all prior periods. Questions 24–25 provide transitional disclosures when applying
EITF 06-4.
25. If an entity chooses to apply the consensus in EITF 06-4 as a change
in accounting principle through a cumulative-effect adjustment to
retained earnings, does the entity disclose the cumulative effect of the
change on retained earnings or on other components of equity or net
assets in the statement of financial position?
[SOP 05-1, par. 8 (ACC 10,920.08)]
26. If an entity chooses to apply the consensus in EITF 06-4 as a change
in accounting principle through retrospective application to all prior
periods, are the following disclosed:

c. The cumulative effect of the change in accounting principle on
retained earnings or other components of equity or net assets in
the statement of financial position as of the beginning of the
earliest period presented?
[EITF 06-4, par. 10]
J1. Employers’ Disclosures for Defined Benefit Pension and Other
Postretirement Plans
Note: If SFAS 158 has been adopted, the following section should be
completed.
Effective Dates for Recognition and Related Disclosure Provisions
The required date of adoption of the recognition and disclosure provisions
of the statement differs for an employer that is an issuer of publicly traded
equity securities (as defined) and an employer that is not. Readers should
refer to the complete statement for any of the conditions that need to be met
for an employer to be deemed to have publicly traded equity securities.
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Yes
_____

No
_____

N/A
_____

a. For each annual statement of income presented, the amounts
recognized in other comprehensive income, showing separately
the net gain or loss and net prior service cost or credit. Those
amounts shall be separated into amounts arising during the period
and reclassification adjustments of other comprehensive income
as a result of being recognized as components of net periodic
benefit cost for the period?

_____

_____

_____

b. For each annual statement of income presented, the net transition
asset or obligation recognized as a reclassification adjustment of
other comprehensive income as a result of being recognized as a
component of net periodic benefit cost for the period?

_____

_____

_____

c. For each annual statement of financial position presented, the
amounts in accumulated other comprehensive income that have
not yet been recognized as components of net periodic benefit cost,
showing separately the net gain or loss, net prior service cost or
credit, and net transition asset or obligation?

_____

_____

_____

An employer with publicly traded equity securities is required to initially recognize the funded status of a defined benefit postretirement plan
(see paragraph 4 of SFAS 158) and to provide the required disclosures (see
paragraph 7 of SFAS 158) as of the end of the fiscal year ending after
December 15, 2006.
An employer without publicly traded equity securities is required to
recognize the funded status of a defined benefit postretirement plan (see
paragraphs 4 and 8 of SFAS 158) and to provide the required disclosures
(see paragraphs 7 and 10 of SFAS 158) as of the end of the fiscal year ending
after June 15, 2007.
However, an employer without publicly traded equity securities is
required to disclose additional information in the notes to financial statements for a fiscal year ending after December 15, 2006, but before June 16,
2007, unless it has applied the recognition provisions of the statement in
preparing those financial statements. See question 2 for those additional
disclosure requirements.
The requirement to measure plan assets and benefit obligations as of the
date of the employer’s fiscal year-end statement of financial position (see
paragraphs 5–6, and 9 of SFAS 158) is effective for fiscal years ending after
December 15, 2008. If in the last quarter of the preceding fiscal year an
employer enters into a transaction that results in a settlement or experiences an event that causes a curtailment of the plan, the related gain or
loss pursuant to SFAS 88 or 106 is required to be recognized in earnings
or changes in unrestricted net assets of that quarter. The requirement in
paragraphs 5(k) and 8(j) of SFAS 132(R) to disclose the measurement date
is eliminated, effective in the year the employer initially adopts the
measurement date provisions of this statement.
Earlier application of the recognition or measurement date provisions is
encouraged; however, early application must be for all of an employer’s
benefit plans. Retrospective application of the statement is not permitted.
1.

Does a business entity that sponsors one or more benefit plans disclose
the following information in the notes to its annual financial statements, separately for pension plans and other postretirement benefit
plans:
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. A brief description of the provisions of the statement?

_____

_____

_____

b. The date that adoption is required?

_____

_____

_____

c. The date the employer plans to adopt the recognition provisions
of the statement, if earlier?
[SFAS 158, par. 14]

_____

_____

_____

_____

_____

_____

_____

_____

_____

d. The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost
over the fiscal year that follows the most recent annual statement
of financial position presented, showing separately the net gain or
loss, net prior service cost or credit, and net transition asset or
obligation?
e. The amount and timing of any plan assets expected to be returned
to the business entity during the 12-month period, or operating
cycle if longer, that follows the most recent annual statement of
financial position presented?
[SFAS 158, par. 7]
2.

Does an employer without publicly traded equity securities disclose
the following information in the notes to the financial statements for
a fiscal year ending after December 15, 2006, but before June 16, 2007,
unless it has applied the recognition provisions of the statement in
preparing those financial statements:

Disclosures Required in the Year of Application
3.

4.

In the year that the recognition provisions of SFAS 158 are initially
applied, does the employer disclose, in the notes to the annual financial statements, the incremental effect of applying this statement on
individual line items in the year-end statement of financial position?
[SFAS 158, par. 20]
In the year that the measurement date provisions of SFAS 158 are
initially applied, does a business entity disclose the separate adjustments of retained earnings and accumulated other comprehensive
income from applying the statement?
[SFAS 158, par. 21]

Note: The disclosures specified by paragraphs 17–18 of SFAS 154, are not
required.
[SFAS 158, par. 22]
5.

If an employer sponsors one or more defined benefit pension plans or
one or more defined benefit postretirement plans, has the following
information been provided separately for pension plans and other
postretirement benefit plans:
a. A reconciliation of beginning and ending balances of the benefit
obligation151 showing separately, if applicable, the effects during
the period attributable to each of the following: service cost, interest cost, contributions by plan participants, actuarial gains and
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For defined benefit pension plans, the benefit obligation is the projected benefit obligation—the actuarial present value as of a date
of all benefits attributed by the pension benefit formula to employee service rendered prior to that date. For defined postretirement
plans, the benefit obligation is the accumulated postretirement benefit obligation—the actuarial present value of benefits attributed to
employee service rendered to a particular date.
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

(1) For each major category of plan assets, which shall include,
but is not limited to, equity securities, debt securities, real
estate, and all other assets, the percentage of the fair value of
total plan assets held as of the measurement date used for
each statement of financial position presented?

_____

_____

_____

(2) A narrative description of investment policies and strategies,
including target allocation percentages or range of percentages for each major category of plan assets presented on a
weighted-average basis as of the measurement date(s) of the
latest statement of financial position presented, if applicable,
and other factors that are pertinent to an understanding of the
policies or strategies such as investment goals, risk management practices, permitted and prohibited investments including the use of derivatives, diversification, and the
relationship between plan assets and benefit obligations?

_____

_____

_____

(3) A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assumption, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?

_____

_____

_____

_____

_____

_____

_____

_____

_____

losses, foreign currency exchange rate changes,161 benefits paid,
plan amendments, business combinations, divestitures, curtailments, settlements, and special termination benefits?
[SFAS 132(R), par. 5a]
b. A reconciliation of beginning and ending balances of the fair value
of plan assets showing separately, if applicable, the effects during
the period attributable to each of the following: actual return on
plan assets, foreign currency exchange rate changes,172 contributions by the employer, contributions by plan participants, benefits
paid, business combinations, divestitures, and settlements?
[SFAS 132(R), par. 5b]
c. The funded status of the plans and the amounts recognized in the
statement of financial position showing separately the assets and
current and noncurrent liabilities recognized?
[SFAS 132(R), par. 5c, as amended by SFAS 158]
d. Information about plan assets:

(4) Disclosure of additional asset categories and additional information about specific assets within a category is encouraged
if that information is expected to be useful in understanding
the risks associated with each asset category and the overall
expected long-term rate of return on assets?
[SFAS 132(R), par. 5d]
e. For defined benefit pension plans, the accumulated benefit obligation?
[SFAS 132(R), par. 5e]
Copyright © 2008
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The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation
whose functional currency is not the reporting currency pursuant to SFAS 52.
2
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Refer to footnote 16.
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f. The benefits (as of the date of the latest statement of financial
position presented) expected to be paid in each of the next five
fiscal years, and in the aggregate for the five fiscal years thereafter?
The expected benefits should be estimated based on the same
assumptions used to measure the company’s benefit obligation at
the end of the year and should include benefits attributable to
estimated future employee service.
[SFAS 132(R), par. 5f]
g. The employer’s best estimate, as soon as it can reasonably be
determined, of contributions expected to be paid to the plan
during the next fiscal year beginning after the date of the latest
statement of financial position presented. Estimated contributions
may be presented in the aggregate combining (1) contributions
required by funding regulations or laws, (2) discretionary contributions, and (3) noncash contributions?
[SFAS 132(R), par. 5g]
h. The amount of net periodic benefit cost recognized, showing
separately the service cost component, the interest cost component, the expected return on plan assets for the period, the gain or
loss component, the prior service cost or credit component, the
transition asset or obligation component, and the gain or loss
recognized due to settlements or curtailments?
i. Separately the net gain or loss and net prior service cost or credit
recognized in other comprehensive income for the period pursuant to paragraphs 25 and 29 of SFAS 87 and paragraphs 52 and 56
of SFAS 106, as amended, and reclassification adjustments of other
comprehensive income for the period, as those amounts, including
amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost?
[SFAS 132(R), par. 5i, as amended by SFAS 158]
ii. The amounts in accumulated other comprehensive income that
have not yet been recognized as components of net periodic benefit cost, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation?
[SFAS 132(R), par. 5ii, as amended by SFAS 158]
j. On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rate, rates of
compensation increase (for pay-related plans), and expected longterm rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost?
[SFAS 132(R), par. 5j]
k. Deleted by SFAS 158
[SFAS 132(R), par. 5k, as amended by SFAS 158]
l. The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?
[SFAS 132(R), par. 51]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____
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m. The effect of a one-percentage-point increase and the effect of a
one-percentage-point decrease in the assumed health care cost
trend rates on (1) the aggregate of the service and interest cost
components of net periodic postretirement health care benefit cost
and (2) the accumulated postretirement benefit obligation for
health care benefits? (For purposes of this disclosure, all other
assumptions shall be held constant, and the effects shall be measured based on the substantive plan that is the basis for the accounting.)
[SFAS 132(R), par. 5m]
n. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related parties and the plan during the period?
[SFAS 132(R), par. 5n]
o. If applicable, any alternative method used to amortize prior service amounts or net gains and losses pursuant to paragraphs 26 and
33 of SFAS 87 or paragraphs 53 and 60 of SFAS 106?
[SFAS 132(R), par. 5o, as amended by SFAS 158]
p. If applicable, any substantive commitment such as past practice
or a history of regular benefit increases used as the basis for
accounting for the benefit obligation?
q. If applicable, the cost of providing special or contractual termination benefits recognized during the period and a description of the
nature of the event?
[SFAS 132(R), par. 5q]
r. An explanation of any significant change in the benefit obligation
or plan assets not otherwise apparent in the other disclosures
required by SFAS 132?
[SFAS 132(R), par. 5r]
s. The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost
over the fiscal year that follows the most recent annual statement
of financial position presented, showing separately the net gain or
loss, net prior service cost or credit, and net transition asset or
obligation?
[SFAS 132(R), par. 5s, as amended by SFAS 158]
t. The amount and timing of any plan assets expected to be returned
to the employer during the 12-month period, or operating cycle if
longer, that follows the most recent annual statement of financial
position presented?
[SFAS 132(R), par. 5t, as amended by SFAS 158]
6.

7.

Are amounts related to the employer’s results of operations disclosed
for each period for which an income statement is presented?
[SFAS 132(R), par. 5]
Are amounts related to the employer’s statement of financial position
disclosed as of the date of each statement of financial position presented?
[SFAS 132(R), par. 5, as amended by SFAS 158]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Employers With Two or More Plans
8.

9.

Are the disclosures required by SFAS 132 aggregated for all of an
employer’s defined benefit pension plans and for all of an employer’s
other defined benefit postretirement plans unless disaggregating in
groups is considered to provide useful information or is otherwise
required by paragraph 6 of SFAS 132 and paragraph 7 of SFAS 132?
[SFAS 132(R), par. 6]
Are disclosures as of the date of each statement of financial position
presented?
[SFAS 132(R), par. 6, as amended by SFAS 158]

Note: Disclosures about pension plans with assets in excess of the accumulated benefit obligation generally may be aggregated with disclosures
about pension plans with accumulated benefit obligations in excess of
assets. The same aggregation is permitted for other postretirement benefit
plans.
[SFAS 132(R), par. 6]
10. If aggregate disclosures are presented, does the employer disclose:
a. The aggregate benefit obligation and aggregate fair value of plan
assets for plans with benefit obligations in excess of plan assets as
of the measurement date of each statement of financial position
presented?
b. The aggregate pension accumulated benefit obligation and aggregate fair value of plan assets for pension plans with accumulated
benefit obligations in excess of plan assets?
[SFAS 132(R), par. 6]
11. If a U.S. reporting entity combines disclosures about pension plans or
other postretirement benefit plans outside the United States with
those for U.S. plans, are the benefit obligations of the plans outside
the United States not significant relative to the total benefit obligation,
and do those plans not use significantly different assumptions?
[SFAS 132(R), par. 7]
Note: A foreign reporting entity that prepares financial statements in
conformity with U.S. GAAP shall apply the preceding guidance to its
domestic and foreign plans.
Reduced Disclosure Requirements for Nonpublic Entities
Note: A nonpublic entity is not required to disclose the information
required by paragraphs 5(a)–(c), 5(h), 5(m), and 5(o)–(r) of SFAS 132(R).
See the related disclosure questions above.
12. For a nonpublic entity181 that sponsors one or more defined benefit
pension plans or one or more other defined benefit postretirement
plans, has the following information been disclosed, separately for
pension plans and other postretirement benefit plans:
Copyright © 2008
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A nonpublic entity is any entity other than one (a) whose debt or equity securities trade in a public market either on a stock
exchange (domestic or foreign) or in the over-the-counter market including securities quoted only locally or regionally, (b) that makes
a filing with a regulatory agency in preparation for the sale of any class of debt or equity securities in a public market, or (c) that is
controlled by an entity covered by (a) or (b).
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Yes
_____

No
_____

N/A
_____

a. The benefit obligation, fair value of plan assets, and funded status
of the plan?
[SFAS 132(R), par. 8a]

_____

_____

_____

b. Employer contributions, participant contributions, and benefits
paid?
[SFAS 132(R), par. 8b]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

c. Information about plan assets:
(1) For each major category of plan assets which shall include,
but is not limited to, equity securities, debt securities, real
estate, and all other assets, the percentage of the fair value of
total plan assets held as of the measurement date used for
each statement of financial position presented?
[SFAS 132(R), par. 8c(1)]
(2) A narrative description of investment policies and strategies,
including target allocation percentages or range of percentages for each major category of plan assets presented on a
weighted-average basis as of the measurement date(s) of the
latest statement of financial position presented, if applicable,
and other factors that are pertinent to an understanding of the
policies or strategies such as investment goals, risk management practices, permitted and prohibited investments including the use of derivatives, diversification, and the
relationship between plan assets and benefit obligations?
[SFAS 132(R), par. 8c(2)]
(3) A narrative description of the basis used to determine the
overall expected long-term rate-of-return-on-assets assumption, such as the general approach used, the extent to which
the overall rate-of-return-on-assets assumption was based on
historical returns, the extent to which adjustments were made
to those historical returns in order to reflect expectations of
future returns, and how those adjustments were determined?
[SFAS 132(R), par. 8c(3)]
Note: Disclosure of additional asset categories and additional information about specific assets within a category is encouraged if that information is expected to be useful in understanding the risks associated with
each asset category and the overall expected long-term rate of return on
assets.
[SFAS 132(R), par. 8c(4)]
d. For defined benefit pension plans, the accumulated benefit obligation?
[SFAS 132(R), par. 8d]
e. The benefits (as of the date of the latest statement of financial
position presented) expected to be paid in each of the next five
fiscal years, and in the aggregate for the five fiscal years thereafter?
(The expected benefits should be estimated based on the same
assumptions used to measure the company’s benefit obligation at
the end of the year and should include benefits attributable to
estimated future employee service.)
[SFAS 132(R), par. 8e]
f. The employer’s best estimate, as soon as it can reasonably be
determined, of contributions expected to be paid to the plan during
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the next fiscal year beginning after the date of the latest statement
of financial position presented? (Estimated contributions may be
presented in the aggregate combining (1) contributions required
by funding regulations or laws, (2) discretionary contributions,
and (3) noncash contributions.)
[SFAS 132(R), par. 8f]
g. The amounts recognized in the statements of financial position,
showing separately the postretirement benefit assets and current
and noncurrent postretirement benefit liabilities?
[SFAS 132(R), par. 8g, as amended by SFAS 158]
h. Separately, the net gain or loss and net prior service cost or credit
recognized in other comprehensive income for the period pursuant to paragraphs 25 and 29 of SFAS 87 and paragraphs 52 and 56
of SFAS 106, as amended, and reclassification adjustments of other
comprehensive income for the period, as those amounts, including
amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost?
[SFAS 132(R), par. 8h, as amended by SFAS 158]
hh. The amounts in accumulated other comprehensive income that
have not yet been recognized as components of net periodic benefit cost, showing separately the net gain or loss, net prior service
cost or credit, and net transition asset or obligation?
[SFAS 132(R), par. 8hh, as amended by SFAS 158]
i. On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rates, rates of
compensation increase (for pay-related plans), and expected longterm rates of return on plan assets specifying, in a tabular format,
the assumptions used to determine the benefit obligation and the
assumptions used to determine net benefit cost?
[SFAS 132(R), par. 8i]
j. Deleted by SFAS 158
[SFAS 132(R), par. 8j, as amended by SFAS 158]
k. The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?
[SFAS 132(R), par. 8k]
l. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related parties and the plan during the period?
[SFAS 132(R), par. 81]
m. The nature and effect of significant non-routine events, such as
amendments, combinations, divestitures, curtailments, and settlements?
[SFAS 132(R), par. 8m]
n. The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost
Copyright © 2008
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_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____
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over the fiscal year that follows the most recent annual statement
of financial position presented, showing separately the net gain or
loss, net prior service cost or credit, and net transition asset or
obligation?
[SFAS 132(R), par. 8n, as amended by SFAS 158]
o. The amount and timing of any plan assets expected to be returned
to the employer during the 12-month period, or operating cycle if
longer, that follows the most recent annual statement of financial
position presented?
[SFAS 132(R), par. 8o, as amended by SFAS 158]
13. Are amounts related to the employer’s results of operations disclosed
for each period for which a statement of income is presented?
[SFAS 132(R), par. 8]
14. Are amounts related to the employer’s statement of financial position
disclosed as of the date of each statement of financial position presented?
[SFAS 132(R), par. 8, as amended by SFAS 158]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Disclosures in Interim Financial Reports
15. If the entity is publicly traded, does it disclose the following information in its interim financial statements that include a statement of
income:
a. The amount of net periodic benefit cost recognized for each period
for which a statement of income is presented, showing separately
the service cost component, the interest cost component, the expected return on plan assets for the period, the gain or loss component, the prior service cost or credit component, the transition
asset or obligation component, and the gain or loss recognized due
to a settlement or curtailment?
b. The total amount of the employer’s contributions paid, and expected to be paid, during the current fiscal year, if significantly
different from amounts previously disclosed pursuant to paragraph 5(g) of SFAS 132? (Estimated contributions may be presented in the aggregate combining (1) contributions required by
funding regulations or laws, (2) discretionary contributions, and
(3) noncash contributions.)
[SFAS 132(R), par. 9, as amended by SFAS 158]
16. If the entity is nonpublic, does it disclose in interim periods, for which
a complete set of financial statements is presented, the total amount
of the employer’s contributions paid, and expected to be paid, during
the current fiscal year, if significantly different from amounts previously disclosed pursuant to paragraph 8(f) of SFAS 132? (Estimated
contributions may be presented in the aggregate combining (a) contributions required by funding regulations or laws, (b) discretionary
contributions, and (c) noncash contributions.)
[SFAS 132(R), par. 10]
Entities That Do Not Report Other Comprehensive Income
17. Did the entity comply with the following instructions: For employers
that do not report other comprehensive income in accordance with
SFAS 130, the references to the net gain or loss, net prior service cost
or credit, and net transition asset or obligation recognized in other
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comprehensive income in paragraphs 5(i) and 8(h) of SFAS 132 shall
instead be to such amounts recognized as changes in unrestricted net
assets arising from a defined benefit plan but not yet included in net
periodic benefit cost?
[SFAS 132(R), par. 10A, as amended by SFAS 158]
18. Did the entity comply with the following instructions: For those
employers, the references to reclassification adjustments of other
comprehensive income in paragraphs 5(i) and 8(h) of SFAS 132 shall
instead be to reclassifications to net periodic benefit cost of amounts
previously recognized as changes in unrestricted net assets arising
from a defined benefit plan but not included in net periodic benefit
cost when they arose?
[SFAS 132(R), par. 10B, as amended by SFAS 158]
19. Did the entity comply with the following instructions: For those
employers, the references to the net gain or loss, net prior service cost
or credit, and net transition asset or obligation recognized in accumulated other comprehensive income in paragraphs 5(ii), 5(s), 8(hh), and
8(n) of SFAS 132 shall instead be to such amounts that have been
recognized as changes in unrestricted net assets arising from a defined
benefit plan but not yet reclassified as components of net periodic
benefit cost?
[SFAS 132(R), par. 10C, as amended by SFAS 158]
20. Did the entity comply with the following instructions: For those
employers, the references to results of operations (including items of
other comprehensive income) in paragraphs 5 and 8 of SFAS 132 shall
instead be to changes in unrestricted net assets and the references to
a statement of income in those paragraphs shall instead be to a
statement of activities?
[SFAS 132(R), par. 10D, as amended by SFAS 158]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Defined Contribution Plans
21. Does the employer disclose the amount of cost recognized for defined
contribution pension plans and for other defined contribution postretirement benefit plans for all periods presented separately from the
amount of cost recognized for defined benefit plans?
[SFAS 132(R), par. 11]
22. Do the disclosures include a description of the nature and effect of any
significant changes during the period affecting comparability, such as
a change in the rate of employer contributions, a business combination, or a divestiture?
[SFAS 132(R), par. 11]
Note: The AICPA staff, helped by industry experts, released two questions and answers, commonly referred to as Technical Practice Aids
(TPAs), on accounting and disclosures for single employer and multiemployer employee benefit plans related to the Medicare Prescription Drug,
Improvement and Modernization Act of 2003 (the Medicare Act):
• TIS section 6931.05, “Accounting and Disclosure Requirements for
Single-Employer Employee Benefit Plans Related to the Medicare
Prescription Drug, Improvement and Modernization Act of 2003”
(continued)
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• TIS section 6931.06, “Accounting and Disclosure Requirements for
Multiemployer Employee Benefit Plans Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003”
These TPAs provide accounting and disclosure guidance for both single
employer and multiemployer plans relating to the effects of the Medicare
Act. Practitioners are encouraged to incorporate this guidance as soon
as practicable. These TPAs are available on the AICPA’s Web site at
www.aicpa.org/Professional+Resources/Accounting+and+Auditing/
Accounting+Standards/recent_tpas.aspx.
Multiemployer Plans
23. Has the employer disclosed the amount of contributions to multiemployer plans for each annual period for which a statement of income
is presented?
[SFAS 132(R), par. 12]
24. If the employer chooses to disclose total contributions to multiemployer plans without disaggregating the amounts attributable to pension plans and other postretirement benefit plans, do the disclosures
include a description of the nature and effect of any changes affecting
comparability, such as a change in the rate of employer contributions,
a business combination, or a divestiture?
[SFAS 132(R), par. 12]
25. In some situations, withdrawal from a multiemployer plan may result
in an employer having an obligation to the plan for a portion of the
unfunded benefit obligation of the pension plans and other postretirement benefit plans. If withdrawal under circumstances that would
give rise to an obligation is either probable or reasonably possible,
have the provisions of SFAS 5, been applied (SFAS 87, paragraph 70)?
[SFAS 132(R), par. 13]
26. If it is either probable or reasonably possible that (a) an employer
would withdraw from the plan under circumstances that would give
rise to an obligation or (b) an employer’s contribution to the fund
would be increased during the remainder of the contract period to
make up a shortfall in the funds necessary to maintain the negotiated
level of benefit coverage (a “maintenance of benefits” clause), has the
employer applied the provisions of SFAS 5 (SFAS 106, paragraph 83)?
[SFAS 132(R), par. 13]
K. Consolidations
1.

2.

If consolidated statements are presented, is the consolidation policy
disclosed?
[ARB 51, par. 5; APB 22, par. 13]
Are the accounts of all majority-owned subsidiaries (except those for
which control is likely to be temporary or does not rest with the
majority owner) consolidated?
[SFAS 94, par. 13]
Practice Tip

Paragraph 1 of ARB No. 51 notes the presumption in GAAP that consolidated financial statements are more
meaningful than parent company-only financial statements, but paragraph 24 of ARB No. 51 acknowledges
(continued)
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Yes
_____

No
_____

N/A
_____

that parent company financial statements may be needed in addition to consolidated financial statements.
However, it does not suggest that parent company financial statements may be prepared in place of
consolidated financial statements. TIS section 1400.32, “Parent-Only Financial Statements and Relationship
to GAAP” (AICPA, Technical Practice Aids) clarifies that, even if a legal or regulatory agreement requires an
entity to submit “restricted” or “special use” parent-only financial statements without related consolidated
financial statements, the restricted or special use parent-only financial statements are not in accordance with
GAAP.
3.

If the financial reporting periods of any subsidiaries are different from
that of the parent, are intervening events that materially affect financial position or results of operations disclosed?
[ARB 51, par. 4]

_____

_____

_____

_____

_____

_____

If the provisions of EITF 06-9 are applicable to the financial statements
of a parent company, are the disclosures required by SFAS 154 made?
[EITF 06-9, par. 5]

_____

_____

_____

Are material intercompany transactions and accounts, and any profits
or losses on assets that are eliminated disclosed?
[ARB 51, par. 6]

_____

_____

_____

Note: EITF 06-9 clarifies that a parent company should report a change
to (or the elimination of) a previously existing difference between the
parent’s reporting period and the reporting period of a consolidated entity
in the parent’s consolidated financial statements as a change in accounting
principle in accordance with the provisions of SFAS 154. This issue does
not apply in situations in which a parent company or an investor changes
its fiscal year-end. This issue is effective for changes occurring in interim
or annual reporting periods beginning after board ratification (November
29, 2006). Earlier application of this guidance is permitted in periods for
which financial statements have not yet been issued.
4.

5.

6.

If a parent company reports a change to (or the elimination of) a
previously existing difference between the parent’s reporting period
and the reporting period of a consolidated entity in the parent’s
consolidated financial statements as described in EITF 06-9, has the
change been reported as a change in accounting principle in accordance with the provisions of SFAS 154, excluding retrospective application if it is impracticable to do so?
[EITF 06-9, par. 4]

Consolidation of Variable Interest Entities
Important: FIN 46(R), Consolidation of Variable Interest Entities, an interpretation of ARB 51, contains different effective dates based on the nature
of the entity applying its provisions. Also, FIN 46(R) contains scope
exceptions that should be considered in determining whether its provisions apply to a particular entity. Financial statement preparers and
auditors should familiarize themselves with the effective date guidance
and scope exceptions contained in FIN 46(R), which can be obtained on
the FASB Web site at www.fasb.org. Note that FIN 46(R) replaces the
original FIN 46, Consolidation of Variable Interest Entities—an interpretation
of ARB No. 51 that was issued in January 2003.
(continued)
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Yes
_____

No
_____

N/A
_____

a. The nature, purpose, size, and activities of the variable interest
entity?

_____

_____

_____

b. The carrying amount and classification of consolidated assets that
are collateral for the variable interest entity’s obligations?

_____

_____

_____

_____

_____

_____

a. The nature of its involvement with the variable interest entity and
when that involvement began?

_____

_____

_____

b. The nature, purpose, size, and activities of the variable interest
entity?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

FSP FIN 46(R)-7, Application of FASB Interpretation No. 46(R) to Investment
Companies, amends FIN 46(R) by clarifying that investments accounted for
at fair value in accordance with the specialized accounting guidance in the
AICPA Audit and Accounting Guide Investment Companies are not subject to
consolidation according to the requirements of that interpretation.
Separate accounts of life insurance entities as described in the AICPA
Audit and Accounting Guide Life and Health Insurance Entities are not
subject to consolidation according to the requirements of FIN 46.
7.

Does the primary beneficiary of a variable interest entity disclose the
following (unless the primary beneficiary also holds a majority voting
interest):

c. Lack of recourse if creditors (or beneficial interest holders) of a
consolidated variable interest entity have no recourse to the general credit of the primary beneficiary?
[FIN 46(R), par. 23]
8.

Does an enterprise that holds a significant variable interest in a
variable interest entity but is not the primary beneficiary disclose:

c. The enterprise’s maximum exposure to loss as a result of its
involvement with the variable interest entity?
[FIN 46(R), par. 24]
Note: For entities to which FIN 46(R) has been applied, the guidance in
FSP FIN 46(R)-5, Implicit Variable Interests under FASB Interpretation No. 46,
should be applied in the first reporting period beginning after March 3,
2005 in accordance with the transition provisions of FIN 46(R). Restatement to the date of the initial application of FIN 46(R) is permitted but not
required. Early application is permitted for periods for which financial
statements have not yet been issued. For entities to which FIN 46(R) has
not been applied, the guidance in FSP FIN 46(R)-5 should be applied in
accordance with the effective date and transition provisions of FIN 46(R).
9.

Does a reporting enterprise that is not the primary beneficiary but
holds a significant implicit variable interest in a VIE disclose the
information in question 8 above?
[FSP FIN 46(R)-5, par. 6]

10. Are disclosures required by SFAS 140, Accounting for Transfers and
Servicing of Financial Assets and Extinguishments of Liabilities—a replacement of FASB Statement No. 125, about a variable interest entity included in the same note to the financial statements as the information
required by FIN 46(R)?
[FIN 46(R), par. 25]
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Yes
_____

No
_____

N/A
_____

a. The number of entities to which this interpretation is not being
applied and the reason why the information required to apply this
interpretation is not available?

_____

_____

_____

b. The nature, purpose, size (if available), and activities of the entity(ies) and the nature of the enterprise’s involvement with the
entity(ies)?

_____

_____

_____

c. The reporting enterprise’s maximum exposure to loss because of
its involvement with the entity(ies)?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

11. If an entity does not apply FIN 46(R) to one or more variable interest
entities or potential variable interest entities because of the condition
described in paragraph 4(g) of FIN 46(R), is the following information
disclosed:

d. The amount of income, expense, purchases, sales, or other measure of activity between the reporting enterprise and the entity(ies)
for all periods presented? (However, if it is not practicable to
present that information for prior periods that are presented in the
first set of financial statements for which this requirement applies,
the information for those prior periods is not required.)
[FIN 46(R), par. 26]
L. Financial Instruments191
Derivative Instruments and Hedging Activities
1.

2.

3.

4.
5.

If an entity holds or issues derivative instruments (or nonderivative
instruments that are designated and qualify as hedging instruments
pursuant to paragraphs 37 and 42 of SFAS 133, as amended by SFAS
138, Accounting for Certain Derivative Instruments and Certain Hedging
Activities—an amendment of FASB Statement No. 133), has disclosure
been made of its objectives for holding or issuing those instruments,
the context needed to understand those objectives, and its strategies
for achieving those objectives?
Does the description distinguish between derivative instruments (and
nonderivative instruments) designated as fair value hedging instruments, derivative instruments designated as cash flow hedging instruments, derivative instruments (and nonderivative instruments)
designated as hedging instruments for hedges of the foreign currency
exposure of a net investment in a foreign operation, and all other
derivatives?
Does the description also indicate the entity’s risk management policy
for each of those types of hedges, including a description of the items
or transactions for which risks are hedged?
For derivative instruments not designated as hedging instruments,
does the description indicate the purpose of the derivative activity?
Qualitative disclosures about an entity’s objectives and strategies for
using derivative instruments may be more meaningful if such objectives and strategies are described in the context of an entity’s overall
risk management profile. If appropriate, an entity is encouraged, but
not required, to provide such additional qualitative disclosures. Have
such disclosures been made?
[SFAS 133, par. 44]
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6.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Do the entity’s disclosures for every reporting period for which a
complete set of financial statements is presented also include the
following:
Fair value hedges
a. For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
under SFAS 52, that have been designated and have qualified as
fair value hedging instruments and for the related hedged items:
(1) The net gain or loss recognized in earnings during the reporting period representing (a) the amount of the hedges’ ineffectiveness and (b) the component of the derivative instruments’
gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?
(2) The amount of net gain or loss recognized in earnings when
a hedged firm commitment no longer qualifies as a fair value
hedge?
[SFAS 133, par. 45a]
Cash flow hedges
b. For derivative instruments that have been designated and have
qualified as cash flow hedging instruments and for the related
hedged transactions:
(1) The net gain or loss recognized in earnings during the reporting period representing (a) the amount of the hedges’ ineffectiveness and (b) the component of the derivative instruments’
gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?
(2) A description of the transactions or other events that will
result in the reclassification into earnings of gains and losses
that are reported in accumulated other comprehensive income, and the estimated net amount of the existing gains or
losses at the reporting date that is expected to be reclassified
into earnings within the next 12 months?
(3) The maximum length of time over which the entity is hedging
its exposure to the variability in future cash flows for forecasted transactions excluding those forecasted transactions
related to the payment of variable interest on existing financial instruments?
(4) The amount of gains and losses reclassified into earnings as
a result of the discontinuance of cash flow hedges because it
is probable that the original forecasted transactions will not
occur by the end of the originally specified time period (as
documented at the inception of the hedging relationship) or
within an additional two-month period of time thereafter?
[SFAS 133, par. 45b, as amended by SFAS 138, par. 4r]
Hedges of the net investment in a foreign operation
c. For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
under SFAS 52, that have been designated and have qualified as
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7.

hedging instruments for hedges of the foreign currency exposure
of a net investment in a foreign operation, the net amount of gains
or losses included in the cumulative translation adjustment during
the reporting period?
[SFAS 133, par. 45c]
The quantitative disclosures about derivative instruments may be more
useful, and less likely to be perceived to be out of context or otherwise
misunderstood, if similar information is disclosed about other financial
instruments or nonfinancial assets and liabilities to which the derivative
instruments are related by activity. Accordingly, in such situations, has
the entity presented a more complete picture of its activities by disclosing
that information? (Encouraged, but not required.)
[SFAS 133, par. 45]

Certain Hybrid Financial Instruments
Notes: SFAS 155, Accounting for Certain Hybrid Financial Instruments—an
amendment of FASB Statements No. 133 and 140, is effective for all financial
instruments acquired, issued, or subject to a remeasurement (new basis)
event occurring after the beginning of an entity’s first fiscal year that
begins after September 15, 2006. The fair value election provided for in
paragraph 4(c) of SFAS 155 may also be applied upon adoption of the
statement for hybrid financial instruments that had been bifurcated under
paragraph 12 of SFAS 133 prior to the adoption of SFAS 155. Earlier
adoption is permitted as of the beginning of an entity’s fiscal year, provided the entity has not yet issued financial statements, including financial
statements for any interim period, for that fiscal year. At adoption, any
difference between the total carrying amount of the individual components of the existing bifurcated hybrid financial instrument and the fair
value of the combined hybrid financial instrument shall be recognized as
a cumulative-effect adjustment to beginning retained earnings. An entity
shall separately disclose the gross gains and losses that make up the
cumulative-effect adjustment, determined on an instrument-by-instrument
basis. Prior periods shall not be restated. SFAS 155 provides a fair value
measurement election for certain hybrid financial instruments with embedded derivatives that otherwise would require bifurcation. Hybrid
financial instruments that are elected to be accounted for in their entirety
at fair value cannot be used as a hedge instrument in a SFAS 133 hedge.
In February 2007, FASB issued SFAS 159, which is effective for financial
statements issued for fiscal years beginning after November 15, 2007.
Early adoption is permitted as of the beginning of a fiscal year that begins
on or before November 15, 2007, provided the organization also elects to
apply the provisions of SFAS 157, Fair Value Measurements. The choice to
adopt early should be made after issuance of this statement but within 120
days of the beginning of the fiscal year of adoption, provided the entity
has not yet issued financial statements, including required notes to those
financial statements, for any interim period of the fiscal year of adoption.
This statement applies to all entities, including not-for-profit organizations. Most of the provisions of this statement apply only to entities that
elect the fair value option. However, the amendment to SFAS 115 applies
to all entities with available-for-sale and trading securities. Some requirements apply differently to entities that do not report net income.
See section AA, “Fair Value Measurements” for more information. Question 10 applies only if SFAS 159 is applicable to the financial statements.
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_____
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8.

9.

If the entity measures hybrid instruments (financial instruments containing embedded derivatives) at fair value in accordance with the
election in SFAS 155 or the practicability exception in SFAS 133, is the
aggregate fair value of those instruments reported separately on the
face of the statement of financial position from the aggregate carrying
amounts of assets and liabilities measured using another measurement attribute? (Only answer the following part to question 8 if SFAS 159
has been adopted. Effective date information is included in section AA, “Fair
Value Measurements” of this checklist.) For those hybrid financial instruments measured at fair value under the election and under the practicability exception in paragraph 16 of SFAS 133, does an entity also
disclose the information specified in paragraphs 18–22 of SFAS 159?
[SFAS 133, par. 44A, as amended by SFAS 155, par. 4E and SFAS 159]
Has the entity provided information that will allow users to understand the effect of changes in the fair value of hybrid financial instruments measured at fair value?
[SFAS 133, par. 44B, as amended by SFAS 155, par. 4E]

10. For those hybrid financial instruments measured at fair value under
the election in SFAS 155 and under the practicability exception in
paragraph 16 of SFAS 155, has the entity disclosed the information in
paragraphs 18–22 of SFAS 159?
[SFAS 133, par. 45A]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Disclosures About Fair Value of Financial Instruments
11. Has the entity disclosed, either in the body of the financial statements
or in the accompanying notes,201the fair value of financial instruments
(except for those excluded in paragraphs 8 and 13 of SFAS 107) for
which it is practicable to estimate fair value?
[SFAS 107, par. 10, as amended by SFAS 157]
12. Has the fair value disclosed in the notes been presented together with
the related carrying amount in a form that makes it clear whether the
fair value and carrying amount represent assets or liabilities and how
the carrying amounts relate to what is reported in the statement of
financial position?
[SFAS 107, par. 10, as amended by SFAS 157]
13. In disclosing the fair value of a financial instrument, has the entity
taken care not to net that fair value with the fair value of other financial
instruments—even if those financial instruments are of the same class
or are otherwise considered to be related, for example, by a risk
management strategy—except to the extent that the offsetting of
carrying amounts in the statement of financial position is permitted
under the general principle in paragraphs 5–6 of FIN 39, or the
exceptions for master netting arrangements in paragraph 10 of FIN 39
and for amounts related to certain repurchase and reverse repurchase
agreements in paragraphs 3–4 of FIN 41, Offsetting of Amounts Related
to Certain Repurchase and Reverse Repurchase Agreements?
[SFAS 107, par. 14]
14. If the organization has offset fair value amounts recognized for the
right to reclaim cash collateral (a receivable) or the obligation to return
Copyright © 2008
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cash collateral (a payable) against fair value amounts recognized for
derivative instruments executed with the same counterparty under
the same master netting arrangement, have the disclosures in FSP FIN
39-1, Amendment of FASB Interpretation No. 39, been made?
[FIN 39, par 10B, as amended by FSP FIN 39-1, par. 4d]
15. If it is not practicable to estimate the fair value of a financial instrument or a class of financial instruments, are the following disclosed:
a. Information pertinent to estimating the fair value of that financial
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity?
b. The reasons why it is not practicable to estimate fair value?
[SFAS 107, par. 14]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: SFAS 126, as amended, makes the disclosures about fair values of
financial instruments prescribed in SFAS 107 optional for reporting entities that:
a. Are nonpublic entities.
b. Have total assets of less than $100 million on the date of the financial
statements.
c. Have no instrument that, in whole or in part, is accounted for as a
derivative instrument under SFAS 133, other than commitments
related to the origination of mortgage loans to be held for sale during
the reporting period.
Disclosure About Concentrations of Credit Risk of All Financial
Instruments
16. Except as indicated in paragraph 15b211 of SFAS 107, has the entity
disclosed all significant concentrations of credit risk arising from all
financial instruments, whether from an individual counterparty or
groups of counterparties? (Group concentrations of credit risk exist if a
number of counterparties are engaged in similar economic characteristics that would cause their ability to meet contractual obligations
to be similarly affected by changes in economic or other conditions.)
[SFAS 107, par. 15a]
17. Has the entity made the following disclosures about each significant
concentration:
a. Information about the (shared) activity, region, or economic characteristic that identifies the concentration?
b. The maximum amount of loss due to credit risk that, based on the
gross fair value of the financial instrument, the entity would incur
if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the
contracts and the collateral or other security, if any, for the amount
due proved to be of no value to the entity?
Copyright © 2008
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SFAS 107, Disclosures about Fair Value of Financial Instruments, paragraph 15b provides that these disclosure requirements do not
apply to the following financial instruments, whether written or held:
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c. The entity’s policy of requiring collateral or other security to
support financial instruments subject to credit risk, information
about the entity’s access to that collateral or other security, and the
nature and a brief description of the collateral or other security
supporting those financial instruments?
d. The entity’s policy of entering into master netting arrangements
to mitigate the credit risk of financial instruments, information
about the arrangements for which the entity is a party, and a brief
description of the terms of those arrangements, including the
extent to which they would reduce the entity’s maximum amount
of loss due to credit risk?
[SFAS 107, par. 15a]
18. Has the entity disclosed quantitative information221 about the market
risks of financial instruments that is consistent with the way it manages or adjusts those risks? (Encouraged, but not required.)
[SFAS 107, par. 15c]
19. Are the classification and presentation consensuses reached in EITF
00-19, Accounting for Derivative Financial Instruments Indexed to, and
Potentially Settled in, a Company’s Own Stock, regarding derivative
financial instruments indexed to, and potentially settled in, a company’s own stock complied with?
[EITF 00-19]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: SFAS 155 amended SFAS 133 in February 2006. SFAS 155 provides
a fair value measurement election for certain hybrid financial instruments
with embedded derivatives that otherwise would require bifurcation.
Hybrid financial instruments that are elected to be accounted for in their
entirety at fair value cannot be used as a hedge instrument in a SFAS 133
hedge.
[SFAS 155, App. B]
FASB Staff Position EITF No. 00-19-2, Accounting for Registration Payment
Arrangements, was issued on December 21, 2006. Readers must refer to
paragraphs 16–22 of the FSP for the effective date and transition requirements. For further guidance readers may refer to Appendix A of the FSP
which provides examples to illustrate the application of the accounting
provisions to various types of registration payment arrangements.
Important: The disclosures in question 18 above are incremental to the
disclosures that may be required under other applicable GAAP and are
required even if the likelihood of the issuer having to make any payments
under the arrangement is remote.
20. Does the issuer of a registration payment arrangement disclose the
following information about each registration payment arrangement
or each group of similar arrangements:
a. The nature of the registration payment arrangement, including the
approximate term of the arrangement, the financial instrument(s)
Copyright © 2008
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Appropriate ways of reporting the quantitative information encouraged will differ for different entities and will likely evolve over
time as management approaches and measurement techniques evolve. Possibilities include disclosing (a) more details about current
positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual
income, of several possible changes in market prices, (c) a gap analysis of interest rate repricing or maturity dates, (d) the duration of
the financial instruments, or (e) the entity’s value at risk from derivatives and from other positions at the end of the reporting period
and the average value at risk during the year. This list is not exhaustive, and an entity is encouraged to develop other ways of reporting
quantitative information.
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Yes
_____

No
_____

N/A
_____

subject to the arrangement, and the events or circumstances that
would require the issuer to transfer consideration under the arrangement?

_____

_____

_____

b. Any settlement alternatives contained in the terms of the registration payment arrangement, including the party that controls the
settlement alternatives?

_____

_____

_____

c. The maximum potential amount of consideration, undiscounted,
that the issuer could be required to transfer under the registration
payment arrangement (including the maximum number of shares
that may be required to be issued). If the terms of the arrangement
provide for no limitation to the maximum potential consideration
(including shares) to be transferred, is that fact disclosed?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

d. The current carrying amount of the liability representing the issuer’s obligations under the registration payment arrangement
and the income statement classification of any gains or losses
resulting from changes in the carrying amount of that liability?
[FSP EITF 00-19-2, par. 12]
21. Are gains and losses (realized and unrealized) on all derivative instruments within the scope of SFAS 133 shown net when recognized in
the income statement, whether or not settled physically, if the derivative instruments are held for trading purposes?
[EITF 02-3]
Note: SFAS 155 amended SFAS 133 in February 2006. SFAS 155 provides
a fair value measurement election for certain hybrid financial instruments
with embedded derivatives that otherwise would require bifurcation.
Hybrid financial instruments that are elected to be accounted for in their
entirety at fair value cannot be used as a hedge instrument in a SFAS 133
hedge.
[SFAS 155, App. B]
22. If derivative transactions are entered into in connection with the
issuance of contingently convertible securities, do disclosures of the
potential impact of the contingently convertible securities include the
terms of those derivative transactions (including the terms of settlement), how those transactions relate to the contingently convertible
securities, and the number of shares underlying the derivatives?
[FSP 129-1, par. 5]
Disclosures About Certain Financial Instruments With Characteristics of
Both Liabilities and Equity
Important: Depending upon whether an entity is a nonpublic entity, a
public entity, or an Securities and Exchange Commission (SEC) registrant,
FSP 150-3 defers the effective date for applying the provisions of SFAS
150, Accounting for Certain Financial Instruments with Characteristics of both
Liabilities and Equity. Readers should read FSP 150-3 to understand the
various effective dates of SFAS 150. FSP 150-3 is available at the FASB Web
site at www.fasb.org.
Early adoption of the provisions of SFAS 150 for instruments within the
scope of the indefinite deferrals established by FSP 150-3 is precluded
during the deferral period.
(continued)
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

a. Are they classified as liabilities?

_____

_____

_____

b. Are they described in the statement of financial position as “shares
subject to mandatory redemption”?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The amount that would be paid, or the number of shares that
would be issued and their fair value, determined under the conditions specified in the contract if the settlement were to occur at
the reporting date?

_____

_____

_____

b. How changes in the fair value of the issuer’s equity shares would
affect those settlement amounts (for example, “the issuer is obligated to issue an additional x shares or pay an additional y dollars
in cash for each $1 decrease in the fair value of one share”)?

_____

_____

_____

c. The maximum amount that the issuer could be required to pay to
redeem the instrument by physical settlement, if applicable?

_____

_____

_____

d. The maximum number of shares that could be required to be
issued, if applicable?

_____

_____

_____

During the deferral period, all public entities as well as nonpublic entities
that are SEC registrants are required to follow the disclosure requirements
in paragraphs 26–27 of SFAS 150 (questions 24–25 below) as well as
disclosures required by other applicable guidance.
23. For items within the scope of SFAS 150, are they presented as liabilities
(or assets in some circumstances), and are those items not presented
between the liabilities section and the equity section of the statement
of financial position?
[SFAS 150, par. 18]
24. If the entity has no equity instruments outstanding but has financial
instruments in the form of shares, all of which are mandatorily
redeemable financial instruments:

c. Are payments to holders of such instruments and related accruals
presented separately from payments to and interest due to other
creditors in statements of cash flows and income?
[SFAS 150, pars. 19 and 28]
25. Do the entities referred to in question 24 above disclose the components of the liability that would otherwise be related to shareholders’
interest and other comprehensive income, if any, subject to the redemption feature (for example, par value and other paid-in amounts
of mandatorily redeemable instruments should be disclosed separately from the amount of retained earnings or accumulated deficit)?
[SFAS 150, par. 28]
26. For issuers of financial instruments within the scope of SFAS 150:
a. Are the nature and terms of the financial instruments and the
rights and obligations embodied in those instruments disclosed?
b. Does that disclosure include information about settlement alternatives, if any, in the contract and identify the entity that controls
the settlement alternatives?
[SFAS 150, par. 26]
27. For all outstanding financial instruments within the scope of SFAS 150
and for each settlement alternative, do issuers disclose:
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e. That a contract does not limit the amount that the issuer could be
required to pay or the number of shares that the issuer could be
required to issue, if applicable?
f. For a forward contract or an option indexed to the issuer’s equity
shares, the forward price or option strike price, the number of
issuer’s shares to which the contract is indexed, and the settlement
date or dates of the contract, as applicable?
[SFAS 150, par. 27]
28. Are unconditional mandatorily redeemable financial instruments
classified as liabilities if those instruments are mandatorily redeemable on fixed dates unless the redemption is required to occur only
upon the liquidation or termination of the reporting entity? (Note: A
mandatorily redeemable financial instrument is conditional if the
obligation depends upon the occurrence of an event not certain to occur.
Death is not uncertain of occurrence; thus, death is not a condition.)
[SFAS 150, pars. 9–10 and A2]
29. Are financial instruments, other than an outstanding share, that, at
inception, (a) embodies an obligation to repurchase the issuer’s equity
shares, or is indexed to such an obligation, and (b) requires or may
require the issuer to settle the obligation by transferring assets, classified as liabilities (or assets in some circumstances)?
[SFAS 150, par. 11]
30. Are financial instruments that embody an unconditional obligation,
or financial instruments other than an outstanding share that embodies a conditional obligation, that the issuer must or may settle by
issuing a variable number of its equity shares, classified as liabilities
(or assets in some circumstances) if, at inception, the monetary value
of the obligation is based solely or predominantly on any one of the
items indicated in paragraph 12 of SFAS 150?
[SFAS 150, par. 12]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Related to the Adoption of SFAS 150
31. Is the cumulative transition adjustment and any subsequent adjustment reported as an excess of liabilities over assets (a deficit) and
changes thereto even though the mandatorily redeemable shares are
reported as a liability?
[FSP FAS 150-2]
32. Is the resulting change in the amount of the mandatorily redeemable
shares, depending on the settlement terms, either measured at the
present value of the amount to be paid at settlement or the amount of
cash that would be paid under the conditions specified in the contract
if settlement occurred at the reporting date recognized as interest cost
(change in redemption amount)?
[FSP FAS 150-2]
33. Although the disclosure requirements of SFAS 150 do not apply for
those mandatorily redeemable instruments of certain nonpublic
companies while application of the provisions of SFAS 150 to those
instruments is deferred, are the disclosure requirements regarding
“Capital Structure: Disclosures” in paragraph 4 of SFAS 129, Disclosure
of Information about Capital Structure, in particular, information about
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Beginning and ending amounts of cumulative translation adjustments?

_____

_____

_____

b. The aggregate adjustment for the period resulting from translation
adjustments and gains and losses from certain hedges and intercompany balances? (Note: Paragraph 45c of SFAS 133 specifies
additional disclosures for instruments designated as hedges of the
foreign currency exposure of a net investment in a foreign operation. See section L, “Financial Instruments.”)

_____

_____

_____

c. The amount of income taxes for the period allocated to translation
adjustments?

_____

_____

_____

_____

_____

_____

the pertinent rights and privileges of the various securities outstanding, including mandatory redemption requirements, still disclosed?
[FSP FAS 150-3]
34. Although the disclosure requirements of SFAS 150 do not apply for
those mandatorily redeemable instruments of certain nonpublic companies while application of the provisions of SFAS 150 to those
instruments is deferred, are the disclosure requirements regarding
“Capital Structure: Disclosures” in paragraph 8 of SFAS 129, which
requires disclosure of the amount of redemption requirements for all
issues of stock that are redeemable at fixed or determinable prices on
fixed or determinable dates in each of the next five years, still disclosed?
[FSP FAS 150-3]
35. During the deferral period, if the entity is a public entity or a nonpublic entity that is an SEC registrant, are the disclosure requirements in
paragraphs 26–27 of SFAS 150 as well as disclosures required by other
applicable guidance complied with?
[FSP FAS 150-3]
36. For instruments that are within the scope of EITF 05-2, Meaning of
“Conventional Convertible Debt Instrument” in Issue, are the applicable
disclosures required by SFAS 129 included by the entity?
[EITF 05-2, par. 10]
37. Weather derivative contracts within the scope of EITF 99-2, Accounting for Weather Derivatives are financial instruments, therefore, are the
existing GAAP disclosures for financial instruments such as those
required in SFAS 107 included?
[EITF 99-2]
M. Foreign Currency
1.

2.

Is the aggregate transaction gain or loss included in net income for the
period disclosed? (Note: For this disclosure, gains and losses on
derivative instruments shall comply with paragraph 45 of SFAS 133.)
[SFAS 52, par. 30, as amended by SFAS 133]
Is an analysis of changes during the period in the accumulated
amount of translation adjustments reported in equity, included, and
does it disclose:

d. The amounts transferred from cumulative translation adjustments
and included in the determination of net income for the period as
a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity?
[SFAS 52, par. 31]
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3.

4.

5.

6.

7.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. A description of the impaired long-lived asset (asset group) and
the facts and circumstances leading to the impairment?

_____

_____

_____

b. If not separately presented on the face of the statement, the amount
of the impairment loss and the caption in the income statement
that includes the loss?

_____

_____

_____

c. The method or methods for determining fair value (whether based
on a quoted market price, prices for similar assets, or another
valuation technique)?

_____

_____

_____

_____

_____

_____

Are rate changes occurring after the date of the financial statements
and the effects on unsettled balances related to foreign currency
translations disclosed, if significant?
[SFAS 52, par. 32]
Are any foreign earnings reported in addition to amounts received in
the U.S. disclosed, if significant?
[ARB 43, Ch. 12, par. 5]
If the reporting entity entered into a foreign currency swap contract
to replace foreign currency debt with reporting currency debt, and the
contract is not executed with the same counterparty under a master
netting arrangement, is the contract accounted for separately and not
netted against the foreign currency debt (because they are two separate legal transactions and do not have the legal right of setoff)?
[EITF 86-25; FIN 39; FSP FIN 39-1, par. 4]
Is the entire change in the fair value of foreign-currency-denominated
available-for-sale debt securities reported in shareholders’ equity?
[EITF 96-15]
Are foreign currency transaction gains and losses on a forward exchange contract or a foreign-currency-denominated liability that is
designated as, and is effective as, a hedge of the foreign-currency-denominated available-for-sale debt security also reported in the SFAS
115 component of shareholders’ equity (to offset the portion of the
market value change of a foreign-currency-denominated availablefor-sale debt security attributable to foreign exchange rates)?
[EITF 96-15]

N. Impairment of Long-Lived Assets to Be Held and Used
1.

2.

Is an impairment loss recognized for a long-lived asset (asset group)
to be held and used included in income from continuing operations
before income taxes in the income statement of a business enterprise?
[SFAS 144, par. 25]
Is the following information disclosed in the notes to the financial
statements that include the period in which an impairment loss is
recognized:

d. If applicable, the segment in which the impaired long-lived asset
(asset group) is reported under SFAS 131?
[SFAS 144, par. 26]
3.

If the occurrence of a significant event or circumstance at any time
during the assessment period results in an expectation that the criteria
in paragraph 42 of EITF 03-13, Applying the Conditions in Paragraph 42
of FASB Statement No. 144 in Determining Whether to Report Discontinued
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

a. The nature of the activities that give rise to continuing cash flows?

_____

_____

_____

b. The period of time continuing cash flows are expected to be
generated? and

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Operations will be met by the end of the assessment period, is the
component’s operations presented as discontinued operations?
[EITF 03-13, par. 13]
4.

Is the following information disclosed in the notes to the financial
statements for each discontinued operation that generates continuing
cash flows:

c. the principal factors used to conclude that the expected continuing
cash flows are not direct cash flows of the disposed component?
[EITF 03-13, par. 17]
5.

6.

Additionally, for each discontinued operation in which the ongoing
entity will engage in a “continuation of activities” with the disposed
component after its disposal and for which the amounts presented in
continuing operations after the disposal transaction include a continuation of revenues and expenses that were intercompany transactions (eliminated in consolidated financial statements) before the
disposal transaction, are the intercompany amounts before the disposal transaction disclosed for all periods presented?
[EITF 03-13, par. 17]
Are the types of continuing involvement, if any, that the entity will
have after the disposal transaction disclosed? Also, is that information
disclosed in the period in which operations are initially classified as
discontinued?
[EITF 03-13, par. 17]

O. Long-Lived Assets and Disposal Groups to Be Disposed Of
Reporting Discontinued Operations
1.

Are the results of operations of a component of an entity (as that phrase
is defined in SFAS 144) that either has been disposed of or is classified
as held for sale reported in discontinued operations in accordance
with paragraph 43 of SFAS 144 (questions 2–5 below) if both of the
following conditions are met:
a. The operations and cash flows of the component have been (or will
be) eliminated from the ongoing operations of the entity as a result
of the disposal transaction? and
b. The entity will not have any significant continuing involvement in
the operations of the component after the disposal transaction?
[SFAS 144, par. 42]

2.

3.

In a period in which a component of an entity either has been disposed
of or is classified as held for sale, does the income statement for current
and prior periods report the results of operations of the component,
including any gain or loss recognized in accordance with paragraph
37 of SFAS 144, in discontinued operations?
[SFAS 144, par. 43]
Are the results of operations of a component classified as held for sale
reported in discontinued operations in the period(s) in which they
occur?
[SFAS 144, par. 43]
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4.

5.

6.

7.

Are the results of discontinued operations, less applicable income
taxes (benefit), reported as a separate component of income before
extraordinary items and the cumulative effect of accounting changes
(if applicable)?
[SFAS 144, par. 43]
Is the gain or loss recognized on the disposal disclosed either on the
face of the income statement or in the notes to the financial statements?
[SFAS 144, par. 43]
Are adjustments to amounts previously reported in discontinued
operations that are directly related to the disposal of a component of
an entity in a prior period classified separately in the current period
in discontinued operations?
[SFAS 144, par. 44]
Are the nature and amount of such adjustments (as discussed in
question 6 above) disclosed?
[SFAS 144, par. 44]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Reporting Disposal Gains or Losses in Continuing Operations
8.

9.

Is a gain or loss, that is recognized on the sale of a long-lived asset
(disposal group) that is not a component of an entity, included in
income from continuing operations before income taxes in the income
statement?
[SFAS 144, par. 45]
If a subtotal such as “income from operations” is presented, does it
include the amounts of those gains or losses considered in question 8
above?
[SFAS 144, par. 45]

Reporting a Long-Lived Asset or Disposal Group Sold or Classified as
Held for Sale
10. If the criteria of paragraph 30 of SFAS 144 are met (and thus a
long-lived asset is classified as held for sale) after the balance sheet
date but before issuance of the financial statements, does the longlived asset continue to be classified as held and used in those financial
statements when issued and is the information required by paragraph
47(a) of SFAS 144 (question 15a below) disclosed in the notes to the
financial statements?
[SFAS 144, par. 33]
11. Is a long-lived asset that is classified as held for sale presented
separately in the statement of financial position?
[SFAS 144, par. 46]
12. Are the assets and liabilities of a disposal group that is classified as
held for sale presented separately in the asset and liability sections,
respectively, of the statement of financial position?
[SFAS 144, par. 46]
13. Are those assets and liabilities considered in question 12 above, not
offset and presented as a single amount?
[SFAS 144, par. 46]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

a. A description of the facts and circumstances leading to the expected disposal, the expected manner and timing of that disposal,
and, if not separately presented on the face of the statement, the
carrying amount(s) of the major classes of assets and liabilities
included as part of a disposal group?

_____

_____

_____

b. The gain or loss recognized in accordance with paragraph 37 of
SFAS 144 and if not separately presented on the face of the income
statement, the caption in the income statement that includes that
gain or loss?

_____

_____

_____

c. If applicable, amounts of revenue and pretax profit or loss reported in discontinued operations?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

14. Are the major classes of assets and liabilities that are classified as held
for sale separately disclosed either on the face of the statement of
financial position or in the notes to financial statements?
[SFAS 144, par. 46]
15. Is the following information disclosed in the notes to the financial
statements that cover the period in which a long-lived asset (disposal
group) either has been sold or is classified as held for sale:

d. If applicable, the segment in which the long-lived asset (disposal
group) is reported under SFAS 131?
[SFAS 144, par. 47]
16. If either paragraph 38 or 40 of SFAS 144 applies, is a description of the
facts and circumstances leading to the decision to change the plan to
sell the long-lived asset (disposal group) and its effect on the results
of operations for the period and any prior periods presented disclosed
in the notes to the financial statements that include the period of that
decision?
[SFAS 144, par. 48]
17. If a long-lived asset is to be disposed of other than by sale, does it
continue to be classified as held and used until it is disposed of?
[SFAS 144, par. 27, as amended by SFAS 153]
P. Transfers and Servicing of Financial Assets and Securitizations
Note: SFAS 156, Accounting for Servicing of Financial Assets—an amendment
of FASB Statement No. 140, among other matters, amends the disclosure
requirements of SFAS 140. The statement is effective as of the beginning
of its first fiscal year that begins after September 15, 2006. Earlier adoption
is permitted under certain conditions. If SFAS 156 has been adopted, the
practitioner should refer to section P1, “Accounting for Servicing Financial Assets.”
1.

2.

Is the policy for requiring collateral or other security disclosed if the
entity has entered into repurchase agreements or securities lending
transactions?
[SFAS 140, par. 17(a)]
If it is not practicable to estimate the fair value of certain assets
obtained or liabilities incurred in transfers of financial assets during
the period, are those items and the reasons why it is not practicable to
estimate fair value described in the notes to the financial statements?
[SFAS 140, par. 17(d)]
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3.

Yes
_____

No
_____

N/A
_____

a. The amounts of servicing assets or liabilities recognized and amortized during the period?

_____

_____

_____

b. The fair value of recognized servicing assets and liabilities for
which it is practicable to estimate that value and the method and
significant assumptions used to estimate the fair value?

_____

_____

_____

c. The risk characteristics of the underlying financial assets used to
stratify recognized servicing assets for purposes of measuring
impairment in accordance with paragraph 63 of SFAS 140?

_____

_____

_____

_____

_____

_____

a. Its accounting policies for initially measuring the retained interests, if any, including the methodology (whether quoted market
price, prices based on sales of similar assets and liabilities, or prices
based on valuation techniques) used in determining their fair
value?

_____

_____

_____

b. The characteristics of securitizations (a description of the transferor’s continuing involvement with the transferred assets, including, but not limited to, servicing, recourse, and restrictions on
retained interests) and the gain or loss from sale of financial assets
in securitizations?

_____

_____

_____

_____

_____

_____

_____

_____

_____

For all servicing assets and servicing liabilities are the following
disclosures made:

d. The activity in any valuation allowance for impairment of recognized servicing assets—including beginning and ending balances,
aggregate additions charged and reductions credited to operations, and aggregate direct write-downs charged against the allowances—for each period for which results of operations are
presented?
[SFAS 140, par. 17(e)]
4.

If the entity has securitized financial assets during any period presented and accounts for that transfer as a sale, are the following items
disclosed for each major asset type:

231

c. The key assumptions used in measuring the fair value of retained
interests at the time of securitization (including, at a minimum,
quantitative information about discount rates, expected prepayments including the expected weighted-average life of prepayable
financial assets, and anticipated credit losses, if applicable)?
d. Cash flows between the securitization SPE and the transferor,
unless reported separately elsewhere in the financial statements
or notes (including proceeds from new securitizations, proceeds
from collections reinvested in revolving-period securitizations,
purchases of delinquent or foreclosed loans, servicing fees, and
cash flows received on interests retained)?
[SFAS 140, par. 17(f)]
5.

If the entity has retained interests in securitized financial assets at the
date of the latest statement of financial position presented, are the
following items disclosed for each major asset type:
a. Its accounting policies for subsequently measuring those retained
interests, including the methodology (whether quoted market
price, prices based on sales of similar assets and liabilities, or prices
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Yes
_____

No
_____

N/A
_____

based on valuation techniques) used in determining their fair
value?

_____

_____

_____

b. The key assumptions used in subsequently measuring the fair
value of those interests (including, at a minimum, quantitative
information about discount rates, expected prepayments including the expected weighted-average life of prepayable financial
assets, and anticipated credit losses, including expected static pool
losses, if applicable)?

_____

_____

_____

c. A sensitivity analysis or stress test showing the hypothetical effect
on the fair value of those interests of two or more unfavorable
variations from the expected levels for each key assumption that
is reported under b. above independently from any change in
another key assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or stress test?

_____

_____

_____

(1) The total principal amount outstanding, the portion that has
been derecognized, and the portion that continues to be
recognized in each category reported in the statement of
financial position, at the end of the period?

_____

_____

_____

(2) Delinquencies at the end of the period?

_____

_____

_____

(3) Credit losses, net of recoveries, during the period?
Disclosure of average balances during the period is encouraged,
but not required.
[SFAS 140, par. 17(g)]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

d. For the securitized assets and any other financial assets that it
manages together with them:241

Collateral
6.

7.

8.

If the entity has pledged any of its assets as collateral that are not
reclassified and separately reported in the statement of financial
position pursuant to paragraph 15(a) of SFAS 140, is the carrying
amount and classification of those assets as of the date of the latest
statement of financial position presented?
[SFAS 140, par. 17(a)(2)]
If the entity has accepted collateral that it is permitted by contract or
custom to sell or repledge, is the fair value, as of the date of each
statement of financial position presented, of that collateral and of the
portion of that collateral that it has sold or repledged disclosed?
[SFAS 140, par. 17(a)(3)]
Is information about the sources and uses of that collateral, as of the
date of each statement of financial position presented, disclosed?
[SFAS 140, par. 17(a)(3)]

P1. Accounting for Servicing Financial Assets
1.

If it is not practicable to estimate the fair value of certain assets
obtained or liabilities incurred in transfers of financial assets during
the period, are those items and the reasons why it is not practicable
to estimate fair value described in the notes to the financial statements?
[SFAS 140, par. 17d]
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2.

Yes
_____

No
_____

N/A
_____

a. Management’s basis for determining its classes of servicing assets
and servicing liabilities per SFAS 140 paragraph 13A, as amended?

_____

_____

_____

b. A description of the risks inherent in servicing assets and servicing
liabilities and, if applicable, the instruments used to mitigate the
income statement effect of changes in fair value of the servicing
assets and servicing liabilities? (Disclosure of quantitative information about the instruments used to manage the risks inherent
in servicing assets and servicing liabilities, including the fair value
of those instruments at the beginning and end of the period, is
encouraged but not required.)

_____

_____

_____

_____

_____

_____

(1) The beginning and ending balances?

_____

_____

_____

(2) Additions (through purchases of servicing assets, assumptions of servicing obligations, and servicing obligations that
result from transfers of financial assets)?

_____

_____

_____

(3) Disposals?

_____

_____

_____

(4) Changes in the fair value during the period resulting from
changes in valuation inputs or assumptions used in the valuation model?

_____

_____

_____

(5) Changes in the fair value during the period resulting from
other changes in fair value and a description of those
changes?

_____

_____

_____

(6) Other changes that affect the balance and a description of
those changes?

_____

_____

_____

For all servicing assets and servicing liabilities, are the following
disclosures made:

c. The amount of contractually specified servicing fees (as defined in
the glossary of SFAS 156), late fees, and ancillary fees earned for
each period for which results of operations are presented, including a description of where each amount is reported in the statement of income?
[SFAS 140, par. 17e, as amended by SFAS 156]
3.

For servicing assets and servicing liabilities measured at fair value,
are the following disclosures made:
a. For each class of servicing assets and servicing liabilities, the
activity in the balance of servicing assets and the activity in the
balance of servicing liabilities (including a description of where
changes in fair value are reported in the statement of income for
each period for which results of operations are presented), including, but not limited to, the following:

b. A description of the valuation techniques or other methods used
to estimate the fair value of servicing assets and servicing liabilities. If a valuation model is used, the description shall include the
methodology and model validation procedures, as well as quantitative and qualitative information about the assumptions used
in the valuation model (for example, discount rates and prepayment speeds)? (An entity that provides quantitative information
about the instruments used to manage the risks inherent in the
servicing assets and servicing liabilities, as encouraged by paragraph 17(e)(2), is also encouraged, but not required, to disclose a
description of the valuation techniques, as well as quantitative
Copyright © 2008
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

(1) The beginning and ending balances?

_____

_____

_____

(2) Additions (through purchases of servicing assets, assumption of servicing obligations, and servicing obligations that
result from transfers of financial assets)?

_____

_____

_____

(3) Disposals?

_____

_____

_____

(4) Amortization?

_____

_____

_____

(5) Application of valuation allowance to adjust carrying value
of servicing assets?

_____

_____

_____

(6) Other-than-temporary impairments?

_____

_____

_____

(7) Other changes that affect the balance and a description of
those changes?

_____

_____

_____

b. For each class of servicing assets and servicing liabilities, the fair
value of recognized servicing assets and servicing liabilities at the
beginning and end of the period if it is practicable to estimate the
value?

_____

_____

_____

c. A description of the valuation techniques or other methods used
to estimate fair value of the servicing assets and servicing liabilities? If a valuation model is used, the description shall include the
methodology and model validation procedures, as well as quantitative and qualitative information about the assumptions used
in the valuation model (for example, discount rates and prepayment speeds)? (An entity that provides quantitative information
about the instrument used to manage the risks inherent in the
servicing assets and servicing liabilities, as encouraged by paragraph 17(e)(2), is also encouraged, but not required, to disclose a
description of the valuation techniques as well as quantitative and
qualitative information about the assumptions used to estimate
the fair value of those instruments.)

_____

_____

_____

d. The risk characteristics of the underlying financial assets used to
stratify recognized servicing assets for purposes of measuring
impairment in accordance with paragraph 63 of SFAS 140, as
amended?

_____

_____

_____

_____

_____

_____

and qualitative information about the assumptions used to estimate the fair value of those instruments.)
[SFAS 140, par. 17f, as amended by SFAS 156]
4.

For servicing assets and servicing liabilities subsequently amortized
in proportion to and over the period of estimated net servicing income
or loss and assessed for impairment or increased obligation:
a. For each class of servicing assets and servicing liabilities, the
activity in the balance of servicing assets and the activity in the
balance of servicing liabilities (including a description of where
changes in the carrying amount are reported in the statement of
income for each period for which results of operations are presented), including, but not limited to, the following:

e. The activity by class in any valuation allowance for impairment of
recognized servicing assets—including beginning and ending balances, aggregate additions charged and recoveries credited to
operations, and aggregate write-downs charged against the allowance—for each period for which results of operations are presented?
[SFAS 140, par. 17g, as amended by SFAS 156]
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5.

Yes
_____

No
_____

N/A
_____

a. Its accounting policies for initially measuring the interests that
continue to be held by the transferor, if any, and servicing assets
or servicing liabilities, if any, including the methodology (whether
quoted market price, prices based on sales of similar assets and
liabilities, or prices based on valuation techniques) used in determining their fair value (per paragraphs 68–70)?

_____

_____

_____

b. The characteristics of securitizations (a description of the transferor’s continuing involvement with the transferred assets, including, but not limited to, servicing, recourse, and restrictions on
interests that continue to be held by the transferor) and the gain or
loss from sale of financial assets in securitizations?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Its accounting policies for subsequently measuring those interests,
including the methodology (whether quoted market price, prices
based on sales of similar assets and liabilities, or prices based on
valuation techniques) used in determining their fair value?

_____

_____

_____

b. The key assumptions used in subsequently measuring the fair
value of those interests (including, at a minimum, quantitative
information about discount rates, expected prepayments including the expected weighted-average life of prepayable financial
assets, and anticipated credit losses, including expected static pool
losses, if applicable)?

_____

_____

_____

If the entity has securitized financial assets during any period presented and accounts for that transfer as a sale, are the following items
disclosed for each major asset type (for example, mortgage loans,
credit card receivables, and automobile loans):

251

c. The key assumptions used in measuring the fair value of interest
that continue to be held by the transferor and servicing assets or
servicing liabilities, if any, at the time of securitization (including,
at a minimum, quantitative information about discount rates,
expected prepayments including the expected weighted-average
life of prepayable financial assets, and anticipated credit losses, if
applicable)?
d. Cash flows between the securitization SPE and the transferor,
unless reported separately elsewhere in the financial statements
or notes (including proceeds from new securitizations, proceeds
from collections reinvested in revolving-period securitizations,
purchases of delinquent or foreclosed loans, servicing fees, and
cash flows received on interests that continue to be held by the
transferor)?
[SFAS 140, par. 17h, as amended by SFAS 156]
6.

If the entity has interests that continue to be held by the transferor in
financial assets that it has securitized or servicing assets or servicing
liabilities relating to assets that it has securitized, at the date of the
latest statement of financial position presented, are the following
items disclosed for each major asset type (for example, mortgage
loans, credit card receivables, and automobile loans):

c. A sensitivity analysis or stress test showing the hypothetical effect
on the fair value of those interests (including any servicing assets
or servicing liabilities) of two or more unfavorable variations from
Copyright © 2008
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

(1) The total principal amount outstanding, the portion that has
been derecognized, and the portion that continues to be
recognized in each category reported in the statement of
financial position, at the end of the period?

_____

_____

_____

(2) Delinquencies at the end of the period?

_____

_____

_____

(3) Credit losses, net of recoveries, during the period?
[SFAS 140, par. 17h, as amended by SFAS 156]

_____

_____

_____

a. Nature of the transactions?

_____

_____

_____

b. Basis of accounting for the assets transferred?

_____

_____

_____

c. Gains or losses recognized on the transfers?
[APB 29, par. 28, fn. 7; FIN 30]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

the expected levels for each key assumption that is reported under
b above independently from any change in another key assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or stress test?
d. For the securitized assets and any other financial assets that it
manages together with them:261

Note: Disclosure of average balances during the period is encouraged,
but not required.
Q. Nonmonetary Transactions
1.

2.

Do disclosures for nonmonetary transactions during the period include:

Is the amount of gross operating revenue recognized as a result of
nonmonetary transactions addressed by EITF 00-8, Accounting by a
Grantee for an Equity Instrument to Be Received in Conjunction with
Providing Goods or Services, disclosed in each period’s financial statements?
[EITF 00-8]

R. Subsequent Events
1.

2.

Are the financial statements adjusted for any changes in estimates
resulting from subsequent events that provide additional evidence
about conditions that existed at the balance sheet date?
[SFAS 5, par. 8; AU 560.03–.04, .07, and 561.01–.10]
Are subsequent events that provide evidence about conditions that
did not exist at the balance sheet date, but arose subsequent to that
date, adequately disclosed to keep the financial statements from being
misleading?
[SFAS 5, par. 11; AU 560.05–.07, .09, and 561.01–.09]

Note: Consider the appropriateness of dual-dating the auditor’s report if
a subsequent event is disclosed in the financial statements.
[AU 530.05]
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Yes
_____

No
_____

N/A
_____

a. The amount of termination benefits accrued and charged to expense and the classification of those costs in the income statement?

_____

_____

_____

b. The number of employees to be terminated?

_____

_____

_____

c. A description of the employee group(s) to be terminated?

_____

_____

_____

d. The amount of actual termination benefits paid and charged
against the liability and the number of employees actually terminated as a result of the plan to terminate employees?

_____

_____

_____

_____

_____

_____

a. Reporting the statement of income effect of recognizing a liability
at the commitment date in income from continuing operations and
not on the face of the statement of income net of taxes?

_____

_____

_____

b. No disclosure made on the face of the statement of income for
earnings per share effect?

_____

_____

_____

_____

_____

_____

a. A description of the major actions comprising the exit plan, activities that will not be continued, including the method of disposition, and the anticipated date of completion?

_____

_____

_____

b. A description of the type and amount of exit costs recognized as
liabilities and the classification of those costs in the income statement?

_____

_____

_____

S. Costs Associated With Exit or Disposal Activities
Note: SFAS 146, Accounting for Costs Associated with Exit or Disposal Activities, is effective for exit or disposal activities initiated after December 31,
2002. For the purposes of SFAS 146, an exit or disposal activity is initiated
when management, having the authority to approve the action, commits
to an exit or disposal plan or otherwise disposes of a long-lived asset
(disposal group) and, if the activity involves the termination of employees, the criteria for a plan of termination in paragraph 8 of SFAS 146 are
met. The provisions of EITF 94-3, Liability Recognition for Certain Employee
Termination Benefits and Other Costs to Exit an Activity (including Certain
Costs Incurred in a Restructuring) shall continue to apply for an exit activity
initiated under an exit plan that met the criteria of EITF 94-3 prior to SFAS
146’s initial application. Questions 1–3 apply only if the provisions of
SFAS 146 are not effective.
1.

If a material liability is recognized for certain employee termination
benefits in accordance with Section A of EITF 94-3, are the following
disclosures made in all periods until the plan of termination is completed:

e. The amount of any adjustment(s) to the liability?
[EITF 94-3, Section A]
2.

If management commits to an exit plan that meets the criteria in
Section B of EITF 94-3, are the following reporting requirements
followed:

c. Revenue and related costs and expenses of activities that will not
be continued should not be combined and reported as a separate
component of income?
[EITF 94-3, Section B]
3.

If the activities that will not be continued are significant to the company’s revenue or operating results, or if the exit costs recognized at
the commitment date are material, are the following disclosures made
in all periods until the exit plan is completed:

Copyright © 2008

FSP §20,300.03

78

2-08

20,400-8

115

Financial Statements and Notes Checklist
Yes
_____

No
_____

N/A
_____

c. A description of the type and amount of exit costs paid and
charged against the liability?

_____

_____

_____

d. The amount of any adjustment(s) to the liability?

_____

_____

_____

_____

_____

_____

Is the following information disclosed in notes to the financial statements that include the period in which an exit or disposal activity is
initiated and any subsequent period until the activity is completed:
a. A description of the exit or disposal activity, including the facts
and circumstances leading to the expected activity and the expected completion date?

_____

_____

_____

b. For each major type of cost associated with the activity (for example, one-time termination benefits, contract termination costs, and
other associated costs):
(1) The total amount expected to be incurred in connection with
the activity, the amount incurred in the period, and the cumulative amount incurred to date?

_____

_____

_____

(2) A reconciliation of the beginning and ending liability balances showing separately the changes during the period attributable to costs incurred and charged to expense, costs
paid or otherwise settled, and any adjustment to the liability
with an explanation of the reason(s) therefor?

_____

_____

_____

c. The line item(s) in the income statement in which the costs in b
above are aggregated?

_____

_____

_____

(1) The total amount of costs expected to be incurred in connection with the activity?

_____

_____

_____

(2) The amount incurred in the period?

_____

_____

_____

(3) The cumulative amount incurred to date, net of any adjustments to the liability with an explanation of the reason(s)
therefor?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

e. For all periods presented, the revenue and net operating income
or losses from activities that will not be continued if those activities
have separately identifiable operations?
[EITF 94-3, Section B]
Note: Questions 4–8 apply only if the provisions of SFAS 146 are effective.
The provisions of SFAS 146 are effective for exit or disposal activities
initiated after December 31, 2002.
4.

d. For each reportable segment:

e. If a liability for a cost associated with the activity is not recognized
because fair value cannot be reasonably estimated, that fact and
the reasons therefor?
[SFAS 146, par. 20]
5.

6.

Are costs associated with an exit or disposal activity that does not
involve a discontinued operation included in income from continuing
operations before income taxes, for example, in a subtotal such as
“income from operations”?
[SFAS 146, par. 18]
Are costs associated with an exit or disposal activity that involves a
discontinued operation included in the results of discontinued operation?
[SFAS 146, par. 18]
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7.

8.

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired?

_____

_____

_____

b. The primary reasons for the acquisition, including a description of
the factors that contributed to a purchase price that results in
recognition of goodwill?

_____

_____

_____

c. The period for which the results of operations of the acquired
entity are included in the income statement of the combined
entity?

_____

_____

_____

d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred
shares, or partnership interests) issued or issuable, the value assigned to those interests, and the basis for determining that value?

_____

_____

_____

e. A condensed balance sheet disclosing the amount assigned to each
major asset and liability caption of the acquired entity at the
acquisition date?

_____

_____

_____

f. Contingent payments, options, or commitments specified in the
acquisition agreement and the accounting treatment that will be
followed should any such contingency occur?

_____

_____

_____

g. The amount of purchased research and development assets acquired and written off in the period (refer to paragraph 42 of SFAS
141) and the line item in the income statement in which the
amounts written off are aggregated?

_____

_____

_____

If an event or circumstance occurs that discharges or removes an
entity’s responsibility to settle a liability for a cost associated with an
exit or disposal activity recognized in a prior period, is the liability
reversed?
[SFAS 146, par. 19]
Are the related costs reversed through the same line item(s) in the
income statement used when those costs were recognized initially?
[SFAS 146, par. 19]

T. Business Combinations
Notes: This section applies if the provisions of SFAS 141 are being
applied to the financial statements. The provisions of SFAS 141 apply to
all business combinations initiated after June 30, 2001. SFAS 141 also
applies to all business combinations accounted for using the purchase
method for which the date of acquisition is July 1, 2001, or later.
For combinations between two or more mutual enterprises, SFAS 141
will not be effective until interpretive guidance related to application of
the purchase method to those transactions is issued. FASB is considering
issues related to the application of the purchase method to combinations
between two or more mutual enterprises in a separate project.
In December 2007, FASB released SFAS 141R, Business Combinations,
which will be effective for business combinations for which the acquisition
date is on or after the beginning of the first annual reporting period
beginning on or after December 15, 2008.
1.

Do the notes to the financial statements of a combined entity disclose
the following information in the period in which a material business
combination is completed:
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

(1) The total amount assigned and the amount assigned to a
major intangible asset class?

_____

_____

_____

(2) The amount of any significant residual value, in total and by
major intangible asset class?

_____

_____

_____

(3) The weighted-average amortization period, in total and by
major intangible asset class?

_____

_____

_____

b. For intangible assets not subject to amortization the total amount
assigned and the amount assigned to any major intangible asset
class?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The number of entities acquired and a brief description of those
entities?

_____

_____

_____

b. The aggregate cost of the acquired entities, the number of equity
interests, (such as common shares, preferred shares, or partnership interests) issued or issuable, and the value assigned to those
interests?

_____

_____

_____

c. The aggregate amount of any contingent payments, options, or
commitments and the accounting treatment that will be followed
should any contingency occur (if potentially significant in relation
to the aggregate cost of the acquired entities)?

_____

_____

_____

_____

_____

_____

h. For any purchase price allocation that has not been finalized, that
fact and the reasons therefore?
i. In subsequent periods, the nature and amount of any material
adjustment made to the initial allocation of the purchase price?
[SFAS 141, par. 51]
2.

Is the following information disclosed in the notes to the financial
statements in the period in which a material business combination is
completed if the amounts assigned to goodwill or to other intangible
assets acquired are significant in relation to the total cost of the
acquired entity:
a. For intangible assets subject to amortization:

c. For goodwill:
(1) The total amount of goodwill and the amount that is expected
to be deductible for tax purposes?
(2) The amount of goodwill by reportable segment (if the combined entity is required to disclose segment information in
accordance with SFAS 131), unless not practicable?
[SFAS 141, par. 52]
3.

If a series of individually immaterial business combinations completed during the period are material in the aggregate, is the following
disclosed:

d. The information described in question 2 above, if the aggregate
amount assigned to goodwill or to other intangible assets acquired
is significant in relation to the aggregate cost of the acquired
entities?
[SFAS 141, par. 53]
4.

If the combined entity is a public business enterprises, is the following
supplemental information on a pro forma basis for the period in
which a material business combinations occurs (or for the period in
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The name and a brief description of the acquired entity and the
percentage of voting equity interests acquired?

_____

_____

_____

b. The primary reasons for the acquisition, including a brief description of the factors that contributed to a purchase price that results
in recognition of goodwill?

_____

_____

_____

c. The period for which the results of operations of the acquired
entity are included in the income statement of the combined
entity?

_____

_____

_____

which a series of individually immaterial business combinations occur that are material in the aggregate) disclosed:
a. Results of operations for the current period as though the business
combination or combinations had been completed at the beginning of the period unless the acquisition was at or near the beginning of the period?
b. Results of operations for the comparable period as though the
business combination or combinations had been completed at the
beginning of that period if comparative financial statements are
presented?
[SFAS 141, par. 54]
5.

Does the supplemental pro forma information display revenue, income before extraordinary items and the cumulative effect of accounting changes, net income, and earnings per share at a minimum?
[SFAS 141, par. 55]

Note: In determining the pro forma amounts, income taxes, interest
expense, preferred share dividends, and depreciation and amortization of
assets shall be adjusted to the accounting base recognized for each in
recording the combination. Pro forma information related to results of
operations of periods prior to the combination shall be limited to the
results of operations for the immediately preceding period.
[SFAS 141, par. 55]
6.

7.

8.

Does the supplemental pro forma information disclose the nature and
amount of material, nonrecurring items included in the reported pro
forma results of operations, if any?
[SFAS 141, par. 55]
In the period in which an extraordinary gain is recognized related to
a business combination, do the notes to the financial statements
disclose the information required by paragraph 11 of APB 30?
[SFAS 141, par. 56]
If a material business combination is completed after the balance sheet
date but before the financial statements are issued, is the information
required by questions 1–2 above disclosed if practicable?
[SFAS 141, par. 57]

Interim Financial Information
9.

For summarized interim financial information of a public business
enterprise is the following information disclosed if a material business
combination is completed during the current year up to the date of
the most recent interim statement of financial position presented:
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Yes
_____

No
_____

N/A
_____

d. The cost of the acquired entity and, if applicable, the number of
shares of equity interests (such as common shares, preferred
shares, or partnership interests) issued or issuable, the value assigned to those interests, and the basis for determining that value?

_____

_____

_____

e. Supplemental pro forma information that discloses the results of
operations for the current interim period and the current year up
to the date of the most recent interim statement of financial position presented (and for the corresponding periods in the preceding
year) as though the business combination had been completed as
of the beginning of the period reported on?

_____

_____

_____

f. The nature and amount of any material, nonrecurring items included in the reported pro forma results of operations?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The nature of the preexisting relationship?

_____

_____

_____

b. The measurement of the settlement amount of the preexisting
relationship, if any, and the valuation method used to determine
the settlement amount?

_____

_____

_____

_____

_____

_____

_____

_____

_____

g. Do the pro forma information disclosures in e above display at a
minimum, revenue, income before extraordinary items and the
cumulative effect of accounting changes (including those on an
interim basis), net income and earnings per share?
[SFAS 141, par. 58]
Other Disclosures and Presentation Items
10. Is any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to reduce goodwill and other noncurrent intangible assets of an acquired
entity or directly to contributed capital (paragraphs 30 and 36 of SFAS
109) disclosed?
[SFAS 109, par. 48]
11. If a material liability is recognized by the combined institution for
costs incurred to (1) exit and activity, (2) involuntarily terminate
employees of an acquired institution, or (3) relocate employees of an
acquired entity, are disclosures made in accordance with EITF 95-3,
Recognition of Liabilities In Connection with a Purchase Business Combination?
[EITF 95-3]
12. Are the following disclosures made for business combinations between parties with a preexisting relationship:

c. The amount of any settlement gain or loss recognized and its
classification in the statement of operations?
[EITF 04-1]
13. Amounts previously recognized as goodwill should not be reclassified as an identifiable intangible asset, however, previously recognized goodwill should be tested for impairment by applying the
consensuses in Step 2 of a goodwill impairment test. As a result of the
application of EITF 04-1, Accounting for Preexisting Relationships between the Parties to a Business Combination, is any effect on a goodwill
impairment charge reported in operating income?
[EITF 04-1]
Copyright © 2008

78

2-08

20,400-13

FSP §20,300.03

120

Life and Health Insurance Entities
Yes
_____

No
_____

N/A
_____

_____

_____

_____

Are the types of products and services from which each reportable
segment derives its revenues disclosed?
[SFAS 131, par. 26]

_____

_____

_____

Has a measure of profit or loss and total assets been reported for each
reportable segment?
[SFAS 131, par. 27]

_____

_____

_____

a. Revenues from external customers?

_____

_____

_____

b. Revenues from transactions with other operating segments of the
reporting entity?

_____

_____

_____

c. Interest revenue?

_____

_____

_____

d. Interest expense?

_____

_____

_____

e. Depreciation, depletion, and amortization expense?

_____

_____

_____

f. Unusual items as described in paragraph 26 of APB 30?

_____

_____

_____

g. Equity in the net income of investees accounted for by the equity
method?

_____

_____

_____

h. Income tax expense or benefit?

_____

_____

_____

i. Extraordinary items?

_____

_____

_____

j. Significant noncash items other than depreciation, depletion, and
amortization expense?
[SFAS 131, par. 27]

_____

_____

_____

a. The amount of investment in equity method investees?

_____

_____

_____

b. Total expenditures for additions to long-lived assets other than
financial instruments and deferred tax assets?
[SFAS 131, par. 28]

_____

_____

_____

U. Segment Information
Note: Public business enterprises are required to provide the disclosures
described in SFAS 131 and nonpublic business enterprises are encouraged
to do so.
1.

2.

3.

4.

5.

Are the factors used to identify the reporting entity’s reportable
segments, including the basis of organization (for example, whether
management has chosen to organize the reporting entity around
differences in products and services, geographic areas, regulatory
environments, or a combination of factors and whether operating
segments have been aggregated) disclosed?
[SFAS 131, par. 26]

If the following specified amounts (a) are included in the measure of
segment profit or loss reviewed by the chief operating decision maker
or (b) are otherwise regularly provided to the chief operating decision
maker, even if not included in that measure of segment profit or loss,
are they disclosed for each reportable segment:

If the following specified amounts are (a) included in the determination of segment assets reviewed by the chief operating decision maker
or (b) are otherwise regularly provided to the chief operating decision
maker, even if not included in that measure of segment assets, are they
disclosed for each reportable segment:
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6.

Yes
_____

No
_____

N/A
_____

a. The basis of accounting for any transactions between reportable
segments?

_____

_____

_____

b. The nature of any differences between the reporting entity’s consolidated income before taxes, extraordinary items, discontinued
operations, and the cumulative effect of changes in accounting
principle?

_____

_____

_____

c. The nature of any differences between the measurements of the
reportable segments’ assets and the reporting entity’s consolidated assets?

_____

_____

_____

d. The nature of any changes from prior periods in the measurement
methods used to determine reported segment profit or loss and
the effect, if any, of those changes on the measure of segment profit
or loss?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Is an explanation of the measurements of segment profit or loss and
segment assets that discloses the following for each reportable segment provided:

e. The nature and effect of any asymmetrical allocations to segments?
[SFAS 131, par. 31]
7.

8.

9.

Are reconciliations of the totals of the reportable segments’ revenues,
measures of profit or loss, assets, and every other significant item of
information disclosed to corresponding consolidated amounts presented with all significant reconciling items separately identified and
described?
[SFAS 131, par. 32]
If the reporting entity changes the structure of its internal organization
in a manner that changes the composition of its reportable segments,
is the corresponding information for prior periods restated and is the
fact that the corresponding items of segment information for earlier
periods have been restated disclosed?
[SFAS 131, par. 34]
If the reporting entity changes the structure of its internal organization
in a manner that changes the composition of its reportable segments
and the corresponding information for prior periods is not restated,
does disclosure in the year in which the change occurs include segment information for the current period under both the old basis and
the new basis?
[SFAS 131, par. 35]

10. For all reporting entities subject to SFAS 131, including those that have
a single reportable segment, are the following enterprise-wide items
disclosed:
a. Revenues from external customers for each product and service or
each group of similar products and services unless it is impracticable to do so?
[SFAS 131, par. 37]
b. The following geographic information unless it is impracticable to
do so:
(1) Revenues from external customers (a) attributed to the reporting entity’s country of domicile and (b) attributed to all
foreign countries in total from which the reporting entity
derives revenue?
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Yes
_____

No
_____

N/A
_____

(2) Revenues from external customers attributed to an individual foreign country, if material?

_____

_____

_____

(3) The basis for attributing revenues from external customers to
individual countries?

_____

_____

_____

(4) Long-lived assets other than financial instruments and deferred tax assets (a) located in the reporting entity’s country
of domicile and (b) located in all foreign countries in total in
which the reporting entity holds assets?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The method used—either the intrinsic value method or the fair
value based method—to account for stock-based employee compensation in each period presented?

_____

_____

_____

b. For an entity the adopts the fair value recognition provisions of
SFAS 123, for all financial statements in which the period of
adoption is presented, is there a description of the method of
reporting the change in accounting principle?

_____

_____

_____

(5) Long-lived assets as described above in an individual foreign
country, if material?
[SFAS 131, par. 38]
c. Information about the extent of the reporting entity’s reliance on
its major customers, including the following:
(1) If revenues from transactions with any single customer
amount to 10 percent or more of the reporting entity’s revenues, that fact, the total amount of revenues from each such
customer, and the identity of the segment or segments reporting the revenue?
[SFAS 131, par. 39]
11. If the information described in questions 10a and b above has not been
disclosed because it is impracticable, is that fact disclosed?
[SFAS 131, pars. 37–38]
V. Postemployment Benefits
1.

If an obligation for postemployment benefits (for example, salary
continuation, supplemental unemployment benefits, severance benefits, disability related benefits, job training and counseling, and continuation of health and insurance coverage) has not been accrued
because the amount cannot be reasonably estimated, is that fact
disclosed in the financial statements?
[SFAS 112, par. 7]

W. Stock Compensation Plans
Note: If the provisions of SFAS 123(R) are effective, refer to questions
12–17 and ignore questions 1–11 below.
1.

Has the entity disclosed the following information in the “Summary
of Significant Accounting Policies” or its equivalent:

c. If awards of stock-based employee compensation were outstanding and accounted for under the intrinsic value method of APB 25
for any period for which an income statement is presented, is there
a tabular presentation of the following information for all periods
presented:
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Yes
_____

No
_____

N/A
_____

(1) Net income and basic and diluted earnings per share as
reported?

_____

_____

_____

(2) The stock-based employee compensation cost, net of related
tax effects, included in the determination of net income, as
reported?

_____

_____

_____

(3) The stock-based employee compensation cost, net of related
tax effects, that would have been included in the determination of net income if the fair value based method had been
applied to all awards?

_____

_____

_____

(4) Pro forma net income as if the fair value based method had
been applied to all awards?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

(1) Those outstanding at the beginning of the year?

_____

_____

_____

(2) Those outstanding at the end of the year?

_____

_____

_____

(3) Those exercisable at the end of the year?

_____

_____

_____

(4) Those granted during the year?

_____

_____

_____

(5) Those exercised during the year?

_____

_____

_____

(6) Those forfeited during the year?

_____

_____

_____

(7) Those expired during the year?

_____

_____

_____

_____

_____

_____

(5) Pro forma basic and diluted earnings per share as if the fair
value based method had been applied to all awards?
[SFAS 148, par. 2(e)]
2.

3.

4.

5.

Does the required pro forma amounts reflect the difference in stockbased employee compensation cost, if any, included in the net income
and the total cost measured by the fair value based method, as well
as additional tax effects, if any, that would have been recognized in
the income statement if the fair value based method had been applied
to all awards?
[SFAS 148, par. 2(e)]
Does the required pro forma per share amounts reflect the change in
the denominator of the diluted earnings per share calculation as if the
assumed proceeds under the treasury stock method, including measured but unrecognized compensation cost and the excess tax benefits
credited to additional paid-in capital, were determined under the fair
value based method?
[SFAS 148, par. 2(e)]
Is a description of the plan(s), including the general terms of awards
under the plan(s) disclosed?
[SFAS 123, par. 46]
Are the following disclosed for each year for which an income statement is presented:
a. The number and weighted-average exercise prices of options for
each of the following groups of options:

b. The weighted-average grant-date fair value of options granted
during the year? (Note: That is, if the exercise prices of some
options differ from the market price of the stock on the grant date,
weighted-average fair values of options shall be disclosed separately for options whose exercise price (1) equals, (2) exceeds, or
(3) is less than the market price of the stock on the grant date.)
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Yes
_____

No
_____

N/A
_____

c. The number and weighted-average grant date-fair value of equity
instruments other than options granted during the year?

_____

_____

_____

d. A description of the method and significant assumptions used
during the year to estimate the fair values of options, including the
following weighted-average information: (1) risk-free interest
rate, (2) expected life, (3) expected volatility, and (4) expected
dividends?

_____

_____

_____

e. Total compensation cost recognized in income for stock-based
employee compensation awards?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The range of exercise prices?

_____

_____

_____

b. The weighted-average exercise price?

_____

_____

_____

c. The weighted-average remaining contractual life?
[SFAS 123, par. 48]

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

f. The terms of significant modifications of outstanding awards?
[SFAS 123, par. 47a–f]
6.

7.

8.

If the reporting entity grants options under multiple stock-based
employee compensation plans, are the items in question 5 above
disclosed separately for different types of awards to the extent that
the differences in the characteristics of the awards make separate
disclosure important to an understanding of the reporting entity’s use
of stock-based compensation?
[SFAS 123, par. 47]
For options outstanding at the date of the latest balance sheet presented, are the following disclosed:

If the range of exercise prices is wide (the highest exercise price
exceeds approximately 150 percent of the lowest exercise price), are
the exercise prices segregated into ranges that are meaningful for
assessing the number and timing of additional shares that may be
issued and the cash that may be received as a result of option exercises
and are the following disclosed for each range:
a. The number, weighted-average exercise price, and weighted-average remaining contractual life of options outstanding?
b. The number and weighted-average exercise price of options currently exercisable?
[SFAS 123, par. 48]

9.

For bonus arrangements issued in connection with the grant of stock
compensation awards, is any amount recognized as a bonus liability
during the service period that exceeds the ultimate bonus paid to the
employee reclassified to equity?
[EITF 00-23]

10. Is the accounting policy for recognizing compensation cost related to
fixed stock awards with pro rata vesting disclosed?
[EITF 00-23]
11. Are changes in fair value of an option award granted to employees,
in unrestricted, publicly traded shares of an unrelated entity prior to
vesting characterized as compensation expense in the employer’s
income statement?
[EITF 02-8]
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Yes
_____

No
_____

N/A
_____

a. The nature and terms of such arrangements that existed during
the period and the potential effects of those arrangements on
shareholders?

_____

_____

_____

b. The effect of compensation cost arising from share-based payment
arrangements on the income statement?

_____

_____

_____

c. The method of estimating the fair value of the goods or services
received, or the fair value of the equity instruments granted (or
offered to grant), during the period?

_____

_____

_____

_____

_____

_____

_____

_____

_____

Notes: The provisions of SFAS 123(R) are effective (a) for public entities
that do not file as small business issuers—as of the beginning of the first
interim or annual reporting period that begins after June 15, 2005; (b) for
public entities that file as small business issuers—as of the beginning of
the first interim or annual reporting period that begins after December 15,
2005; and (c) for nonpublic entities—as of the beginning of the first annual
reporting period that begins after December 15, 2005.
These questions apply only if the provisions of SFAS 123(R) are effective.
12. If the entity has one or more share-based payment arrangements, does
it disclose information that enables users of the financial statements
to understand:

d. The cash flow effects resulting from share-based payment arrangements?
[SFAS 123(R), par. 64]
Notes: Paragraphs A240–A241 of SFAS 123(R) indicate the minimum
information needed to achieve those objectives and illustrate how the
disclosure requirements might be satisfied. In some circumstances, an
entity may need to disclose information beyond that listed in paragraph
A240 to achieve the disclosure objectives.
On October 20, 2006, FSP FAS 123 (R)-6, Technical Corrections of FASB
Statement No. 123(R), which addresses certain technical corrections of
SFAS 123(R). Specifically, it amends paragraph A240(d)(1) to exempt
nonpublic entities from disclosing the aggregate intrinsic value of outstanding fully vested share options (or share units), among other matters.
The provisions in FSP FAS 123(R)-6 are effective in the first reporting
period beginning after October 20, 2006. If in applying SFAS 123(R) an
entity did so in a manner consistent with the provisions of this FSP, then
that entity should continue to apply the provisions in this FSP to prior
periods. However, if an entity did not apply SFAS 123(R) in a manner
consistent with the provisions of this FSP, then that entity should retrospectively apply the provisions in this FSP to prior periods when those periods’
financial statements are included for comparative purposes with currentperiod financial statements. Early application of this FSP is permitted in
periods for which financial statements have not yet been issued.
13. If the entity acquires goods or services other than employee services
in share-based payment transactions, does it provide disclosures
similar to those in question 11 above required by paragraph 64 of
SFAS 123(R) to the extent that those disclosures are important to an
understanding of the effects of those transactions on the financial
statements?
[SFAS 123(R), par. 65]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

a. Recognized as an increase to additional paid-in capital?

_____

_____

_____

b. Included in the pool of excess tax benefits available to absorb tax
deficiencies on share-based payment awards (as described in paragraphs 62–63 of SFAS 123(R))?

_____

_____

_____

_____

_____

_____

a. A general description of the asset retirement obligations and the
associated long-lived assets?

_____

_____

_____

b. The fair value of assets that are legally restricted for purposes of
settling asset retirement obligations?

_____

_____

_____

14. If the entity has multiple share-based payment arrangements with
employees, does it disclose information separately for different types
of awards under those arrangements to the extent that differences in
the characteristics of the awards make separate disclosure important
to an understanding of the entity’s use of share-based compensation?
(See paragraph A240 of SFAS 123(R).)
[SFAS 123(R), par. 65]
Notes: EITF 06-11, Accounting for Income Tax Benefits of Dividends on
Share-Based Payment Awards, is effective for income tax benefits that result
from dividends on equity-classified employee share-based payment
awards that are declared in fiscal years beginning after December 15, 2007,
and interim periods within those fiscal years. Early application is permitted as of the beginning of a fiscal year for which interim or annual financial
statements have not yet been issued. Retrospective application to previously issued financial statements is prohibited.
This EITF clarifies that a realized income tax benefit from dividends or
dividend equivalents charged to retained earnings and that are paid to
employees for equity classified nonvested equity shares, nonvested equity
share units, and outstanding equity share options should be recognized
as an increase to additional paid-in capital. The amount recognized in
additional paid-in capital for the realized income tax benefit from dividends on those awards should be included in the pool of excess tax
benefits available to absorb tax deficiencies on share-based payment
awards (as described in paragraphs 62–63 of SFAS 123(R)).
15. If an entity awards its employees, as part of a share-based payment
arrangement, with (a) dividends on equity-classified nonvested
shares, (b) dividend equivalents on equity-classified nonvested share
units, or (c) payments equal to the dividends paid on the underlying
shares while an equity-classified share option is outstanding, and
those dividends or dividend equivalents are charged to retained
earnings under SFAS 123(R) resulting in an income tax deduction for
the employer, is the realized income tax benefit:

c. That is reclassified from additional paid-in capital to the income
statement when an entity’s estimate of forfeitures increases (or
actual forfeitures exceed the entity’s estimates), limited to the
entity’s pool of excess tax benefits available to absorb tax deficiencies on the date of the reclassification?
[EITF 06-11; SFAS 123(R), fn. 61]
X. Asset Retirement Obligations
1.

Is the following information about its asset retirement obligations
disclosed:
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. The carrying amounts for the major types of invested assets of the
closed block?

_____

_____

_____

b. Future policy benefits and policyholders’ account balances?

_____

_____

_____

c. Policyholder dividend obligation?

_____

_____

_____

c. A reconciliation of the beginning and ending aggregate carrying
amount of asset retirement obligations showing separately the
changes attributable to (1) liabilities incurred in the current period,
(2) liabilities settled in the current period, (3) accretion expense,
and (4) revisions in estimated cash flows, whenever there is a
significant change in one or more of those four components during
the reporting period?
[SFAS 143, par. 22]
2.

3.

If the fair value of an asset retirement obligation cannot be reasonably
estimated is that fact and the reasons therefore disclosed?
[SFAS 143, par. 22]
In addition to the disclosures required by paragraphs 19(c)–19(d), and
21 of APB 20, is the liability for the asset retirement obligation computed on a pro forma basis disclosed in the footnotes for the beginning
of the earliest year presented and at the end of all years presented as
if SFAS 143 and FIN 47, Accounting for Conditional Asset Retirement
Obligations—an interpretation of FASB Statement No. 143, had been
applied during all periods affected?
[SFAS 143, par. 27; FIN 47, par. 11]

Y. Demutualizations and Formations of Mutual Insurance Holding
Companies
1.

2.

3.

Are the nature and terms of a demutualization or formation of and
MIHC and the basis of presentation and terms of operation of the
closed block disclosed?
[SOP 00-3, par. 24 (ACC 10,810.24)]
Is a general description of the method of emergence of earnings from
the closed block, presentation of assets and liabilities of the closed
block, and policyholder dividend obligation provided?
[SOP 00-3, par. 24 (ACC 10,810.24)]
If a closed block has formed, is the following disclosed (Note: Refer
to SOP 00-3, Appendix A, “Illustrative Guidance—Footnote Disclosure for the Closed Block,” for an illustrative example):
a. A general description of the closed block, including the purpose
of the closed block, the types of insurance policies included, and
the nature of the cash flows that increase and decrease the amount
of closed block liabilities?
[SOP 00-3, par. 25a (ACC 10,810.25)]
b. An indication the continuing responsibility of the insurance enterprise to support the payment of contractual benefits and the nature
of expenses charged to the closed block operations?
[SOP 00-3, par. 25a (ACC 10,810.25)]

4.

Is summarized financial data of the closed block as of, or for periods
ending on the date of, the financial statements presented, including
at a minimum:
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Yes
_____

No
_____

N/A
_____

d. Premiums?

_____

_____

_____

e. Net investment income?

_____

_____

_____

f. Realized investment gains and losses?

_____

_____

_____

g. Policyholder benefits?

_____

_____

_____

h. Policyholder dividends?

_____

_____

_____

_____

_____

_____

a. The nature of the guarantee, including the approximate term, how
the guarantee arose, and the events or circumstances that would
require the guarantor to perform under the guarantee?

_____

_____

_____

b. The maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the
guarantee?

_____

_____

_____

c. If the terms of the guarantee provide for no limitation to the
maximum potential future payments under the guarantee, is that
fact disclosed?

_____

_____

_____

d. If the guarantor is unable to develop an estimate of the maximum
potential amount of future payments under its guarantee, are the
reasons why the maximum potential amount cannot be estimated
disclosed?

_____

_____

_____

e. The current carrying amount of the liability, if any, for the guarantor’s obligations under the guarantee, including the amount, if
any, recognized under SFAS 5, paragraph 8, regardless of whether
the guarantee is freestanding or embedded in another contract?

_____

_____

_____

_____

_____

_____

i. The amount of maximum future earnings remaining to inure to
the benefit of stockholders from the assets and liabilities of the
closed block as well as an analysis of the changes in the policyholder dividend obligation?
[SOP 00-3, par. 25b (ACC 10,810.25)]
Note: GAAP disclosures that typically would be required for the various
specific elements included in the closed block need not be made separately
for the closed block if the nature of the information for the closed block
would not differ significantly from that already included for the reporting
entity as a whole. For example, it is not necessary to show a separate
schedule of contractual maturities of closed block fixed maturity securities
if the relative composition of contractual maturities is similar to those of
the reporting entity taken as a whole. However, if the relative maturities
of the closed block fixed maturities securities differ from those of the
reporting entity taken as a whole, separate disclosures should be made.
[SOP 00-3, par. 25c (ACC 10,810.25)]
Z. Guarantees
1.

Is the following information disclosed by a guarantor about each
guarantee, or each group of similar guarantees, even if the likelihood
of the guarantor’s having to make any payments under the guarantee
is remote:

f. The nature of—
(1) Any recourse provisions that would enable the guarantor to
recover from third parties any of the amounts paid under the
guarantee? and
(2) Any assets held either as collateral or by third parties that,
upon the occurrence of any triggering event or condition under
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

a. The guarantor’s accounting policy and methodology used in determining its liability for product warranties (including any liability associated with extended warranties)?

_____

_____

_____

b. A tabular reconciliation of the changes in the guarantor’s aggregate product warranty liability for the reporting period?

_____

_____

_____

(1) The beginning balance of the aggregate product warranty
liability?

_____

_____

_____

(2) The aggregate reductions in that liability for payments made
(in cash or in kind) under the warranty?

_____

_____

_____

(3) The aggregate changes in the liability for accruals to product
warranties issued during the reporting period, and the aggregate changes in the liability for accruals related to preexisting
warranties, including adjustments related to changes in estimates?

_____

_____

_____

_____

_____

_____

_____

_____

_____

the guarantee, the guarantor can obtain and liquidate to
recover all or a portion of the amounts paid under the guarantee?
g. If estimable, the approximate extent to which the proceeds from
liquidation of those assets would be expected to cover the maximum potential amount of future payments under the guarantee?
[FIN 45, par. 13]
2.

For product warranties and other guarantee contracts that are excluded from the initial recognition and initial measurement requirements of FIN 45, Guarantor’s Accounting and Disclosure Requirements
for Guarantees, Including Indirect Guarantees of Indebtedness of Others—
an interpretation of FASB Statements No. 5, 57, and 107 and rescission of
FASB Interpretation No. 34, pursuant to paragraph 7(b) of FIN 45
(collectively referred to as product warranties), is the following information disclosed:

c. Does the tabular reconciliation present—

(4) The ending balance of the aggregate product warranty liability?
[FIN 45, par. 14]
3.

Are the disclosure requirements in paragraphs 13–14 of FIN 45 complied with for intellectual property infringement indemnifications as
described in FSP 45-1?
[FSP 45-1]

Note: FSP FIN 45-3, Application of FASB Interpretation No. 45 to Minimum
Revenue Guarantees Granted to a Business or Its Owners, is effective for new
minimum revenue guarantees issued or modified on or after the beginning of the first fiscal quarter following November 10, 2005, the date that
the final FSP was posted to the FASB Web site. Earlier application of the
provisions of the FSP is permitted. The guarantor’s previous accounting
for minimum revenue guarantees issued prior to the date of FSP FIN 45-3’s
initial application should not be revised or restated to reflect the effect of
the recognition and measurement provisions of FIN 45.
4.

Are the disclosure requirements in paragraphs 13–16 of FIN 45 applied to all minimum revenue guarantees in financial statements of
interim or annual periods ending after the beginning of the first fiscal

Copyright © 2008

78

2-08

20,400-23

FSP §20,300.03

130

Life and Health Insurance Entities

quarter following November 10, 2005, the date that the final FSP was
posted to the FASB Web site? Thus, the disclosure requirements in
paragraphs 13–16 should be applied to any minimum revenue guarantees issued prior to the initial application of the FSP, regardless of
whether those guarantees were recognized and measured under FIN
45?
[FSP FIN 45-3, par. 7]
AA. Fair Value Measurements
Notes: In February 2007, FASB issued SFAS 159, which is effective for
financial statements issued for fiscal years beginning after November 15,
2007. Early adoption is permitted as of the beginning of a fiscal year that
begins on or before November 15, 2007, provided the organization also
elects to apply the provisions of SFAS 157. The choice to adopt early
should be made after issuance of this statement but within 120 days of the
beginning of the fiscal year of adoption, provided the entity has not yet
issued financial statements, including required notes to those financial
statements, for any interim period of the fiscal year of adoption.
This statement applies to all entities. Most of the provisions of this statement apply only to entities that elect the fair value option. However, the
amendment to SFAS 115 applies to all entities with available-for-sale and
trading securities. Some requirements apply differently to entities that do
not report net income.
The statement permits an organization to irrevocably elect fair value as
the initial and subsequent measurement attribute for certain financial
assets and financial liabilities on a contract-by-contract basis, with changes
in fair value recognized in earnings (or another performance indicator if
the business entity does not report earnings) at each subsequent reporting
date. The provisions of this statement need not be applied to immaterial
items. If SFAS 159 is applicable to the financial statements (and related
notes) of the entity, questions 8–14 should be answered.
In September 2006, FASB issued SFAS 157, which is effective for financial
statements issued for fiscal years beginning after November 15, 2007, and
interim periods within those fiscal years. Earlier application is encouraged, provided that the reporting entity has not yet issued financial
statements for that fiscal year, including any financial statements for an
interim period within that fiscal year.
The statement shall be applied prospectively as of the beginning of the
fiscal year in which this statement is initially applied. Certain exceptions
apply. Readers should refer to the statement for those exceptions.
The statement establishes a single definition of fair value and a framework
for measuring fair value in GAAP, and also expands disclosures about fair
value measurements. The statement applies under other accounting pronouncements that require or permit fair value measurements, the FASB
having previously concluded in those accounting pronouncements that
fair value is the relevant measurement attribute. Accordingly, this statement does not require any new fair value measurements, but the application of it will change current practice.
The statement retains the exchange price notion already established
within GAAP but clarifies, among other matters, that fair value is the price
(continued)
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_____

_____

_____
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Yes
_____

No
_____

N/A
_____

a. The fair value measurements at the reporting date.

_____

_____

_____

b. The level within the fair value hierarchy in which the fair value
measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets
or liabilities (Level 1), significant other observable inputs (Level
2), and significant unobservable inputs (Level 3).

_____

_____

_____

(1) Total gains or losses for the period (realized and unrealized),
segregating those gains or losses included in earnings (or
changes in net assets), and a description of where those gains
or losses included in earnings (or changes in net assets) are
reported in the statement of income (or activities).

_____

_____

_____

(2) Purchases, sales, issuances, and settlements (net).

_____

_____

_____

(3) Transfers in and/or out of Level 3 (for example, transfers due
to changes in the observability of significant inputs).

_____

_____

_____

d. The amount of the total gains or losses for the period in subparagraph (c)(1) above included in earnings (or changes in net assets)
that are attributable to the change in unrealized gains or losses
relating to those assets and liabilities still held at the reporting date
and a description of where those unrealized gains or losses are
reported in the statement of income (or activities).

_____

_____

_____

that would be received to sell the asset or paid to transfer the liability (that
is, an exit price) and not the price that would be paid to acquire the asset
or paid to transfer the liability (that is, an entry price). Additionally, the
statement establishes a fair value hierarchy that prioritizes the inputs to
valuation techniques used to measure fair value into three broad levels. If
SFAS 157 is applicable to the financial statements (and related notes) of
the entity, questions 1–7 should be answered.
In December 2007, FASB issued proposed FSP FAS 157-b, “Effective Date
of FASB Statement No. 157” with the aim to delay the effective date of
SFAS 157 for all nonfinancial assets and nonfinancial liabilities, except
those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). The delay is intended to
allow the board and constituents additional time to consider the effect of
various implementation issues that have arisen, or that may arise, from
the application of SFAS 157.
1.

For assets and liabilities that are measured at fair value on a recurring
basis in periods subsequent to initial recognition (for example, trading
securities), the reporting entity shall disclose information that enables
users of its financial statements to assess the inputs used to develop
those measurements and for recurring fair value measurements using
significant unobservable inputs (Level 3), the effect of the measurements on earnings (or changes in net assets) for the period. To meet
that objective, the reporting entity shall disclose the following information for each interim and annual period (except as otherwise
specified) separately for each major category of assets and liabilities:

c. For fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period
attributable to the following:271
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

a. The fair value measurements recorded during the period and the
reasons for the measurements.

_____

_____

_____

b. The fair value measurements recorded during the period and the
reasons for the level within the fair value hierarchy in which the
fair value measurements in their entirety fall, segregating fair
value measurements using quoted prices in active markets for
identical assets or liabilities (Level 1), significant other observable
inputs (Level 2), and significant unobservable inputs (Level 3).

_____

_____

_____

c. For fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used
to develop the inputs.

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

e. In annual periods only, the valuation technique(s) used to measure
fair value and a discussion of changes in valuation techniques, if
any, during the period.
[SFAS 157, par. 32]
2.

For assets and liabilities that are measured at fair value on a nonrecurring basis in periods subsequent to initial recognition (for example,
impaired assets), the reporting entity shall disclose information that
enables users of its financial statements to assess the inputs used to
develop those measurements. To meet that objective, the reporting
entity shall disclose the following information for each interim and
annual period (except as otherwise specified) separately for each
major category of assets and liabilities:

d. In annual periods only, the valuation technique(s) used to measure
fair value and a discussion of changes, if any, in the valuation
technique(s) used to measure similar assets and/or liabilities in
prior periods.
[SFAS 157, par. 33]
3.

4.

5.

Are the quantitative disclosures required in questions 1–2 above
presented using a tabular format? (See Appendix A of SFAS 157 for
implementation guidance and examples.)
[SFAS 157, par. 34]
Is the fair value information disclosed under SFAS 157 and the fair
value information disclosed under other accounting pronouncements
(for example, SFAS 107) combined in the periods in which those
disclosures are required, if practicable? (Encouraged, but not required.)
[SFAS 157, par. 35]
Is information about other similar measurements (for example, inventories measured at market value under ARB 43, Chapter 4) disclosed,
if practicable? (Encouraged, but not required.)
[SFAS 157, par. 35]

Transition Guidance
6.

At the date that SFAS 157 is initially applied to the financial instruments, is the difference between the carrying amounts and the fair
values of those instruments recognized as a cumulative-effect adjustment to the opening balance of retained earnings (or other appropriate components of equity or net assets in the statement of financial
position) for that fiscal year, presented separately?
[SFAS 157, par. 38]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

(1) A description of those similar items and the reasons for
partial election?

_____

_____

_____

(2) Information to enable users to understand how the group of
similar items relates to individual line items on the statement
of financial position?

_____

_____

_____

Note: The disclosure requirements of SFAS 154 for a change in accounting
principle do not apply.
7.

Are the disclosure requirements of SFAS 157 (paragraphs 32–35),
including those disclosures that are required in annual periods only,
applied in the first interim period of the fiscal year in which this
statement is initially applied?
[SFAS 157, par. 39]

Note: The disclosure requirements of SFAS 157, including those disclosures that are required in annual periods only, shall be applied in the first
interim period of the fiscal year in which this statement is initially applied.
The disclosure requirements of this statement need not be applied for
financial statements for periods presented prior to initial application of
this statement.
Note: The disclosures described in paragraphs 18–22 of SFAS 159 are
required for items measured at fair value under the option in SFAS 159
and the option in paragraph 16 of SFAS 133 (as amended by SFAS 155).
Those disclosures are not required for securities classified as trading securities under SFAS 115, life settlement contracts measured at fair value
pursuant to FSP FTB 85-4-1, “Accounting for Life Settlement Contracts by
Third-Party Investors,” or servicing rights measured at fair value pursuant
to SFAS 156. Entities shall provide the disclosures required by paragraphs
18–22 of SFAS 159 in both interim and annual financial statements. Entities
are encouraged but are not required to present the disclosures required
by SFAS 159 in combination with related fair value information required
to be disclosed by other statements (for example, SFAS 107 and SFAS 157).
Appendix B of SFAS 159 provides illustrative fair value disclosures.
8.

9.

If the organization reports assets and liabilities at fair value pursuant
to the fair value option in SFAS 159, has it either (a) presented the
aggregate of fair value and non-fair-value amounts in the same line
item in the statement of financial position and parenthetically disclosed the amount measured at fair value included in the aggregate
amount or (b) presented two separate line items to display the fair
value and non-fair-value carrying amounts of similar assets and
liabilities?
[SFAS 159, par. 15]
As of each date for which a statement of financial position is presented, do the entities disclose the following information about items
measured at fair value under the option in SFAS 159 or the option in
paragraph 16 of SFAS 133:
a. Management’s reasons for electing a fair value option for each
eligible item or group of similar eligible items?
b. If the fair value option is elected for some but not all eligible items
within a group of similar eligible items:
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

c. For each line item in the statement of financial position that
includes an item or items for which the fair value option has been
elected:
(1) Information to enable users to understand how each line item
in the statement of financial position relates to major categories of assets and liabilities presented in accordance with
SFAS 157’s fair value disclosure requirements?
(2) The aggregate carrying amount of items included in each line
item in the statement of financial position that are not eligible
for the fair value option, if any?
[SFAS 159, par. 18]
10. As of each date for which a statement of activities is presented, has
the organization disclosed the following information about items
measured at fair value under the option in SFAS 159 or the option in
paragraph 16 of SFAS 133:
a. For each line item in the statement of financial position, the
amounts of gains and losses from fair value changes during the
period included in earnings and in an intermediate measure of
operations, if one is presented, and in which line in the income
statement those gains and losses are reported? (An organization
may meet this requirement by disclosing amounts of gains and
losses that include amounts of gains and losses for other items
measured at fair value, such as items required to be measured at
fair value.)
b. A description of how interest and dividends are measured and
where they are reported in the income statement?
[SFAS 159, par. 19]
11. Has the organization disclosed the methods and significant assumptions used to estimate the fair value of items for which the fair value
option has been elected?
[SFAS 159, par. 21]
12. If an organization elects the fair value option at a remeasurement
event, has it disclosed the following for the period of the election:
a. Qualitative information about the nature of the event?
b. Quantitative information by line item in the statement of financial
position indicating which line items in the statement of activities
include the effect of initially electing the fair value option for an
item?
[SFAS 159, par. 22]
Transition Guidance
Note: Retrospective application of SFAS 159 to fiscal years preceding the
effective date, which would involve restatement of previously issued
financial statements, is not permitted because of the elective nature of the
statement and the benefit of hindsight. Readers should refer to paragraph
30 of SFAS 159 for specific requirements applicable to the early adoption
of this statement.
13. At the date that SFAS 159 is initially applied to the financial statements, is the effect of the adoption attributable to the election of the
fair value option for selected financial assets and financial liabilities
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

(1) The pretax portion of the cumulative-effect adjustment to
retained earnings (or appropriate class or classes of net assets)
for items on that line?

_____

_____

_____

(2) The fair value at the effective date (or early adoption date) of
eligible items for which the fair value option is elected and
the carrying amount of those same items immediately before
electing the fair value option?

_____

_____

_____

b. The net effect on the entity’s deferred tax assets and liabilities of
electing the fair value option?

_____

_____

_____

c. Management’s reasons for electing the fair value option for each
existing eligible item or group of similar eligible items?

_____

_____

_____

(1) A description of those similar items and the reasons for
partial election?

_____

_____

_____

(2) Information to enable users to understand how the group of
similar items relates to individual line items on the statement
of financial position?

_____

_____

_____

_____

_____

_____

accounted for as a cumulative-effect adjustment to the opening balance of retained earnings (or other appropriate components of equity
or net assets in the statement of financial position) as of the effective
date , and not the beginning of the earliest year presented?
[SFAS 159, par. 25]
14. Has the organization electing the fair value option for items existing
at the effective date provided the following in its annual and firstinterim-period financial statements for the fiscal year that includes the
effective date (or early adoption date):
a. A schedule that presents the following by line item in the statement of financial position:

d. If the fair value option is elected for some but not all eligible items
within a group of similar eligible items:

e. The amount of valuation allowances that were removed from the
statement of financial position because they related to items for
which the fair value option was elected?
[SFAS 159, par. 27]

[The next page is 20,401.]
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FSP Section 20,400
Auditors’ Reports Checklist
This section of the checklist has been developed primarily to address the requirements most
likely to be encountered when reporting on financial statements of commercial corporations
in accordance with generally accepted auditing standards (GAAS) as issued by the Auditing
Standards Board (ASB), a senior technical committee of the AICPA. Certain key differences
in reporting requirements between audits conducted in accordance with GAAS and audits
conducted in accordance with the rules and standards of the Public Company Accounting
Oversight Board (PCAOB) are identified in bold text throughout this section of the checklist.
However, the differences identified are not intended to be all inclusive, and readers should
seek appropriate guidance for a comprehensive source of reporting requirements associated
with audits conducted in accordance with the rules and standards of the PCAOB.
Applicability of Standards of the PCAOB
Publicly held companies and other issuers (see definition below) are subject to the provisions
of the Sarbanes-Oxley Act of 2002 (act) and related Securities and Exchange Commission
(SEC) regulations implementing the act. Their outside auditors are also subject to the
provisions of the act and to the rules and standards issued by the PCAOB.
The provisions of the act, the regulations of the SEC, and the rules and standards of the
PCAOB are numerous and are not all addressed in this section or in this checklist. Issuers
and their auditors should understand the provisions of the act, the SEC regulations
implementing the act, and the rules and standards of the PCAOB, as applicable to their
circumstances.
Definition of an Issuer
The act states that the term issuer means an issuer (as defined in section 3 of the Securities
Exchange Act of 1934 [15 U.S.C. 78c]), the securities of which are registered under section 12
of that act (15 U.S.C. 78l), or that is required to file reports under section 15(d) (15 U.S.C.
78o(d)), or that files or has filed a registration statement that has not yet become effective
under the Securities Act of 1933 (15 U.S.C. 77a et seq.), and that it has not withdrawn.
Issuers, as defined by the act, and other entities when prescribed by the rules of the SEC
(collectively referred to in this checklist as issuers or issuer) and their public accounting firms
(who must be registered with the PCAOB) are subject to the provisions of the act,
implementing SEC regulations, and the rules and standards of the PCAOB, as appropriate.
Nonissuers are those entities not subject to the act or the rules of the SEC.
The act mandates a number of requirements concerning auditors of issuers, including
mandatory registration with the PCAOB, the setting of auditing standards, inspections,
investigations, disciplinary proceedings, prohibited activities, partner rotation, and reports
to audit committees, among others. Auditors of issuers should familiarize themselves with
applicable provisions of the act and the standards of the PCAOB. The PCAOB continues to
establish rules and standards implementing provisions of the act concerning the auditors of
issuers.
The act authorizes the PCAOB to establish auditing and related attestation, quality control,
ethics, and independence standards to be used by registered public accounting firms in the
preparation and issuance of audit reports for entities subject to the act or the rules of the SEC.
Accordingly, public accounting firms registered with the PCAOB are required to adhere to
all PCAOB standards in the audits of issuers, as defined by the act, and other entities when
prescribed by the rules of the SEC. Readers should refer to the PCAOB Web site at www.
pcaob.org and the SEC Web site at www.sec.gov for more information.
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.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of
the AICPA as a nonauthoritative practice aid.
.02 Explanation of References:
AR =

Reference to section number in AICPA Professional Standards (vol. 2)

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

SAS =

AICPA Statement on Auditing Standards

SSARS =

AICPA Statement on Standards for Accounting and Review Services

.03 Checklist Questionnaire:

1.

2.

3.

4.

Is every financial statement audited specifically identified in the
introductory paragraph of the auditor’s report?
[AU 508.06]
Do the titles of the financial statements referred to in the introductory
paragraph of the auditor’s report match the titles of the financial
statements presented?
[Generally Accepted]
Do the dates of the financial statements referred to in the introductory
paragraph of the auditor’s report match the dates of the financial
statements presented?
[Generally Accepted]
Is the report appropriately addressed?
[AU 508.09]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Practice Tip
Auditing Interpretation No. 17, “Clarification in the Audit Report of the Extent of Testing of Internal Control
Over Financial Reporting in Accordance With Generally Accepted Auditing Standards” (AICPA, Professional
Standards, vol. 1, AU sec. 9508, paragraphs .85–.88), which interprets AU section 508, Reports on Audited
Financial Statements (AICPA, Professional Standards, vol. 1), provides language that may be added to the
auditor’s standard report on the financial statements of a nonissuer to clarify differences between a GAAS
audit and an audit conducted in accordance with the standards of the PCAOB. Auditing Interpretation No.
18, “Reference to PCAOB Standards in an Audit Report on a Nonissuer” (AICPA, Professional Standards, vol.
1, AU sec. 9508, paragraphs .89–.92), which interprets AU section 508, explains how the auditor should report
if engaged to also follow PCAOB auditing standards in the audit of a nonissuer.
5.

Does the auditor’s report include appropriate:
a. A title that includes the word “independent”?
[AU 508.08a]
b. A statement that the financial statements identified in the report
were audited?
[AU 508.08b]
c. A statement that the financial statements are the responsibility of
management and that the auditor’s responsibility is to express an
opinion on the financial statements based on his or her audit?
[AU 508.08c]
d. (Audits of Nonissuers Only) A statement that the audit was
conducted in accordance with GAAS and an identification of the

Copyright © 2008

78

FSP §20,400.01

2-08

20,402

_____

_____

_____

_____

_____

_____

_____

_____

_____

139

Auditors’ Reports Checklist
Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

j. The manual or printed signature of the auditor’s firm?
[AU 508.08i]

_____

_____

_____

k. The date of the audit report?
[AU 508.08j]

_____

_____

_____

country of origin of those standards (for example, auditing standards generally accepted in the United States of America or U.S.
GAAS)?
[AU 508.08d]
e. (Audits of Issuers Only) A statement that the audit was conducted
in accordance with the standards of the PCAOB (United States)?
[PCAOB Auditing Standard No. 1, Appendix, par. 3]
f. A statement that these standards require that the auditor plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement?
[AU 508.08e]
g. A statement that an audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial
statements; assessing the accounting principles used and significant estimates made by management; and evaluating the overall
financial statement presentation?
[AU 508.08f]
h. A statement that the auditor believes that his or her audit provides
a reasonable basis for his or her opinion?
[AU 508.08g]
i. An opinion as to whether the financial statements present fairly,
in all material aspects, the financial position of the company as of
the balance sheet date and the results of operations and its cash
flows for the period then ended in conformity with generally
accepted accounting principles (GAAP) and an identification of
the country of origin of those accounting principles (for example,
accounting principles generally accepted in the United States of
America or U.S. GAAP?
[AU 508.08h]

Practice Tip
Paragraph .08 of AU section 508 illustrates the form of the auditor’s standard report on financial statements
covering a single year and on comparative financial statements.
Notes: In November 2006, the AICPA’s ASB issued SAS 113, Omnibus
Statement on Auditing Standards—2006 (AICPA, Professional Standards, vol.
1), which provides, among other things, the following new guidance:
(1) Revises the terminology used in the 10 standards in AU section
150, Generally Accepted Auditing Standards (AICPA, Professional
Standards, vol. 1), to reflect the terminology used in AU section 120,
Defining Professional Requirements in Statements on Auditing Standards (AICPA, Professional Standards, vol. 1).
(2) Adds a footnote to the headings prior to paragraphs .35 and .46
of AU section 316, Consideration of Fraud in a Financial Statement
Audit (AICPA, Professional Standards, vol. 1), to provide a clear link
between the auditor’s consideration of fraud and the auditor’s
(continued)
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

If the accountant is not independent, has he or she followed one of the
two reporting alternatives available:
a. Disclaiming the opinion with respect to the financial statements
and specifically stating that he or she is not independent? or
b. Issuing a compilation report in accordance with SSARS indicating
the lack of independence (nonpublic companies only)?
[AU 504.05 and .09–.10; AR 100.21 and .48]

_____

_____

_____

_____

_____

_____

If the opinion is based in part on the report of another auditor:
a. Does the introductory paragraph of the standard report disclose
the fact that the opinion is based, in part, on the report of other
auditors?
b. Does the opinion paragraph include a reference to the report of
the other auditor?
[AU 508.11a and .12–.13]

_____

_____

_____

_____

_____

_____

assessment of risk and the auditor’s procedures in response to
those assessed risks.
(3) Replaces, throughout the SASs, the term completion of fieldwork
with the term date of the auditor’s report, except in paragraph .74 of
AU section 316, which states, in part, that the auditor should, at
or near the completion of fieldwork, evaluate whether the accumulated results of auditing procedures and other observations
affect the assessment of the risks of material misstatement due to
fraud made earlier in the audit
(4) Changes the convention for dating the management representation
letter by requiring that it be dated as of the date of the auditor’s
report, consistent with the requirement in AU section 339, Audit
Documentation (AICPA, Professional Standards, vol. 1), that the auditor’s report not be dated prior to the date on which the auditor has
obtained sufficient appropriate audit evidence.
Items 1–2 in the previous list are effective for audits of financial statements
of nonissuers for periods beginning on or after December 15, 2006. Earlier
application is permitted. Items 3–4 above are effective for audits of financial statements of nonissuers for periods ending on or after December 15,
2006. Earlier application is permitted.
6.

7.

8.

9.

If a subsequent event disclosed in the financial statements occurs after
the original date of the independent auditor’s report but before the
issuance of the related financial statements, has the auditor followed
one of the following two methods available for dating the report:
a. Dual dating, in which the independent auditor’s responsibility for
events occurring subsequent to the original report date is limited
to the specific event referred to in an explanatory note in the report
(or otherwise disclosed)? or
b. Dating the report as of the later date, in which the independent
auditor’s responsibility for subsequent events extends to the date
of the report?
[AU 530.03–.05]

If, to prevent the financial statements from being misleading because
of unusual circumstances, the financial statements contain a departure from an accounting principle promulgated by a body designated
by the AICPA Council to establish such principles, does the report
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include, in a separate paragraph or paragraphs, the information required by the rule?
[AU 508.11b and .15]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

10. If there is substantial doubt about the entity’s ability to continue as a
going concern:
a. Does the report include an explanatory paragraph, following the
opinion paragraph, to reflect that conclusion?
b. Is that conclusion expressed through the use of the phrase “substantial doubt about its (the entity’s) ability to continue as a going
concern” or similar wording that includes the terms substantial
doubt and going concern?
[AU 508.11c; AU 341.12]
11. (Audits of Nonissuers Only) Is the report dated no earlier than the
date on which the auditor has obtained sufficient appropriate audit
evidence to support the opinion on the financial statements?
[AU 530.01]
12. (Audits of Issuers Only) Prior to the report release date, among other
matters, has the auditor obtained sufficient evidence to support the
representations in the auditor’s reports?
[PCAOB Auditing Standard 3, par. A53]

Practice Tips
In evaluating whether there is substantial doubt about the entity’s ability to continue as a going concern, the
auditor’s evaluation is based on his or her knowledge of relevant conditions that exist at or have occurred
prior to the date of the auditor’s report. If, after considering identified conditions and events and management’s plans, the auditor concludes that substantial doubt about the entity’s ability to continue as a going
concern for a reasonable period of time remains, the audit report should include an explanatory paragraph
to reflect that conclusion.
In a going concern paragraph, the auditor should not use conditional language in expressing a conclusion
concerning the existence of substantial doubt about the entity’s ability to continue as a going concern. See
paragraph .13 of AU section 341, The Auditor’s Consideration of an Entity’s Ability to Continue as a Going Concern
(AICPA, Professional Standards, vol. 1), for an example.
13. If there has been a material change between periods in accounting
principles or in the method of their application that has a material
effect on the comparability of the reporting entity’s financial statements:
a. Does the report include an explanatory paragraph, following the
opinion paragraph that refers to the change?
b. Does the explanatory paragraph identify the nature of the change
and refer the reader to the note to the financial statements that
discusses the change in detail?
[AU 508.11d and .16–.18]
c. If the change in the accounting principle is a change in reporting
entity that did not result from a transaction or an event, is an
explanatory paragraph included in the auditor’s report? (Note: A
change in the reporting entity resulting from a transaction or
event, such as the creation, cessation, or complete or partial purchase or disposition of a subsidiary or other business unit does not
require that an explanatory paragraph about consistency be included in the auditor’s report.)
[AU 420.08]
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Yes
_____

No
_____

N/A
_____

_____

_____

_____

(1) The date of the auditor’s previous report?

_____

_____

_____

(2) The type of opinion previously expressed?

_____

_____

_____

(3) The circumstances or events that caused the auditor to express a different opinion?

_____

_____

_____

_____

_____

_____

(1) That the financial statements of the prior period were audited
by another auditor?

_____

_____

_____

(2) The date of the predecessor auditor’s report?

_____

_____

_____

(3) The type of report issued by the predecessor auditor?

_____

_____

_____

(4) If the report was other than a standard report, the substantive
reasons therefore including a description of the nature of and
reasons for the explanatory paragraph added to the predecessor’s report or his or her opinion qualification?

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

14. In an updated report, if the opinion is different from the opinion
previously expressed on the financial statements of a prior period:
a. Does the report include an explanatory paragraph, preceding the
opinion paragraph that discloses all of the substantive reasons for
the different opinion?
b. Does the explanatory paragraph disclose:

(4) That the auditor’s updated opinion on the financial statements of the prior period is different from his or her previous
opinion on those statements?
[AU 508.11e and .69]
15. If financial statements of a prior period (presented for comparative
purposes) have been audited by a predecessor auditor whose report
is not presented:
a. Does the introductory paragraph of the report indicate:

b. If the financial statements have been restated, does the introductory paragraph indicate that the predecessor auditor reported on
the financial statements of the prior period before restatement?
[AU 508.11e and .74]
16. Is an explanatory paragraph (or other explanatory language) added
to the standard auditor’s report if:
a. The auditor wishes to clarify that an audit performed in accordance with GAAS does not require the same level of testing and
reporting on internal control over financial reporting as an audit
of an issuer when Section 404(b) of the Sarbanes-Oxley Act is
applicable? (Note: Not required—Interpretation No. 17 of AU
section 508 provides an example report.)
[AU 9508.85–.88]
b. The audit is conducted in accordance with both GAAS and the
PCAOB’s auditing standards?
[AU 9508.89–.92]
17. Is an explanatory paragraph (or other explanatory language) added to
the standard auditor’s report if the prior period’s financial statements
are audited by a predecessor auditor who had ceased operations?
[AU 9508.60–.75]
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18. If selected quarterly financial data required by SEC Regulation S-K
has been omitted or has not been reviewed, does the report include
an additional paragraph stating that fact?
[AU 508.11f; AU 722.50]
19. If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from prescribed guidelines, the auditor is unable to complete prescribed procedures with respect to such information, or the auditor is unable to
remove substantial doubt about whether the supplementary information conforms to prescribed guidelines, does the report include an
additional paragraph stating that fact?
[AU 508.11g; AU 558.08]
20. If the audit also was conducted in accordance with International
Standards on Auditing, in their entirety, does the auditor’s report
indicate that the audit was also conducted in accordance with another
set of auditing standards?
[AU 9508.56–.59]
21. If other information in a document containing audited financial statements is materially inconsistent with information appearing in the
financial statements, has it been determined whether the financial
statements, the auditor’s report, or both require revision?
[AU 508.11h; AU 550.04]
22. If certain other information has been subjected to auditing procedures
applied in the audit of the basic financial statements, does the auditor
express an opinion on whether the information is fairly stated in all
material respects in relation to those financial statements taken as a
whole in the auditor’s report describing clearly the character of the
auditor’s work and the degree of responsibility the auditor is taking?
[AU 550.07; AU 558.09]
23. If the auditor decides to emphasize a matter regarding the financial
statements in the report, is the explanatory information presented in
a separate paragraph that avoids use of phrases such as “with the
foregoing (following) explanation”?
[AU 508.11 and .19; AU 9410.18; AU 9342.03]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: In March 2006, the AICPA’s ASB issued SAS Nos. 104–111, which
provide extensive guidance concerning the auditor’s assessment of the
risks of material misstatement in a financial statement audit, and the
design and performance of audit procedures whose nature, timing and
extent are responsive to the assessed risks. Among other things, the SASs
establish standards and provide guidance on evaluating whether the
audit evidence obtained affords a reasonable basis for an opinion regarding the financial statements under audit. The SASs are effective for audits
of financial statements for periods beginning on or after December 15,
2006; earlier application is permitted.
24. If it has not been possible to conduct the audit in accordance with
GAAS or to apply all of the procedures considered necessary in the
circumstances, has consideration been given to the need to issue a
qualified opinion or to disclaim an opinion?
[AU 508.22]
25. If a qualified opinion is to be expressed because of a scope limitation:
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Yes
_____

No
_____

N/A
_____

a. Are all of the substantive reasons for the qualification disclosed in
one or more explanatory paragraphs preceding the opinion paragraph?

_____

_____

_____

b. Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of?

_____

_____

_____

c. Is the situation described and referred to in both the scope and
opinion paragraphs?

_____

_____

_____

_____

_____

_____

d. Does the wording in the opinion paragraph indicate that the
qualification pertains to the possible effects on the financial statements and not the scope limitation itself?
[AU 508.22–.32; AU 318.76]

Practice Tips
Scope limitations can be imposed by the client or by circumstances such as the timing of the auditor’s work,
the inability to obtain sufficient appropriate audit evidence, or an inadequacy in the accounting records.
Sufficient appropriate audit evidence includes, among other things, management having asserted responsibility for the final financial statements. As provided in Technical Practice Aid (TPA) Technical Questions
and Answers (TIS) section 9100.06, “Signing and Dating Reports” (AICPA, Technical Practice Aids), the
auditor will need to have the signed management representation letter in hand prior to releasing the auditor’s
report because management’s refusal to furnish written representations constitutes a limitation on the scope
of the audit sufficient to preclude an unqualified opinion.
In circumstances in which the auditor is unable to obtain sufficient appropriate audit evidence to support
management’s assertions about the nature of a matter involving an uncertainty and its presentation or
disclosure in the financial statements, the auditor should consider the need to express a qualified opinion or
to disclaim an opinion because of a scope limitation.
[AU 508.22 and .31]
In circumstances in which the auditor is unable to audit the existence or measurement of interests in
investments in securities and interests in trusts, the auditor should consider whether that scope limitation
requires the auditor to either qualify his or her opinion or to disclaim an opinion, as discussed in paragraphs
.22–.26 of AU section 508; Auditing Interpretation No. 1, “Auditing Interests in Trusts Held by a Third-Party
Trustee and Reported at Fair Value” of AU section 328, Auditing Fair Value Measurements and Disclosures
(AICPA, Professional Standards, vol. 1, AU sec. 9238, paragraphs .01–.04); and Auditing Interpretation No. 1,
“Auditing Investments in Securities Where a Readily Determinable Fair Value Does Not Exist” of AU section
332, Auditing Derivative Instruments, Hedging Activities, and Investments in Securities (AICPA, Professional
Standards, vol. 1, AU sec. 9332, paragraphs .01–.04).
Note: Consult the AU Topical Index to the AICPA Professional Standards
under “Scope of Audit—Limitations” for additional references to specific
types of scope limitations that could result in either a qualified or disclaimer of opinion.
26. Is a qualified opinion or disclaimer of opinion expressed if the auditor’s understanding of internal control raises doubts about the auditability of an entity’s financial statements, such as:
a. Concerns about the integrity of an entity’s management cause the
auditor to conclude that the risk of management misrepresentation in the financial statements is such that an audit cannot be
conducted?
b. Concerns about the condition and reliability of an entity’s records
cause the auditor to conclude that it is unlikely that sufficient
appropriate audit evidence will be available to support an unqualified opinion on the financial statements?
[AU 314.109]
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Yes
_____

No
_____

N/A
_____

a. Modifying the audit opinion on the basis of a scope limitation?

_____

_____

_____

b. Obtaining legal advice about the consequences of different courses
of action?

_____

_____

_____

c. Communicating with an appropriate third party (for example, a
regulator)?

_____

_____

_____

_____

_____

_____

_____

_____

_____

a. Are all of the substantive reasons for the disclaimer stated in a
separate paragraph or paragraphs?

_____

_____

_____

b. Does the report state that the scope of the audit was not sufficient
to warrant the expression of an opinion?

_____

_____

_____

c. Does the report avoid identifying procedures that were performed?

_____

_____

_____

d. Is the scope paragraph omitted?

_____

_____

_____

_____

_____

_____

Notes: In December 2006, the AICPA’s ASB issued SAS 114, The Auditor’s
Communication With Those Charged With Governance (AICPA, Professional
Standards, vol. 1, AU sec. 380), which states, among other things, that the
auditor of nonissuers should communicate certain matters related to the
audit of financial statements to those charged with governance. The term
those charged with governance refers to those with responsibility for overseeing the strategic direction of the entity and obligations related to the
accountability of the entity, including overseeing the entity’s financial
reporting process and internal control over financial reporting. Before
communicating matters with those charged with governance, the auditor
may discuss them with management unless it is inappropriate to do so.
For example, it may not be appropriate to discuss with management
questions of management’s competence or integrity. The SAS also addresses the auditor’s responsibilities to evaluate the adequacy of the
two-way communication between the auditor and those charged with
governance, and the existence of any significant difficulties in dealing with
management.
This statement supersedes SAS 61, Communication With Audit Committees,
and is effective for audits of financial statements of nonissuers for periods
beginning on or after December 15, 2006. Questions 28–29 should be
answered if SAS 114 is applicable to the audit.
27. If, in the auditor’s judgment, the two-way communication between
the auditor and those charged with governance as described in SAS
114 is not adequate and the situation cannot be resolved, thereby
prohibiting the auditor from obtaining all the audit evidence required
to form an opinion on the financial statements, has the auditor considered the following:

d. Withdrawing from the engagement?
[AU 380.63]
28. If, in the auditor’s judgment, significant difficulties in dealing with
management such as those described in SAS 114 have been encountered, has the auditor considered modifying the audit opinion on the
basis of a scope limitation?
29. If an opinion is disclaimed because of a scope limitation:

e. If there are reservations about fair presentation of the financial
statements in conformity with GAAP, are they described in the
report?
[AU 508.62–.63]
Copyright © 2008

78

2-08

20,409

FSP §20,400.03

146

Life and Health Insurance Entities
Yes
_____

No
_____

N/A
_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: Consult the AU Topical Index to the AICPA Professional Standards
under “Scope of Audit—Limitations” for additional references to specific
types of scope limitations that could result in either a qualified or disclaimer of opinion.
30. If the financial statements are materially affected by a departure from
GAAP (including, for example, inadequate disclosure, inappropriate
accounting principles, and unreasonable accounting estimates), has
consideration been given to the need to issue a qualified opinion or
an adverse opinion?
[AU 508.35]
31. If a qualified opinion is to be expressed because of a GAAP departure:
a. Are all of the substantive reasons that have led to the conclusion
that there is a departure from GAAP disclosed in one or more
separate explanatory paragraphs preceding the opinion paragraph?
b. Does the qualified opinion include the word except or exception in
a phrase such as except for or with the exception of and a reference to
the explanatory paragraph?
c. Does the explanatory paragraph disclose the principle effects of
the departure on financial position, results of operations, and cash
flows, if practicable, or state that the effects are not reasonably
determinable?
[AU 508. 21 and AU 508.37–.39]
32. If an adverse opinion is to be expressed because of a GAAP departure:
a. Are all of the substantive reasons for the adverse opinion disclosed
in one or more separate explanatory paragraphs preceding the
opinion paragraph?
b. Does the explanatory paragraph disclose the principle effects of
the departure on financial position, results of operations, and cash
flows, if practicable, or state that the effects are not reasonably
determinable?
c. State that the financial statements do not present fairly the financial position, or results of operations or cash flows in conformity
with GAAP?
[AU 508.58–.60]
Notes: Consult the AU Topical Index to the AICPA Professional Standards
under “Departures From Standard Report” for additional information.
Readers may also wish to refer to TPA TIS section 1400.31, “GAAP
Departure for FIN No. 46(R)” (AICPA, Technical Practice Aids), for assistance in determining the implications on the auditor’s report if the reporting entity does not consolidate a variable interest entity.
33. If information accompanies the basic financial statements and auditor’s report in an auditor-submitted document, is it accompanied by
a report that:
a. States that the audit was performed for the purpose of forming an
opinion on the basic financial statements taken as a whole?
b. Specifically identifies the accompanying information?
c. States that the accompanying information is presented for purposes of additional analysis and is not a required part of the basic
financial statements?
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d. Includes either an opinion on whether the accompanying information is fairly stated in all material respects in relation to the basic
financial statements taken as a whole or a disclaimer of opinion
(depending on whether the information was subjected to the
auditing procedures applied in the audit of the basic financial
statements)?
[AU 551.05–06]

Yes
_____

No
_____

N/A
_____

_____

_____

_____

Practice Tip
AU section 532, Restricting the Use of an Auditor’s Report (AICPA, Professional Standards, vol. 1), provides
guidance to auditors in determining whether an engagement requires a restricted-use report and, if so, what
elements to include in that report.
34. If the financial statements and reports will be used by parties or
distributed by the entity to parties other than the regulatory agencies
to whose jurisdiction the entity is subject, has the standard form of
report been modified as appropriate because of the departures from
GAAP and has an additional paragraph been added to express an
opinion on whether the financial statements are presented in conformity with the regulatory basis of accounting? (Note: Auditing
Interpretation No. 15, “Auditor Reports on Regulatory Accounting or
Presentation When the Regulated Entity Distributes the Financial
Statements to Parties Other Than the Regulatory Agency Either Voluntarily or Upon Specific Request” of AU section 623, Special Reports
[AICPA, Professional Standards, vol. 1, AU sec. 9623, paragraphs .96–
.98], provides an example report.)
[AU 544.04; AU 9623.96–.98]
35. If supplementary information is included in a client-prepared document and the auditor has not subjected to the procedures described
in AU section 558, Required Supplementary Information (AICPA, Professional Standards, vol. 1), is the information either marked “unaudited”
or has the auditor included an explanatory paragraph in the report
disclaiming an opinion on the information?
[AU 558.03]
36. For other comprehensive bases of accounting statements (for example, statutory statements), has the auditor considered necessary disclosure requirements of AU section 623 surrounding items that are
the same as, or similar to, those in financial statements prepared in
conformity with GAAP?
[AU 9623.60–.81]

_____

_____

_____

_____

_____

_____

_____

_____

_____

Note: Auditing Interpretation No. 12, “Evaluation of the Appropriateness
of Informative Disclosures in Insurance Enterprises’ Financial Statements
Prepared on a Statutory Basis,” of AU section 623 (AIPCA, Professional
Standards, vol. 1, AU sec. 9623, paragraphs .60–.81), clarifies that provisions of the NAIC Accounting Practices and Procedures Manual or any
other explicit rejection of a GAAP disclosure do not negate the requirements of AU section 623.

[The next page is 20,501.]
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Supplemental Information for Life
Insurance Companies That Are
Securities and Exchange
Commission Registrants
.01 Footnote 3 to AU section 411, The Meaning of Present Fairly in Conformity With Generally Accepted
Accounting Principles (AICPA, Professional Standards, vol. 1), states, in part, that for Securities and Exchange
Commission (SEC) registrants, rules and releases of the SEC have an authority similar to other officially
established accounting principles.
Regulation S-X is the primary source of requirements for financial statements and related footnotes required
to be included in documents filed with the SEC. In addition to Regulation S-X, preparers and auditors of
financial statements should be familiar with the SEC’s Financial Reporting Releases (FRR) and Staff Accounting Bulletins (SAB). FRRs communicate the SEC’s position on accounting and auditing principles and
practices. SABs represent interpretations and practices followed by the Division of Corporation Finance and
the Office of the Chief Accountant of the SEC. Insurance companies are subject to the requirements of Articles
1-4, 7, 10, and 12 of Regulation S-X.
When determining compliance with SEC requirements, preparers and auditors should refer to the appropriate SEC pronouncements to ensure compliance with SEC disclosure rules. In particular, the following
documents should be consulted:

• Regulation S-X, Article 1, Application of Regulation S-X
• Regulation S-X, Article 2, Qualifications and Reports of Accountants
• Regulation S-X, Article 3, General Instructions as to Financial Statements
• Regulation S-X, Article 4, Rules of General Application
• Regulation S-X, Article 7, Insurance Companies
• Regulation S-X, Article 10, Interim Financial Statements
• Regulation S-X, Article 12, Form and Content of Schedules
• Staff Accounting Bulletins—SABs reflect the SEC staff’s views regarding accounting-related disclosure practices. They represent interpretations and policies followed by the Division of Corporation
Finance and the Office of the Chief Accountant in administering the disclosure requirements of the
federal securities laws.

• Financial Reporting Releases—FRRs adopt, change, or interpret requirements relating to accounting,
auditing, and disclosure issues.

[The next page is 20,601.]
Copyright © 2008

78

2-08

20,501

FSP §20,500.01

Illustrative Financial Statements

151

FSP Section 20,600
Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted
accounting principles (GAAP). The financial statements are for illustrative purposes only, are not intended
to be comprehensive and are not intended to establish preference among alternative principles acceptable
under GAAP. Decisions about the application of the GAAP discussed in the accounting and financial
reporting sections of the AICPA Audit and Accounting Guide Life and Health Insurance Entities, should not
be made by reference to the illustrative financial statements but by a careful reading to the specified
authoritative literature. The illustrative financial statements reflect many of the minimum disclosure requirements for a life and health insurance entity but do not include all of the amounts or transactions discussed
in other chapters of the guide or that might be found in practice. For example, the illustrative notes
indicate the subject matter generally required to be disclosed, but they should be expanded, reduced, or
otherwise modified to suit individual circumstances based on a careful reading of the specified authoritative literature.
.02 The illustrative financial statements do not include other transactions not unique to life and health
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertainties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative
pronouncements for guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established accounting principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.
.04 Auditors of SEC-registrant financial statements are reminded that, in May 2007, the Public Company
Accounting Oversight Board (PCAOB) adopted Auditing Standard No. 5, An Audit of Internal Control Over
Financial Reporting That Is Integrated with An Audit of Financial Statements (AICPA, PCAOB Standards and
Related Rules, Rules of the Board, “Standards”), which was later approved by the SEC on July 25, 2007. This
standard replaces Auditing Standard No. 2, An Audit of Internal Control Over Financial Reporting Performed in
Conjunction With an Audit of Financial Statements (AICPA, PCAOB Standards and Related Rules, Rules of the
Board, “Standards”). Auditing Standard No. 5, is principles-based and presents a risk-based, top-down
approach designed to increase the likelihood that material weaknesses will be found before resulting in a
material misstatement of a company’s financial statements, while eliminating unnecessary procedures. The
standard was also designed to make audits more scaleable for smaller or less complex companies. This new
standard is required for all audits of internal control for fiscal years ending on or after November 15, 2007.
However, early adoption is permitted and encouraged. For more information, readers may refer to the
AICPA Audit Risk Alert titled SEC and PCAOB Alert—2007/08 (product no. 022498kk).
.05 The illustrative financial statements also do not reflect the impact of laws and regulations of the
insurance entity’s state of domicile. The impact on the financial statements of such laws and regulations vary
by state. Many states require conformity with the codification of statutory accounting practices in the
National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual to the
extent it does not conflict with its own state laws and regulations. Refer to the NAIC Accounting Practices and
Procedures Manual, NAIC Annual Statement Instructions, and specific state laws and regulations to determine
the impact of codification and individual state laws and regulations.
.06 These illustrative financial statements are not intended to include items that should be accounted for
under the requirements of Financial Accounting Standards Board (FASB) Statement of Financial Accounting
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Standards (SFAS) 133, Accounting for Derivative Instruments and Hedging Activities, and, therefore, do not
reflect the requirements of SFAS 133 or its amendments. Practitioners should refer to SFAS 133 and related
amendments for guidance on reporting derivative instruments and hedging activities. Items in the balance
sheet and income statement have been cross-referenced to the applicable chapters of this guide, for ease of
locating information.
.07 Life and health insurance entities generally present unclassified balance sheets.
.08 Also, preparers and auditors of SEC-registrant financial statements are reminded that as discussed
in Staff Accounting Bulletin (SAB) No. 74, Topic 11M, Disclosure of the Impact that Recently Issued Accounting
Standards will have on the Financial Statements of the Registrant when Adopted in a Future Period, and Auditing
Interpretation No. 3, “The Impact on an Auditor’s Report of an FASB Statement Prior to the Statement’s
Effective Date” of AU section 410, Adherence to Generally Accepted Accounting Principles (AICPA, Professional
Standards, vol. 1, AU sec. 9410, paragraphs .13–.18) filings with the SEC that include financial statements for
a period ending after the issuance of an accounting standard but before the required date of adoption of that
accounting standard should include disclosure of the impact that the recently issued accounting standard
will have on the financial position and results of operations of the registrant when such standard is adopted
in a future period. The following disclosures should be considered by registrants:

• A brief description of the new standard, the date that adoption is required and the date that the
registrant plans to adopt, if earlier;

• A discussion of the methods of adoption allowed by the standard and the method expected to be
utilized by the registrant, if determined;

• A discussion of the impact that adoption of the standard is expected to have on the financial
statements of the registrant, unless unknown or not reasonably estimable. In that case, a statement
to that effect may be made;

• Disclosure of the potential impact of other significant matters that the registrant believes might result
from the adoption of the new standard (such as technical violations of debt covenant agreements,
planned or intended changes in business practices, etc.).
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ABC LIFE INSURANCE COMPANY
Balance Sheet
December 31, 20X2 and 20X1
(Amounts in Thousands)1
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost
(estimated fair value: $47,830 in 20X2 and $45,255 in 20X1)
Fixed maturities, available for sale, at estimated fair value
(amortized cost: $247,525 in 20X2 and $219,565 in 20X1)
Trading account securities, at estimated fair value
(cost: $4,220 in 20X2 and $4,419 in 20X1)
Mortgage loans
Real estate
Policy loans
Short-term investments
Total investments
Cash and cash equivalents
Accrued investment income
Premiums due and other receivables,1 net of allowance
of $4,500 and $2,100 for doubtful accounts
Reinsurance receivable on paid and unpaid losses
Reinsurance receivable related to contract holder liabilities
Deferred policy acquisition costs
Property and equipment, net of accumulated depreciation
Other assets
Separate account assets
Total assets
Liabilities
Future policy benefits
Guaranteed interest contracts
Policyholders funds on deposit
Unpaid claims
Policyholders dividends
Amounts held in escrow and accrued expenses
Deferred federal income taxes
Other liabilities
Separate account liabilities
Total liabilities
Commitments and contingencies (Note 12)
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20X2

20X1

$ 44,864

$ 46,310

255,893

214,563

3,950
79,258
6,410
43,549
7,515
441,439
5,285
6,660

4,190
106,692
6,147
51,013
6,321
435,236
3,343
8,026

1,647
596
5,714
38,936
501
152
732
$501,662

1,092
407
3,048
36,429
420
158
525
$488,684

$345,887
21,342
49,408
5,418
2,335
4,977
1,412
253
732
431,764

$341,207
23,555
46,202
4,737
3,450
4,562
1,027
4,465
525
429,730
(continued)

1

1
Statement of Position (SOP) 01-6, Accounting by Certain Entities (Including Entities With Trade Receivables) That Lend to or Finance the
Activities of Others (AICPA, Technical Practice Aids, ACC sec. 10,850), requires, among other things, that the summary of significant
accounting policies include the basis for accounting for trade receivables, and the classification and method of accounting for other
receivables. SOP 01-6 requires that a description of the accounting policies and methodology the entity used to estimate its allowance
for doubtful accounts be included in the notes to the financial statements. Such a description should identify the factors that influenced
management’s judgment and may also include discussion of risk elements relevant to particular categories of financial instruments. In
addition, SOP 01-6 requires that the summary of significant accounting policies include the policy for charging off uncollectible trade
receivables.
SOP 01-6 contains other presentation and disclosure requirements that may apply to the financial statements of insurance entities.
Readers should refer to the full text of SOP 01-6.
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Shareholders’ Equity
Capital stock: authorized—5,000,000 shares of $2 par value;
3,341,624 shares issued and outstanding
Retained earnings
Accumulated other comprehensive income
Total shareholders’ equity
Total liabilities and shareholders’ equity
See accompanying notes to financial statements.
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20X2

20X1

6,683
57,776
5,439
69,898
$501,662

6,683
55,522
(3,251)
58,954
$488,684
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ABC LIFE INSURANCE COMPANY
Statements of Income
Years Ended December 31, 20X2 and 20X1
(Amounts in Thousands)
20X2

20X1

$24,833
10,141
20
1,961
32,998
4,222
74,175

$24,783
9,153
43
1,844
35,141
(2,670)
68,294

Benefits and Other Expenses
Policyholder benefits
Interest credited to policyholder accounts
General expenses
Amortization of deferred policy acquisition costs
Underwriting, acquisition, and insurance expenses
Policyholders’ dividends
Total benefits and expenses
Income before income taxes

39,158
4,363
4,288
1,276
18,029
4,665
71,779
2,396

30,815
4,156
4,984
1,305
17,266
6,898
65,424
2,870

Income taxes:
Current
Deferred
Total income taxes
Net income
Net income per common share
Dividends per common share

1,547
(1,405)
142
2,254
.67
—

Premiums and Other Revenues
Premiums:
Life and annuity premiums
Accident and health premiums
Other premiums
Contract holder fees
Net investment income
Net realized gains (losses) on investments and other
Total premiums and other revenues

601
540
1,141
1,729
.52
.98

See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY
Statements of Comprehensive Income (Loss)
Years Ended December 31, 20X2 and 20X1
(Amounts in Thousands)
Net Income
Other comprehensive income (loss)
Total comprehensive income (loss)

20X2
$ 2,254
8,690
$10,944

20X1
$ 1,729
(1,730)
$
(1)

See Note 5 to the financial statements for information about other comprehensive income (loss).
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ABC LIFE INSURANCE COMPANY
Statement of Changes in Shareholders’ Equity
Years Ended December 31, 20X2 and 20X1
(Amounts in Thousands)
Accumulated
Other
Comprehensive
Income (Loss)

Total
Shareholders’
Equity

Capital
Stock

Retained
Earnings

$6,683
—
—
—

$57,068
1,729
(3,275)
—

$(1,521)
—
—
(1,730)

$62,230
1,729
(3,275)
(1,730)

Balance at December 31, 20X1
Net income for 20X2
Other comprehensive income

6,683
—
—

55,522
2,254
—

(3,251)
—
8,690

58,954
2,254
8,690

Balance at December 31, 20X2

$6,683

$57,776

Balance at January 1, 20X1
Net income for 20X1
Shareholders’ dividends
Other comprehensive income (loss)

$ 5,439

$69,898

See accompanying notes to financial statements.
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ABC LIFE INSURANCE COMPANY
Statements of Cash Flows
Years Ended December 31, 20X2 and 20X1
(Amounts in Thousands)
20X2
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net
cash provided by operating activities:
Interest credited to universal life policies
Accrual of discount on investments, net
Net realized (gains) losses on investments
Depreciation and amortization
Amortization of deferred policy acquisition costs
Deferred federal income taxes
Change in operating assets and liabilities:
Accrued investment income
Capitalization of deferred policy acquisition costs
Policy liabilities
Other items, net
Net cash provided by operating activities
Cash flows from investing activities:
Cost of investments purchased:
Fixed maturities and equity securities
Mortgage loans and real estate
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities
Mortgage loans and real estate
Policy loans, net
Short-term investments, net
Net cash provided by investing activities

$

2,254

20X1
$

1,729

7,927
(976)
(4,222)
3,041
1,276
(2,538)

10,445
(1,328)
2,670
3,534
1,305
540

1,366
(3,783)
(3,440)
(644)
261

880
(6,645)
(16,234)
3,269
165

(228,053)
(921)

(122,495)
—

206,051
27,970
2,320
409
7,776

95,177
18,621
6,468
15,446
13,217

—

(3,275)

Cash flows from financing activities:
Dividends to shareholders
Receipts from universal life policies credited to
contract holder account balances
Return of contract holder account balances on
universal life policies
Withdrawals from interest-sensitive contracts
Cash used in financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

(4,165)
(3,718)
(9,848)
(13,046)
(6,095)
(11,674)
1,942
1,708
3,343
1,635
$ 5,285 $ 3,343

Supplemental cash flow information:
Income taxes paid

$

See accompanying notes to financial statements.
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.14

ABC LIFE INSURANCE COMPANY
Notes to Financial Statements
Years Ended December 31, 20X2 and 20X1
Note 1: Organization and Significant Accounting Policies
Organization. ABC Life Insurance Company (ABC or the Company) is a stock life insurance
company incorporated in the state of ABC that offers individual life, disability income, long-term
care, annuity, and investment products. ABC does business in the continental United States, with
a concentration in New York, New Jersey, and Connecticut.
Basis of presentation. The significant accounting policies followed by ABC that materially affect
financial reporting are summarized below. The accompanying financial statements have been
prepared in accordance with generally accepted accounting principles (GAAP) that differ from
statutory accounting practices (SAP) used for regulatory authorities. The preparation of the
financial statements in conformity with GAAP requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from those estimates.
Investments. Fixed maturity securities available for sale consist of bonds, notes, and redeemable
and nonredeemable preferred stock not classified as either trading or held to maturity, and are
reported at estimated fair value. Unrealized holding gains and losses, net of tax, on available-forsale securities are reported as a net amount in other comprehensive income. Deferred policy
acquisition cost offsets for universal life type contracts and amounts attributable to certain
participating contracts are recorded as a separate component of accumulated other comprehensive income. Fixed maturity securities held to maturity consist of bonds, notes, redeemable and
nonredeemable preferred stock which the insurance company has the intent and ability to hold
to maturity, and are reported at amortized cost and adjusted for amortization of premium or
discount. Declines in fair value of individual held-to-maturity and available-for-sale securities
below their cost that are other then temporary have resulted in write-downs of the individual
securities to their fair value. The related write-downs have been included in earnings as realized
losses. Trading account securities consist of bonds, notes, and redeemable and nonredeemable
preferred stock, and common stock held principally for resale in the near term, and are recorded
at their estimated fair values. Realized and unrealized gains and losses on trading account
securities are included in other income.
Mortgage loans on real estate are carried at unpaid balances and are adjusted for amortization of
premium or discount, less allowance for losses. Real estate held for sale is carried at the lower of
depreciated cost or fair value less estimated selling costs. Real estate classified as held-for-sale is
no longer depreciated. Real estate, including real estate acquired in satisfaction of debt, is carried
at depreciated cost. Impaired real estate is written down to fair value with the impairment loss
being included in net realized gains (losses) on investments and other. Upon foreclosure (including in-substance foreclosure), the carrying value of the property is recorded at the lower of cost
or fair value (less selling costs if to be sold), which becomes its new cost basis. The estimated fair
value for real estate is determined based upon independent appraisals and other available
information about the property, which may take into consideration a number of factors, including:
(i) discounted cash flows (ii) sales of comparable properties (iii) geographic location of property
and related market conditions (iv) disposition costs.
Foreclosed properties are actively managed by the company in order to maximize their value.
Subsequent to foreclosure, the carrying value of the property is periodically evaluated and a
valuation allowance is established, if necessary, to reflect any additional amounts considered
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unrecoverable upon sale. At the time of the sale, the difference between the sales price and the
carrying value is recorded as a realized gain or loss. Policy loans are carried at unpaid balances.
Short-term investments are stated at amortized cost, which approximates fair value.
Provisions for impairments of securities classified as held to maturity are included in net realized
gains (losses) on investments and other. Realized gains and losses are determined by specific
identification.
Cash and cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Cash
equivalents are highly liquid financial instruments with an original maturity of three months or less.
Deferred policy acquisition costs. Commissions and other costs of acquiring traditional life insurance, universal life insurance and investment products, and accident and health insurance, that
vary with and are primarily related to the production of new and renewal business, have been
deferred. Traditional life insurance and accident and health insurance acquisition costs are being
amortized over the premium-paying period of the related policies using assumptions consistent
with those used in computing future policy benefit liabilities. For universal life-type contracts and
investment contracts that include significant surrender charges or that yield significant revenues
from sources other than the investment of contract holders’ funds, the deferred contract acquisition cost amortization is matched to the recognition of gross profit.
Otherwise, deferred contract acquisition costs on investment contracts are amortized using an
accounting method that recognizes acquisition costs as expenses at a constant rate applied to net
policy liabilities. The effect on the deferred acquisition costs (DAC) asset that would result from
realization of unrealized gains (losses) is recognized with an offset to accumulated other comprehensive income in consolidated shareholders’ equity as of the balance sheet date.
In September 2005, the Accounting Standards Executive Committee (AcSEC) issued Statement of
Position (SOP) 05-1, Accounting by Insurance Enterprises for Deferred Acquisition Costs in Connection
With Modifications or Exchanges of Insurance Contracts (AICPA, Technical Practice Aids, ACC sec.
10,920). SOP 05-1 provides guidance on accounting by insurance enterprises for deferred acquisition costs on internal replacements of insurance and investment contracts other than those
specifically described in SFAS 97, Accounting and Reporting by Insurance Enterprises for Certain
Long-Duration Contracts and for Realized Gains and Losses from the Sale of Investments. SOP 05-1
defines an internal replacement as a modification in product benefits, features, rights, or coverages
that occurs by the exchange of a contract for a new contract, or by amendment, endorsement, or
rider to a contract, or by the election of a feature or coverage within a contract. SOP 05-1 is effective
for internal replacements occurring in fiscal years beginning after December 15, 2006, with earlier
adoption encouraged. In reporting disclosures about the accounting policy on internal replacements, entities should comply primarily with the requirements of paragraph 28 of SOP 05-1, and
describe the accounting policy applied to internal replacements.
Deferred sales inducements. Costs related to sales inducements offered on sales to new customers,
principally on investment contracts and primarily in the form of additional credits to the
customer’s account value or enhancements to interest credited for a specified period, which are
beyond amounts currently being credited to existing contracts, are deferred and recorded as other
assets. All other sales inducements are expensed as incurred and included in interest credited to
contract holders’ funds. Deferred sales inducements are amortized to income using the same
methodology and assumptions as deferred acquisition costs, and are included in interest credited
to contract holders’ funds. Deferred sales inducements are periodically reviewed for recoverability and written down when necessary.
Property and equipment. Property and equipment are reported at cost, net of accumulated depreciation of $1,915,000 and $1,721,000 in 20X2 and 20X1, respectively. Property and equipment are
depreciated using the straight-line method over their estimated useful lives.
Future policy benefits and expenses. The liabilities for traditional life insurance and accident and
health insurance contract benefits and expenses are computed using a net level premium method
including assumptions as to investment yields, mortality, withdrawals, and other assumptions
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based on ABC’s experience modified as necessary to reflect anticipated trends and to include
provisions for possible unfavorable deviations. Liability interest assumptions are graded and range
from 3 percent to 10 percent. Benefit liabilities for traditional life insurance contracts include certain
deferred profits on limited-payment policies that are being recognized in income over the contract
term. Contract benefit claims are charged to expense in the period that the claims are incurred.
The accrued account balance for nontraditional life insurance and investment contracts is computed
as deposits net of withdrawals made by the contract holder, plus amounts credited based on contract
specifications, less contract fees and charges assessed, plus any additional interest. Interest crediting
rates for universal life and investment products range from 5.50 percent to 9.25 percent.
Included in contract holders’ account balances is a provision for contract holder dividends. Benefit
liabilities for contract holders’ account balances are computed under a retrospective deposit
method and represent contract account balances before applicable surrender charges. Contract
benefits and claims that are charged to expense include benefit claims incurred in the period in
excess of related contract account balances. Interest crediting rates for universal life and investment products range from 5.50 percent to 9.25 percent. Benefits and expenses are charged against
the account balance to recognize costs as incurred over the estimated lives of the contracts.
Expenses include interest credited to contract account balances and benefits paid in excess of
contract account balances.
Minimum Guarantees. The company issues variable annuity contracts through separate accounts
where the company contractually guarantees to the contract holder total deposits made to the contract
less any partial withdrawals plus a minimum return. This guarantee includes benefits that are payable
in the event of death, annuitization, or at specified dates during the accumulation period.
Accounting policy for health liabilities. Unpaid claims on accident and health policies represent the
estimated liability for benefit expenses both reported but not paid and incurred but not reported to
ABC through December 31. ABC does not discount its liabilities for unpaid claims. Liabilities for
unpaid claims are estimated using individual case-basis valuations and statistical analyses. Those
estimates are subject to the effects of trends in claim severity and frequency. Although considerable
variability is inherent in such estimates, management believes that the liabilities for unpaid claims are
adequate. The estimates are continually reviewed and adjusted as necessary as experience develops
or new information becomes known; such adjustments are included in current operations.
Income taxes. The Company uses the asset and liability method as identified in SFAS 109,
Accounting for Income Taxes. Federal income taxes are charged or credited to operations based upon
amounts estimated to be payable or recoverable as a result of taxable operations for the current
year. Deferred income taxes have been provided for temporary differences between the tax basis
of assets and liabilities and their reported amounts in the financial statements using enacted
income tax rates and laws.
Reinsurance. In the normal course of business, the Company seeks to limit its exposure to loss on
any single insured and to recover a portion of benefits paid by ceding reinsurance to other
insurance entities or reinsurers under excess coverage and coinsurance contracts. The Company
retains a maximum of $400,000 of coverage per individual life. Amounts paid or deemed to have
been paid for reinsurance contracts are recorded as reinsurance receivable.
Insurance premium revenues. Traditional life premiums, which include those products with fixed
and guaranteed premiums and benefits and consist principally of whole life insurance contracts,
limited-payment life insurance contracts, and certain annuities with life contingencies, are generally recognized as revenue when due. Revenues on universal life and investment-type contracts
consist of contract charges against contract holders’ funds for the cost of insurance,administration,
surrender charges, actuarial margin, and other fees. Accident and health insurance premiums are
recognized as revenue pro rata over the terms of the contracts.
Separate accounts. Separate account assets and liabilities generally represent funds maintained in
accounts to meet specific investment objectives of contract holders who bear the investment risk.
Investment income and investment gains and losses accrue directly to such contract holders. The
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assets supporting the variable portion of both traditional variable annuities and variable contracts
with guarantees are carried at fair value and reported as summary total separate account assets
with an equivalent summary total reported for liabilities. Amounts assessed against the contract
holders for mortality, administrative, and other services are included in revenue and changes in
liabilities for minimum guarantees are included in policyholder benefits in the Statement of
Operations. Separate account net investment income, net investment gains and losses, and the
related liability changes are offset within the same line item in the Statement of Operations.
Business risks and uncertainties. The development of liabilities for future policy benefits for the
Company’s products requires management to make estimates and assumptions regarding mortality, morbidity, lapse, expense, and investment experience. Such estimates are primarily based
on historical experience and future expectations of mortality, morbidity, expense, persistency,
and investment assumptions. Actual results could differ materially from those estimates. Management monitors actual experience and, if circumstances warrant, revises its assumptions and
the related future policy benefit estimates.
The Company’s investments are primarily comprised of fixed maturity securities, equity securities, real estate, and mortgage loans. Significant changes in prevailing interest rates and geographic conditions may adversely affect the timing and amount of cash flows on such investments
and their related values. In addition, the value of these investments is often derived from an
appraisal, an estimate or opinion of value. A significant decline in the fair value of these
investments could have an adverse effect on the Company’s balance sheet.
The Company regularly invests in mortgaged backed securities (MBS) and other securities
subject to prepayment and call risk. Significant changes in prevailing interest rates may adversely affect the timing and amount of cash flows on such securities. In addition, the amortization of market premium and accretion of market discount for MBS is based on historical
experience and estimates of future payment speeds on the underlying mortgage loans. Actual
prepayment speeds will differ from original estimates and may result in material adjustments to
amortization or accretion recorded in future periods.
Codification. The NAIC revised the Accounting Practices and Procedures Manual in a process
referred to as Codification. Codification became effective on January 1, 2001. The Company’s state
of domicile has adopted the provisions of the revised manual effective January 1, 2001. The revised
manual has changed to some extent, prescribed statutory accounting practices, and has resulted
in changes to the Company’s statutory-based financial statements. The cumulative effect of
changes in accounting principles adopted to conform to the revised Accounting Practices and
Procedures Manual of $____ has been reported as an adjustment to increase (decrease) surplus in
the Company’s statutory-based financial statements as of January 1, 2001.
Guaranty Funds. Guaranty fund (and other) assessments are accrued at the time the events occur
on which assessments are expected to be based.
Note 2: Earnings Per Common Share
Basic and diluted earnings per common share (EPS) are as follows.
(Thousands, except per
Income
Shares
common share data)
(Numerator) (Denominator)

Per Common
Share Amount

20X2
Net income
Income applicable to common ownership

2,254
2,254

3,342

.67

20X1
Net income
Income applicable to common ownership

1,729
1,729

3,342

.52
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Note 3: Investments
In reporting disclosures about investments in securities, entities should comply primarily with
the requirements of paragraphs 6, 17, and 19–22 of SFAS 115, Accounting for Certain Investments in
Debt and Equity Securities (as amended); paragraphs 17–18 of FSP FAS 115-1/124-1, The Meaning
of Other-Than-Temporary Impairment and Its Application to Certain Investments; paragraphs 47–48 of
SFAS 60, Accounting and Reporting by Insurance Enterprises (as amended); paragraphs 22–23, and
28 of SFAS 91, Accounting for Nonrefundable Fees and Costs Associated with Originating or Acquiring Loans
and Initial Direct Costs of Leases—an amendment of FASB Statements No. 13, 60, and 65 and a rescission
of FASB Statement No. 17 (as amended); and Appendix C of the Life and Health Insurance Entities
Audit and Accounting Guide. Other disclosure requirements may also be applicable.
Note 4: Fair Value of Financial Instruments
The following methods and assumptions were used to estimate the fair value of each class of
financial instruments for which it is practicable to estimate that value in conformity with SFAS
157, Fair Value Measurements, and SFAS 159, The Fair Value Option for Financial Assets and Financial
Liabilities—Including an amendment of FASB Statement No. 115.
Short-term investments. For those short-term instruments amortized cost is a reasonable estimate
of fair value.
Investment securities and trading account assets. For securities held for trading purposes and
marketable equity securities held for investment purposes, fair values are based on quoted market
prices or dealer quotes. For other securities held as investments, fair value equals quoted market
price, if available. If a quoted market price is not available, fair value is estimated using quoted
market prices for similar securities.
Mortgage loans on real estate and policy loans. The fair value of mortgage loans on real estate is
estimated using discounted cash flows. The fair value of policy loans is estimated by discounting
the future cash flows using reasonable assumptions for mortality and repayments and using the
current rates at which similar loans would be made to contract holders with similar credit ratings
and the same remaining maturities.
The estimated fair values of ABC’s mortgage loans on real estate and policy loans are as
follows.
20X2
20X1
(Amounts in thousands)
Carrying
Fair
Carrying
Fair
Amount
Value
Amount
Value

Mortgage loans on real estate
Policy loans

$79,258
43,549

$83,506
60,000

$106,692
51,013

$112,027
59,000

Note 5: Accumulated Other Comprehensive Income
Accumulated other comprehensive income (loss) represents cumulative gains and losses on
items that are not reflected in earnings. The balances and activity for the years 20X2 and 20X1 are
as follows.
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20X2
20X1
(Amounts in thousands)
Changes in net unrealized gains (losses) on investment securities:
Net unrealized gains (losses) arising during the period
Reclassification adjustment for gains (losses) included
in net earnings
Changes in net unrealized gains (losses) on investment securities
Adjustments for:
Policyholder liabilities, deferred acquisition costs and deferred
federal income taxes
Changes in net unrealized gains (losses) net of adjustments
Total other comprehensive income (loss)

$13,324

$(1,873)

46
13,370

(300)
(2,173)

(4,680)
8,690
$ 8,690

443
(1,730)
$(1,730)

Note 6: Income Taxes
Significant components for income tax expense attributable to continuing operations are as
follows.
20X2
20X1
(Amounts in thousands)
Current income tax expense
$ 1,547
$ 601
Deferred income tax (benefit) expense
(1,405)
540
Total income tax expense
$ 142
$1,141
Deferred income taxes reflect the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income
tax purposes. Significant components of the company’s deferred tax liabilities and assets are as
follows.
December 31,
December 31,
20X2
20X1
(Amounts in thousands)
Deferred tax liabilities:
Deferred policy acquisition costs
$13,131
$12,297
Future policy benefits
—
512
Accrual of discount on bonds
924
1,982
Other
3,641
1,024
Total deferred tax liabilities
17,696
15,815
Deferred tax assets:
Policyholder dividends
Future policy benefits
Deferred policy acquisition costs
Investment valuation allowance
Retirement plan accruals
Tax credits and loss carryforwards
Investment income differences
Other
Total deferred tax assets
Valuation allowance for deferred tax assets
Net deferred tax assets
Net deferred tax liabilities

8,067
851
2,078
1,087
1,917
1,820
574
406
16,800
(516)
16,284
$ 1,412

8,224
—
1,561
1,651
497
1,945
556
354
14,788
—
14,788
$ 1,027

A Valuation allowance has been established due to the uncertainty of realized certain tax credits
and loss carryforwards, and a portion of other deferred tax assets.
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A reconciliation of federal income tax expense as presented in the financial statements and income
taxes calculated using the statutory corporate tax rate follows.
20X2
20X1
(Amounts in thousands)
Income from operations
$2,396
$2,870
Application of income tax rate (35%)
Small company deduction for life insurance companies
Policyholders’ share of income (loss) in excess of (less than)
dividends paid
Dividend received deduction
Other
Total tax expense

838
(556)

1,005
(496)

(264)
(3)
127
$ 142

752
(50)
(70)
$1,141

Note 7: Concentration of Credit Risk
At December 31, 20X2, ABC held unrated or less-than-investment grade corporate debt securities
of $8,000,000, net of allowance for losses, with an aggregate market value of $7,500,000. Those
holdings amounted to 4 percent of ABC’s corporate debt securities investments and less than 2
percent of total assets. The holdings of less-than-investment grade securities are widely diversified and of satisfactory quality based on ABC’s investment policies and credit standards. ABC
also invests in mortgage loans principally involving commercial real estate. At December 31, 20X2,
3 percent of such mortgages ($2,000,000) involved properties located in California and Arizona.
Such investments consist of first mortgage liens on completed income-producing properties, and
mortgages on individual properties do not exceed $300,000.
Note 8: Liability for Unpaid Claims and Claim Adjustment Expenses
The liability for unpaid claims and claim adjustment expenses is based on the estimated amount
payable on claims reported prior to the balance sheet date that have not yet been settled, claims
reported subsequent to the balance sheet date that have been incurred during the period then
ended, and an estimate (based on prior experience) of incurred but unreported claims relating to
such period.
Activity in the liability for unpaid claims and claim adjustment expenses for the Company’s health
and disability coverages is summarized as follows.

Balance, beginning of year
Less: reinsurance recoverables
Net balance, beginning of year
Amount incurred, related to
Prior years
Current year
Total
Amount paid, related to
Prior years
Current year
Total
Net balance, end of year
Plus: reinsurance recoverables
Balance, end of year
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(Amounts in thousands)
$ 4,737
$ 7,669
296
1,018
4,441
6,651
$

(297)
26,197
25,900

6,923
18,303
25,226
5,115
303
$ 5,418

$

313
25,671
25,984

8,937
19,257
28,194
4,441
296
$ 4,737
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As a result of changes in estimates of insured events in prior years, the claims and claim
adjustment expenses (net of reinsurance recoveries of $(7,000) and $722,000 in 20X2 and 20X1,
respectively) decreased by $297,000 in 20X2 reflecting lower-than-anticipated losses on
, and increased by $313,000 in 20X1 reflecting higher-than-anticipated losses and
related expenses for claims for
.
Note 9: Minimum Guarantees
The following summarizes the liabilities for guarantees on variable contracts reflected in the
general account:

Balance at January 1
Incurred guarantee
benefits2
Paid guarantee
benefits
Balance at
December 31, 20XX3

Minimum
Guaranteed Death
Benefit (MGDB)

Guaranteed
Minimum
Accumulation
Benefit (GMAB)

Guaranteed
Minimum Income
Benefit (GMIB)

Totals

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

$X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

$X,XXX,XXX

12

The minimum guaranteed death benefit (MGDB) liability is established equal to a benefit ratio
multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit
payments. The benefit ratio is calculated as the estimated present value of all expected contract
benefits divided by the present value of all expected contract charges. The Company regularly
evaluates estimates used and adjusts the additional liability balance, with a related charge or
credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions
should be revised.
The following assumptions and methodology were used to determine the MGDB liability at
December 31, 20XX:

•

Data used was 1,000 stochastically generated investment performance scenarios.

•

Mean investment performance assumption was XX.

•

Volatility assumption was XX.

•

Mortality was assumed to be 90 percent of the Annuity 2000 table.

•

Lapse rates vary by contract type and duration and range from 1 percent to 20 percent,
with an average of 3 percent.

•

Discount rate was XX percent.

Guaranteed minimum accumulation benefits are considered to be derivatives under SFAS 133,
and are recognized at fair value through earnings.
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For guaranteed minimum accumulation benefits, incurred guarantee benefits incorporates all changes in fair value other than
amounts resulting from paid guarantee benefits.
2

3
Included in the total reserve balance are reserves for variable annuity death benefits of $_____, variable annuity income benefits of
$_______ and other guarantees of $______.
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The guaranteed minimum income benefit (GMIB) liability is established equal to a benefit
ratio multiplied by the cumulative contract charges earned, plus accrued interest less contract
benefit payments. The benefit ratio is calculated as the estimated present value of all expected
contract benefits divided by the present value of all expected contract charges. The Company
regularly evaluates estimates used and adjusts the additional liability balance, with a related
charge or credit to benefit expense, if actual experience or other evidence suggests that earlier
assumptions should be revised. The assumptions used for calculating the GMIB liability at
December 31, 20XX, are consistent with those used for calculating the MGDB liability.
[Underlying assumptions for the liability related to income benefits include assumed future
annuitization elections based on factors such as the extent of benefit to the potential annuitant,
eligibility conditions and the annuitant’s attained age.] In addition, the calculation of the
GMIB liability assumes X percent of the potential annuitizations that would be beneficial to
the contract holder will be elected.
Note 10: Reinsurance
The Company utilizes indemnity reinsurance agreements to reduce its exposure to large losses
in all aspects of its insurance business. Such reinsurance permits recovery of a portion of losses
from reinsurers, although it does not discharge the primary liability of the Company as direct
insurer of the risks reinsured. The Company evaluates the financial strength of potential reinsurers and continually monitors the financial condition of reinsurers. The following tables include
premium amounts ceded/assumed to/from other companies.
Direct
Amount

Ceded to
Assumed from
Other Companies
Other Companies
(Amounts in thousands)

Net
Amount

20X2
Premiums:
Life insurance
Accident and health
Annuities
Total earned premiums

$2,090
1,440
3,130

$ 560
1,290
—

$3,330
—
70

$4,860
150
3,200

$6,660

$1,850

$3,400

$8,210

$2,080
1,510
1,840

$ 520
1,370
—

$3,680
—
30

$5,240
140
1,870

$5,430

$1,890

$3,710

$7,250

20X1
Premiums:
Life insurance
Accident and health
Annuities
Total earned premiums

Note 11: Separate Accounts
At December 31, 20X1 and 20X2, the company had the following variable contracts with guarantees. The Company’s variable annuity contracts may offer more than one type of guarantee in
each contract; therefore, the sum of amounts listed exceeds the total account balances of variable
annuity contracts’ separate accounts with guarantees.
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Return of net deposits plus a minimum return:1263
In the event of death
Account value

$XXX

$XXX

Net amount at risk4

$XXX

$XXX

XX

XX

X-X%

X-X%

Average attained age of contract holders
Range of guaranteed minimum return rates
At annuitization
Account value
Net amount at risk

5

Weighted average period remaining until expected annuitization
Range of guaranteed minimum return rates

$XXX

$XXX

$XXX

$XXX

XX

XX

X-X%

X-X%

Accumulation at specified date
Account value
Net amount at risk

6

Range of guaranteed minimum return rates

$XXX

$XXX

$XXX

$XXX

X-X%

X-X%

Account balances of contracts with guarantees were invested in variable separate accounts as
follows:
Asset Type
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
Obligations of states of the United States and
political subdivisions of the states

December 31, 20X1

December 31, 20X2

$

$

$X,XXX,XXX

$X,XXX,XXX

Corporate debt securities:
—Investment grade
—Noninvestment grade
Foreign debt securities
Mortgage-backed securities
Equity securities (including mutual funds)7
Real estate
Mortgage loans
Derivative financial instruments
Cash and cash equivalents
Total
4

Assets transferred from the general account to the separate accounts are recognized at fair value
to the extent of third-party contract holders’ proportionate interest in separate accounts when the
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Defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.

2

5
Defined as the present value of the minimum guaranteed annuity payments determined in accordance with the terms of the
contract in excess of the current account balance.
3

4

6

Defined as the present value of the guaranteed minimum accumulation balance in excess of the current account balance.

7

The insurance enterprise may want to consider disclosing mutual funds by investment objective or other meaningful groupings
that are useful in understanding the nature of the guarantee risk.
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arrangement meets applicable criteria (paragraph 11 of SOP 03-1, Accounting and Reporting by
Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts
(AICPA, Technical Practice Aids, ACC sec. 10,870). The gains recognized assets transferred to the
separate accounts during 20X2 and 20X1 were XX,XXX and XX,XXX, respectively.
Note 12: Guaranty Fund Assessments
At December 31, 20X2 and 20X1, ABC has recorded $45,000 and $67,000, respectively, in liabilities
related to guaranty fund (and other) assessments which are included in other liabilities in the
balance sheet. At December 31, 20X2 and 20X1, the carried liability was reduced by recoverables
for related premium tax offsets and policy surcharges in the amount of $25,000 and $35,000,
respectively. The period over which the assessments are expected to be paid and the recorded
premium tax offsets and policy surcharges are expected to be realized is up to five and four years,
respectively.
Note 13: Statutory Financial Information
Under the law of ABC State, the state of incorporation, the maximum dividend that may be paid
(without prior approval of the (ABC State) Insurance Department), in any twelve-month period
is the greater of (a) net investment income for the preceding calendar year or (b) 10 percent of
contract holders’ surplus at the end of the preceding calendar year. In general, net investment
income for dividend purposes is interpreted by the Insurance Department to be the statutory
pretax net investment income including net realized capital losses but excluding net realized
capital gains. The maximum permissible amount of dividends for 20X3, based on statutory net
investment income for 20X2, is $20,000.
The Company, which is domiciled in ABC State, prepares its statutory financial statements in
accordance with accounting principles and practices prescribed or permitted by the ABC state
insurance department, which (state of domicile) recognizes for determining solvency under the
(state of domicile) Insurance Law. The commissioner of the state of domicile Insurance Department has the right to permit other practices that may deviate from prescribed practices. Prescribed
SAP are those practices that are incorporated directly or by reference in state laws, regulations,
and general administrative rules applicable to all insurance enterprises domiciled in (state of
domicile). Permitted SAP encompass all accounting practices that are not prescribed; such
practices differ from state to state, may differ from company to company within a state, and may
change in the future.
Note: Although the following reconciliation to statutory financial information is not required to
be disclosed in financial statements prepared in conformity with GAAP, insurance entities
sometimes include such disclosures to facilitate use of those financial statements for purposes of
filing with state regulatory authorities. The second disclosure on variances from NAIC SAP (as
defined below) and permitted accounting practices is required under SOP 94-5, Disclosures of
Certain Matters in the Financial Statements of Insurance Enterprises (AICPA, Technical Practice Aids,
ACC sec. 10,630), as amended by SOP 01-5, Amendments to Specific AICPA Pronouncements for
Changes Related to the NAIC Codification (AICPA, Technical Practice Aids, ACC sec. 10,840).
The following reconciles ABC’s statutory net income and statutory surplus and capital stock
determined in accordance with accounting practices prescribed or permitted by the Insurance
Department of Connecticut with net earnings (loss) and equity on a GAAP basis.
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20X2

20X1

(Amounts in thousands)
Statutory net income
Adjustments:
Future policy benefits and policyholders’ account balances
Deferred policy acquisition costs
Deferred federal income tax (expense) benefit
Valuation of investments
Postretirement benefits
Other, net

$ 3,572

GAAP net income

$ 2,254

$ 1,729

Statutory surplus and capital stock
Asset valuation reserves
Statutory surplus, capital stock and asset valuation reserves

$65,388
(1,054)
(875)

$54,505
(1,972)
(967)

Adjustments:
Fixed income securities
Future policy benefits and policyholders’ account balances
Deferred federal income taxes
Valuation of investments
Deferred policy acquisition costs
Postretirement benefits
Other, net

(29,472)
115
(1,412)
772
38,936
(2,272)
(228)

(27,905)
270
(1,027)
891
36,429
(2,354)
1,084

GAAP equity

$69,898

$58,954

572
60
(1,405)
115
272
(932)

$ 2,719
894
40
540
270
354
(3,088)

The Company’s statutory financial statements are presented on the basis of accounting practices
prescribed or permitted by the [state of domicile] Insurance Department. [State of domicile] has
adopted the NAIC Accounting Practices and Procedures Manual as the basis of its statutory accounting practices (NAIC SAP), except that it has retained the prescribed practice of writing off goodwill
immediately to statutory surplus in the year of acquisition.
In addition, the commissioner of [state of domicile] Insurance Department has the right to permit
other specific practices that may deviate from prescribed practices. The commissioner has
permitted the Company to record its home office property at estimated fair value instead of at
depreciated cost, as required by NAIC SAP. This accounting practice increased statutory capital
and surplus by $X million and $X million at December 31, 20X2 and 20X1, respectively, over what
it would have been had the permitted practice not been allowed. The Company’s statutory capital
and surplus, including the effects of the permitted practice, was $X million and $X million at
December 31, 20X2 and 20X1, respectively.
Had the Company amortized its goodwill over ten years and recorded its home office property
at depreciated cost, in accordance with NAIC SAP, the Company’s capital and surplus would
have been $X million and $X million at December 31, 20X2 and 20X1, respectively.
Note 14: Commitments and Contingencies
Future minimum rental payments, principally for administrative offices, under noncancellable
operating leases at December 31, 20X2, are: 20X3, $1,113,000; 20X4, $1,064,000; 20X5, $1,011,000;
20X6, $976,000; 20X7, $976,000; and $3,906,000 thereafter. Rental expense was $1,164,000 in 20X2
and $1,184,000 in 20X1.
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ABC is named as defendant in a number of legal actions arising primarily from claims made under
insurance contracts or in connection with previous reinsurance agreements. These actions have
been considered in establishing its contract benefit liability. Management and its legal counsel are
of the opinion that the settlement of these actions will not have a material effect on ABC’s financial
position or results of operations.
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Comment Letter
We welcome any comments and suggestions you have regarding this Checklist. Please send this
completed form to: AICPA Accounting and Auditing Publications Team, 220 Leigh Farm Road,
Durham, NC 27707. Thank you.
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